Wikipedia:Arbitration/Requests/Case/Medicine/Evidence

From Wikipedia, the free encyclopedia
Main case page (Talk) — Evidence (Talk) — Workshop (Talk) — Proposed decision (Talk)

Case clerks: Dreamy Jazz (Talk) & Guerillero (Talk) Drafting arbitrators: Bradv (Talk) & David Fuchs (Talk) & Maxim (Talk)

Evidence presented by SandyGeorgia[edit]

WPMED tension is long-standing[edit]

The WPMED dispute erupted after the drug pricing RFC, but the tension has involved broader issues since at least 2012.

Wiki Project Med Foundation (WPMEDF) is a Wikimedia thematic organization and an advocacy organization with its own governing board and projects, aims, applications and interests, based upon Wikipedia content. It was started in 2012 by, among others, Doc James and Bluerasberry. WPMEDF requires an email address renewal every two years and has "frequent, ongoing internal communications via email". Members must assert when re-applying biannually that they support the WPMEDF (advocacy) mission. The overall mission of WPMEDF aligns with the principles of the Wikimedia movement but implementation aspects of WPMEDF projects and collaborations has not always aligned with the principles, policies and goals of English Wikipedia. As examples, the content on Wikipedia should be freely and easily created and can be edited online by anyone (for example, the Osmosis videos), the lead of an article should be a summary of its most important contents, and Wikipedia is not a sales catalog. Methods used in implementation of external projects—such as internet-in-a-box, translation task force, journal collaboration, and others—have created the appearance of conflicts of interest as well as conflict with the wider community.

For example, one of WPMEDF's Projects is an ... effort to get academic credit for contributing to Wikipedia. This desire for publication can put WPMEDF editors in conflict with overall aims of an encyclopedia anyone can edit, lend a motivation to semi-protect articles unnecessarily to assure minimal change in content, a motivation to edit war, and de-motivation to keep articles updated once preferred versions have been "set" in content review processes.

These issues have placed some WPMEDF members in tension with WP:MED founding members, many of whom were responsible for initially crafting the guideline pages for the Medicine Project, WP:MEDRS and WP:MEDMOS, who coincidentally are almost all Featured article writers. Longtime productive WPMED members have been alienated by seeing the MEDMOS guideline applied as if it were policy when that suits WPMEDF goals, while Wikipedia policy is ignored as if were guideline when that suits WPMEDF goals (for example, WP:NOT on drug pricing).

Current and former officers and advisers of WPMEDF include, but are not limited to:

  1. User:Avicenno membership
  2. User:Bluerasberry, secretary
  3. User:CFCF
  4. User:Doc James, founding member & co-treasurer
  5. User:FloNight
  6. User:JenOttawa
  7. User:RexxS, chair

Some WPMEDF members have expressed conflicts of interest[edit]

The WPMEDF project to journal publish has led to conflicts of interest. Bluerasberry posted this study for discussion at WT:MED, where a potential conflict is seen: the article assessments being measured are often done by WPMEDF members who may support article assessments without reason, (Dyxlexia GA) or semi-protect the preferred version for purposes of publications (Excessive semi-protection).

is "interested in working with us" (in the context of other WPMEDF collaborations).

Five areas of fait accompli[edit]

The fundamental conflict has arisen not with the goals of WPMEDF or the apps and projects themselves, but in concerns about the accuracy of the medical content being pushed out via these apps, and the methods used to achieve these broad changes (which at times have been shown to compromise the integrity of English Wikipedia content). While the goals of spreading medical information to Lower and Middle Income Countries (LMIC) are laudable, concerns are that content spread to them should be accurate, timely and policy-compliant. The Osmosis videos, for example, had numerous errors, and could not be edited by anyone, and Wikipedia was used to further the commercial interests of a third party, rather than a community project that anyone could edit, yet were forced into the first sections of articles. Other examples on this Evidence page show that content on the English Wikipedia has been negatively impacted: that is the essence of the conflict.

  • WPMED focus has shifted away from making sure the English Wikipedia has the best, most timely and most accurate medical information, to instead pushing information out the door via apps even when that information is shown dated or inaccurate. More focus on external apps has meant less focus on accuracy in overall content, and alienation of experienced editors.
  • Similarly, disregard for accuracy and verifiability was shown when Osmosis videos were forced into articles-- even leads where Featured article writers had carefully curated the content for over a decade, only to find inaccurate and dated information added via videos that can't be edited
  • The fait accompli was accomplished in each case with methods that at times appeared "stealth" or without regard for consensus-building, with poor use of edit summaries, edit warring, indications of tag-teaming, and with intimidation and accusations aimed at those who are critical of these approaches or who speak up about the problems.

Long-standing editors, concerned about the impact on English Wikipedia medical content have ended up a) retreating from medical editing, or b) on the receiving end of blunderbuss and bad-faith accusations when they speak up, and c) accused of "bludgeoning" because they fully engage dispute resolution, with policy-based reasoning, rather than by simply reverting their peers.

There have been broadly five areas of conflict, dating many years, in which one (occasionally two) editors—often editing too fast, rarely engaging talk (see Editcountitis section) and in topics where they are not experts—have installed controversial changes and personal preferences across hundreds to thousands of articles, and not always with full disclosure to other WPMED participants.

  1. Re-ordering of sections of every medical article to a set order, although the MEDMOS list is explicitly only a suggestion for writing new articles or substantially rewriting existing articles. MEDMOS says:

    The following lists of suggested sections are intended to help structure a new article or when an existing article requires a substantial rewrite. Changing an established article simply to fit these guidelines might not be welcomed by other editors. The given order of sections is also encouraged but may be varied, particularly if that helps your article progressively develop concepts and avoid repetition.

  2. Re-ordering the narrative of the lead in medical articles, although the accuracy and flow may be disrupted. Every condition/disease is different. But James re-ordered the leads of hundreds of articles and THEN inserted wording into MEDMOS to reflect HIS practice. Fait accompli, reflected recently in this discussion during the March 3 mainpage appearance of Tourette syndrome.
  3. Altering language in the leads of hundreds of articles according to James' personal notions of what words are more easily translated or that he finds difficult.
  4. Adding Osmosis videos to the first section of hundreds of articles (not to External links), amid concerns of COI and commercial motive, often with no edit summaries
  5. Adding drug prices to leads, with concerns about deficits in core policies of verifiability, original research, weight, NOPRICE and the lead guideline (and to be used in the same leads tailored for apps). Evidence of the fait accompli provided in other Evidence on the page.
    Note, while he is adding drug prices to leads only, James has acknowledged at another article that "the lead should not contain content not also in the body of the article."

Adding VideoWiki vidoes (an evolving conflict): with demonstrated inaccuracies, and still hard to edit, these videos are being inserted into leads of articles (rather than as External links). The quality is still problematic, details are still being worked out, and yet they have been inserted into a couple dozen articles already. (See WTMED archive) This is the same pattern seen in the other five instances.

Bluerasberry[edit]

Bluerasberry advocates for drug price inclusion against policy[edit]

Advocacy is the use of Wikipedia to promote personal beliefs or agendas at the expense of Wikipedia's goals and core content policies, including verifiability and neutral point of view.

Bluerasberry (WPMEDF) has been a force behind advocacy for inserting prices into pharmaceutical articles, backed by James (WPMEDF), who inserted prices into more than 500 articles, before, during and after a 2016 RFC that found no consensus for an exception to WP:NOT policy. Bluerasberry holds that the NOT policy does not apply because it is 15 years old, and that there was a plan for drug pricing content (emphasis added): [2]

The plan has always been that this price information is a pilot, and after we discuss the multiple major social issues around managing this, then we plan for a next set of development processes which include tools, more collaboration, policy development, and better control over this content.

Bluerasberry inserts deceptive NOPRICE redirects[edit]

In 2019, it was discovered that Bluerasberry had altered redirects, away from NOT policy and to an essay he created, in which he asserted an inaccurate statement:

Bluerasberry canvasses at RFC[edit]

After a discussion about pinging the editors who had been reverted by James on drug price articles, Bluerasberry canvassed the Video Game Project.[4][5] Twenty-six editors editors who attempted to uphold policy were not pinged, while others were canvassed. Editors reverted were 7 student editors (now all gone), 6 IPs, and 13 still-active editors, including Hipal/Ronz and Seraphimblade (who had weighed in on the RFC or formulation), @Pol098, Jorge Stolfi, Surtsicna, Gprobins, Jrfw51, Garzfoth, Pol098, Zefr, D A Patriarche, David notMD, and Mparagas18: and others.

Bluerasberry alters talk posts to control the narrative[edit]

At the Talk:Simvastatin RFC, Bluerasberry:

CFCF[edit]

As all medical editors have a shared concern about the quality of medical content, tempers can flare, discussion can become heated, and some editors simmer up quickly (but then simmer down quickly as well), and we generally can go on to being able to work together and defend each other in spite of our disagreements. [6] [7] [8] [9] But I have had a different experience with CFCF.

CFCF casts aspersions and refuses to provide diffs[edit]

During the December 2019 ANI,

These diffless fabrications include (but are not limited to)
  1. "does not respect WP:BRD"
  2. "massive issues with WP:CIVILITY"
  3. "unclear editing goals (WP:NOTHERE)"
  4. "often coming to issues which he lacks knowledge of"
  5. "acting by changing tens or even hundreds of articles at once, totally ignoring consensus”
  6. “disruptive per WP:POINTY. His style of editing is a danger to any collaborative work on this encyclopedia.”

CFCF engages in battlegound intimidation with blunderbuss accusations[edit]

A few weeks later, at Wikipedia:Manual of Style/Medicine-related articles/RFC on lead guideline for medicine-related articles (the worst RFC ever formulated, thanks to moi), I experienced a similar blast of battleground behavioral accusations from CFCF, which I experienced as an attempt to intimidate. For launching an (admittedly malformed) RFC, and then trying to work towards consensus on talk (and we did achieve some consensus on talk), CFCF charges me with WP:Disruptive, WP:Gaming, WP:Deadhorse, [10] WP:bad faith, Wikipedia:Tendentious editing, and WP:ICANTHEARYOU. [11]

Barkeep49—adminning the WP:MEDMOS issues—did not see a problem in my actions.

In November 2019, CFCF stated: "Colin — You really seem clueless here ... someone who is in far too deep water."

CFCF fails to AGF[edit]

During the 2018 Osmosis video discussions, CFCF said to editor Clayoquot, "this has been discussed extensively before this seems like conspiratorial thinking on your part in order to justify this inane discussion".

Similar (labeling good-faith edits as "disruptive") was seen in edit summaries when CFCF restored some Osmosis videos that had been removed for failing verification: [12] [13] [14]

CFCF closes discussions he is involved in, alters posts of others and uses excess markup on talk to control the narrative[edit]

During the March 2018 Osmosis video WT:MED discussions: CFCF

  • closes and archives an ongoing discussion (with a misleading edit summary, "archival bug")
  • which SarahSV restores,
  • and Francis Schonken questions, and
  • SarahSV points out that CFCF has a COI as an officer of WPMEDF, as does James, and
  • TenOfAllTrades remarks: saying, "It is...problematic...that Doc James remains the current sole point of contact with Osmosis, and has taken upon himself the decision to terminate the collaboration with them. Bluntly, I have to ask—how did he assume the authority to estabish and terminate such relationships in the first place? While it is obvious from the ongoing RfC that the community objects strongly to the way that Wikipedia has been used as a marketing medium to build Osmosis' brand, and it is appropriate that we communicate that to Osmosis in no uncertain terms, it is also apparent that Doc James has not effectively assessed or understood the community's views over the last couple of years. Why is Doc James still holding himself out as Wikipedia's representative to Osmosis?"
  • While Clayoquot remarks that CFCF has given no evidence the videos were based on Wikipedia leads, in spite of multiple complaints, and
  • CFCF responds to his closing of the thread with, “I wanted to get rid of this shit-storm from this page”.

Again, on 9 December 2019, in an ongoing discussion, CFCF installed a new, second-level header that cut off my response from the section it was replying to and part of, and mischaracterized the dispute. I repaired and reminded CFCF. But the behavior persists:

On 28 March, following the 27 March close of the drug pricing RFC, Colin starts a discussion at WT:MED with a neutral heading, "RFC on pharmaceutical drug prices".

On 29 March

Over an entire day, while multiple editors were trying to discuss timing, interpretation and implementation of the RFC conclusions, a good deal of time was wasted on restoring sections as CFCF attempts to control the narrative.

Doc James[edit]

Conflicts of interest have impacted James' use of tools[edit]

Medical articles are often semi-protected—a practice that discourages editor recruitment and can result in outdated, inaccurate versions of articles. Leads only are maintained for the purposes of WPMEDF-inspired projects, with overall content stagnating. Medical Featured articles have seen once vibrant growth flatline since 2015 and fall out of date, as the focus of WPMED has moved towards off-en.Wikipedia projects and away from overall content improvement.

Semi-protection at times appears unnecessary. There seems to be a pattern that, once an article is promoted to GA or FA (or its contents "set" for the translation project or internet-in-a-box), the preferred version is imdefinitely semi-protected.

This over sized WPMEDF-project template was installed in the references section, pointing to an eight-year-old internal "peer review". Since that review would not hold up to WP:MEDDATE, it is surprising that medical editors would place it in the reference section, rather than External links.

James has a long-term history of edit warring[edit]

On July 14, 2009, James was restricted by Arbcom for editwarring. On July 25, 2009, he was blocked for 48 hours for editwarring in breach of that restriction. This is his only block for editwarring. His edit warring has never abated; some samples:

In a dispute with Ronz/Hipal,
04:01, September 19, 2019 James remarks "So basically we have one opinion in each direction"
01:03, September 27, 2019 Ozzie appears to "agree w/ Doc James"
01:08, September 27, 2019 After four reverts by James, Ozzie reverts to James version
16:48, September 27, 2019 Ronz/Hipal undoes Ozzie's edit
17:50, September 29, 2019 James says, "Ronz the majority of people commenting here disagree with you,"
September 30, 2019 James reinserts price data in a series of edits.
Before Ozzie adds an "agree w/ Doc James" (providing no policy-based rationale), there was no consensus.
  • 2015: Significant edit warring, appearance by QuackGuru and Ozzie10aaaa, result is page protection
  • 2014: e-cigs again, with an appearance from QuackGuru, both warned
  • 2011: Although James editwarred, the other editor had more reverts than James, so page protected.

Case study: Schizophrenia, James editwars with senior editors and content experts[edit]

James and Ozzie10aaaa have installed a set order of sections in every medical article, even though MEDMOS says:

The following lists of suggested sections are intended to help structure a new article or when an existing article requires a substantial rewrite. Changing an established article simply to fit these guidelines might not be welcomed by other editors. The given order of sections is also encouraged but may be varied, particularly if that helps your article progressively develop concepts and avoid repetition.

Casliber is a practicing psychiatrist and prolific FA writer. I pinged him to the schizophrenia talk page in December 2019 because the article had fallen out of compliance with FA standards.

After Cas re-ordered the sections in the article to a narrative that he held better worked for the topic, James reverted in several edits without the courtesy of discussing with Cas. I reverted. James reverted again.

Yet another WPMED RFC is held, and found the suggested order of sections should not be altered, but a practicing psychiatrist and prolific FA writer surely knows how to structure an article on schizophrenia.

Case study: Down syndrome, edit war over an apostrophe[edit]

WPMEDF-inspired projects aim for standardizing the leads of English Wikipedia medical content in ways tailored to WPMEDF products, but not necessarily to Wikipedia guidelines.

I have followed Down syndrome intermittently since its 2006 WP:FAC and 2010 WP:FAR.

Diffs of extended edit war and first appearances by editors to dispute
01:39 20 February James initiates talk discussion
00:25 26 February, after considerable back and forth with both Jenny Jankel and Chaheel Riems disagreeing with James, Ozzie enters an "agree w/ Doc James".
This is Ozzie's first appearance at Down syndrome, except for a year earlier, when he installed the personal preference for order of sections—another ongoing area of conflict
13:52 26 February, Jenny Jenkel mentions the history between Ozzie and James
17:39 27 February, James responds, "we have a history of being the two most prolific medical editors on English Wikipedia"
Jenny observes the trend seen elsewhere, "If you could ever actually produce your own rationale, maybe that would help."
17A:49 29 February James (who misinterprets voting as consensus) notes three-to-two
07:56 4 March Chaheel Riens starts a proposal on talk
02:05 12 March, with three against his preference, James pings Ozzie
04:02 13 March Flyer22 Frozen appears to add a "per Doc James" support, in Flyer's first-ever appearance at Down syndrome
20:30 23 March having failed to gain consensus for his personal preference (even with Ozzie and Flyer support), James starts an "either-or", "mine or theirs" RFC
18:53 25 March, with three-to-two against James, CFCF supports James in CFCF's first-ever engagement with Down syndrome
00:38 28 March Flyer22 Frozen: with James failing to gain consensus agrees with James

James never had consensus, yet edit warred ten times to install a personal preference. When that failed, he started an RFC, and reinforcements who have either never before engaged the article or enter little reasoning to support their position, appear and support "per Doc James"; in this case, Ozzie, CFCF and Flyer22 Reborn.

Wikilawyering 1[edit]

At the Ethosuximide RFC, the closing admins had been pinged twice to clarify, but James interprets the RFC conclusion as applying to "numerical" prices only, and repings the admins for a third clarification after they had just been pinged by WhatamIdoing. Wugapodes responds: "I would encourage editors to read Wikipedia:The rules are principles and Wikipedia:Tendentious editing before trying to find more loopholes as my patience is growing thin." [21]

After Wugapodes clarified the RFC findings, James interspersed his own interpretation of that out of chronological order, and outdented it, creating the effect of highlighting his single interpretation and conclusion in the discussion.

Wikilawyering 2[edit]

WP:MEDLEAD has long been disputed. I started a December 2019 RFC on MEDLEAD, which was a well-and-good disaster, malformed by me, made worse by my attempts to fix it mid-stream—which I have many times acknowledged. I learned a lesson there from WhatamIdoing, who then asked WPMED editors to hold off on any more RFCs umtil the Drug pricing RFC concluded. Nonetheless, in spite of some blunderbuss by others at the MEDLEAD RFC, RexxS, Ian Furst and I achieved some compromise on talk.

After the inconclusive close of the MEDLEAD RFC, and during the drug pricing RFC, with pleas by WAID to hold off on further action, the talk page bot archived the dispute discussion on the MEDLEAD RFC. And yet, James removed the disputed tag from MEDLEAD, stating that there was no ongoing discussion. We subsequently made progress and seem to be at a position of some tentative consensus, but a more collegial approach would have been to un-archive the ongoing discussion, or raise the matter on talk; the dispute was clearly ongoing, but had been archived by the talk page bot.

Source to text issues[edit]

At times, it appears that James is editing too fast, and fails to grasp or fully engage issues of source-to-text integrity. This occurred several times during the formulation of the RFC, as we were searching for an example of otherwise-policy-compliant (V, WEIGHT, NPOV, OR) drug price text that could be presented in the RFC for the LEAD and NOT question. (We never could find an example.) In trying to sort through this, and understand how James had generated the price data in over 500 articles, it was never apparent that James was following the issue (one sample). This resulted in having to repeat things to James, which then leads to the "bludgeoning" charge.

Similar occurred at Talk:Pyrimethamine. I laid out multiple problems with source-to-text integrity and the correct use of sources (for example, press releases), but after extended discussion between James, Hipal/Ronz and myself, it is not clear that James ever understood the questions or issues, while Hipal and I both understood each other.

Similar occurred in the Dementia with Lewy bodies examples I described at the Lead restructuring section. In that example, James did not seem to be following the sourcing problem, and instead reverted to an old source to support his text.

I do not know if these issues occur because James edits too fast, or if he is just not accustomed to the kinds of sourcing issues that come up outside of MEDRS, with regular RS; I know that it can take a lot of typing to communicate with James, which puts the "bludgeon" charge in context.

James' conflicts of interest may impact his choice of sources[edit]

WP:MEDORG states that (emphasis mine):[22]

Guidelines and position statements provided by major medical and scientific organizations are important on Wikipedia because they present recommendations and opinions that many caregivers rely upon (or may even be legally obliged to follow). Guidelines by major medical and scientific organizations sometimes clash with one another (for example, the World Health Organization and American Heart Association on salt intake), which should be resolved in accordance with WP:WEIGHT. Guidelines do not always correspond to best evidence, but instead of omitting them, reference the scientific literature and explain how it may differ from the guidelines. ... Statements and information from reputable major medical and scientific bodies may be valuable encyclopedic sources. These bodies include the U.S. National Academies (including the National Academy of Medicine and the National Academy of Sciences), the British National Health Service, the U.S. National Institutes of Health and Centers for Disease Control and Prevention, and the World Health Organization. The reliability of these sources ranges from formal scientific reports, which can be the equal of the best reviews published in medical journals, through public guides and service announcements, which have the advantage of being freely readable, but are generally less authoritative than the underlying medical literature.

WP:MEDSCI states that (emphasis mine):[23]

Wikipedia policies on the neutral point of view and not publishing original research demand that we present prevailing medical or scientific consensus, which can be found in recent, authoritative review articles, in statements and practice guidelines issued by major professional medical or scientific societies (for example, the European Society of Cardiology or the Infectious Disease Society of America) and widely respected governmental and quasi-governmental health authorities (for example, AHRQ, USPSTF, NICE, and WHO), in textbooks, or in some forms of monographs. Although significant-minority views are welcome in Wikipedia, such views must be presented in the context of their acceptance by experts in the field. Additionally, the views of tiny minorities need not be reported. Finally, make readers aware of controversies that are stated in reliable sources. A well-referenced article will point to specific journal articles or specific theories proposed by specific researchers.

WPMEDF has a collaboration with WHO. James at times has shown a preference for using WHO (a WPMEDF partner) as a source rather than weighing all sources as encouraged by NPOV, and considering the underlying medical literature as more authoritative.

Sample
WHO at Hearing loss.
Note: Featured article Dengue fever also relies heavily on WHO, rather than the underlying literature. Overreliance on NIH sources (another partner) is discussed in the Lead structuring section on Dementia with Lewy bodies.
Sample
USPSTF at prostate cancer

Prostate cancer screening is a highly controversial topic, where content warrants careful exploration of what the literature and various scientific organizations and bodies support in their screening guidelines. In July 2015, James mentioned a possible collaboration with the USPSTF. In 2018, my husband was diagnosed with advanced prostate cancer and missed the opportunity for early detection--because his doctor followed the dated USPSTF guidelines-- when I discovered that all of Wikipedia's prostate-cancer-related articles were outdated. Following MEDSCI and MEDORG guidelines, and NPOV and DUE policies, I replaced text based on a dated 2012 source to reflect multiple position statements of various organizations updated to 2018. (The USPSTF had had to back off of their dated position, as it was shown to lead to increased cases of advanced prostate cancer.) Although I had provided policy and MEDRS-compliant and timely sources that reflect all POVs and positions held by various scientific and medical organizations, I was reverted by James. After very few edits to the articles, I voluntarily backed out of any further editing to that suite of articles because of my COI and personal involvement, even though my edits were correct and policy-compliant.

The entire suite of articles is preferencing the USPSTF view over others.

It is distasteful that, while most editors understood that I was upset after my husband was diagnosed with advanced cancer that could have been detected earlier, CFCF has chosen to introduce this two-year-old issue to evidence. This is an example of why I say my experience with CFCF is different than my experience with other medical editors, who sometimes simmer up, but then simmer down again quickly. It was particularly disturbing during that upsetting time that Jytdog threatened to have me topic banned even though I had already voluntarily stopped editing the suite of articles after very few edits.

The articles do not correctly reflect the body of literature nor the positions of all organizations even today, and that is what Wikipedia should do on a controversial topic. If this is how a knowledgeable, MEDRS-compliant, experienced editor’s sourced content is treated, imagine the treatment the average editor gets from medical editors. This is a serious issue on Wikipedia, where we should explore the topic rather than present one view only, and yet the messenger was shot and threatened with a topic ban, while we reflect generally one position only-- that of the USPSTF.

Ozzie10aaaa[edit]

Intersecting contribs Ozzie and Doc James[edit]

As demonstrated at Ivermectin, Simvastatin, and Down syndrome, Ozzie10aaaa frequently backs James in editwars and supports James in disputes on articles where Ozzie had never previously appeared, and without providing policy-based rationale. On Ozzie’s most common rationale, Wikipedia search engine reveals:

  • Concur w/Doc James [24]
  • Agree w/ Doc James [25]
  • Agree w/ DocJames [26]

Analysis of a small portion of James–Ozzie intersecting contribs is at User:SandyGeorgia/Editor interaction. James encounters a dispute on an article where OZ has never before engaged, Ozzie10aaaa is there quickly, not fully engaging, but "agreeing per Doc James" with rare exceptions. In the majority of instances, while James had a long history at each article, Ozzie had no prior engagement, and only appeared when James encountered conflict. Ozzie disagreed with James in two instances.

In other MEDMOS discussions, Ozzie similarly supports James without providing reasoning.[27]

Content from User:SandyGeorgia/Editor interaction, added Der Wohltemperierte Fuchs talk 14:12, 11 June 2020 (UTC)[reply]

Analysis of a small portion of James–Ozzie intersecting contribs

Ozzie10aaaa frequently and swiftly supports James in disputes on articles where Ozzie had never previously appeared, and without providing policy-based rationale. On Ozzie’s most common rationale, Wikipedia search engine reveals:

  • Concur w/Doc James [28]
  • Agree w/ Doc James [29]
  • Agree w/ DocJames [30]
A typical, recent example is here.

Looking at considerable specific instances of overlapping edits for talk pages only,

This analysis does not cover actual article edits by James reinforced by Ozzie reverts (also pointed out in other evidence), or instances, such as pointed out in James’ edit warring section, where Ozzie weighs in at AN3, or instances at ANI.

The pattern is, James encounters a dispute on an article where OZ has never before engaged, Ozzie10aaaa is in there quickly, not necessarily fully engaging, but “agreeing per Doc James” with rare exceptions. In the majority instances, while DJ had a long history at each article, OZ had no prior engagement, and only appears when DJ encounters conflict.
OZ disagreed with James in two instances.
Location Diffs Doc James
edit time
Ozzie10aaaa
edit time time
Ozzie10aaaa comment
following James comment
Nature of dispute Notes
Talk:Norepinephrine RFC [31] 15:43, 26 September 2015 16:37, 26 September 2015 seems reasonable [agreeing with James] Naming dispute OZ no prior article engagement
Talk:Onasemnogene abeparvovec [32] 12:56, 18 November 2019 12:57, 18 November 2019 agree w/Doc James Drug infobox and lead dispute OZ no prior article engagement
long editwarring dispute with Kashmiri
Talk:Testosterone [33] [34] 12:17, October 30, 2016 12:18, October 30, 2016 would support a split [agreeing with Doc James] article split OZ no prior article engagement, many editors engaged
Talk:Testosterone (2) [35] 20:23, 10 November 2016 20:57, November 10, 2016 first choice is better [agreeing with Doc James] order of lead OZ no prior article engagement
Talk:Presidency of Donald Trump [36] 10:44, 25 June 2018 10:58, 25 June 2018 any medically related claim should be of a higher standard(review, clearly this one is not[52]), however in this case...-- MEDRS neutrality dispute Atypical: OZ was there before DJ, in a broader Wikipedia RFC, and… enters a complete rationale for his !vote
Talk:Trypophobia [37] 00:02, 27 October 2018 10:27, 27 October 2018 keep in lede/do not collapse readers should get use to per[3] Lead image, Flyer22 Reborn OZ no prior article engagement; broad RFC, many editors opining had no article engagement
Talk:Autologous conditioned serum [38] 15:30, 30 September 2018 15:34, 30 September 2018 agree(and have edited accordingly) [agreeing with James in three instances in this dispute] WEIGHT dispute OZ no prior article engagement. No other editors engaged
Talk:Rape [39] 14:20, 6 December 2015 14:24, 6 December 2015 agree [with Doc James] Terminology dispute WT:MED alerted, Flyer22 Reborn
Talk:Atropine [40] 05:06, 21 August 2015 21:38, 22 August 2015 ‘’Atropine is a medication used to treat certain types of nerve agent and pesticide poisonings, some types of slow heart rate, and to decrease saliva production during surgery[‘’1], does work better for the common reader,the more specifics of this anticholinergic can be discussed in any section (appropriate section)later in the article itself. Lead OZ no prior article engagement, but many others engaged as well
Talk:2019–2020 vaping lung illness outbreak [41] 12:52, 29 December 2019 12:56, 29 December 2019 yes agree it would be good to split [agreeing with Doc James] Merge proposal, QuackGuru OZ no prior article engagement.
Seraphimblade, “This is the wrong venue. If you disagree with the close of an AfD, that's settled thataway” and challenges Quack Guru
Talk:Domestic violence against men [42] 21:32, 14 July 2015 20:28, 14 July 2015 the sources (indicated by Flyer22) must comply with Wikipedia:Identifying reliable sources (medicine) Content dispute with dubious attempt to apply MEDRS broadly ANI, the whole gang is in there. Flyer22 Reborn, Jytdog.
Talk:Suicide awareness [43] 19:49, 17 June 2019 20:24, 17 June 2019 agree w/ Doc James Content dispute OZ no prior article engagement
Talk:Schistosomiasis [44] 11:21, 10 January 2016 11:27, 10 January 2016 agree w/ DocJames Multiple instances on same page, lots of “muddled thinking” (WAID) OZ no prior article engagement; FloNight semi-protection
Talk:Tooth decay [45] 06:20, 7 November 2016 10:34, 7 November 2016 per the reason of Ryk72, the diagram could go elsewhere (the picture is far superior...IMO) Lead image OZ no prior article engagement, this instance shows Ozzie capable of forming an independent opinion
Talk:Stillbirth [46] 23:50, 27 November 2017 01:08, 28 November 2017 agree w/ Doc James Content dispute OZ no prior article engagement, but later does the controversial MEDMOS section order change
Talk:Bed bug [47] 00:14, 19 October 2018 00:25, 19 October 2018 agree w/ Doc James comment search for the term nearly all pages are mainly about the infestation Contested James move that was overturned, DJ and OZ were the only two arguing for the article name change OZ no prior article engagement
Talk:Clear liquids [48] 09:14, 28 August 2016 09:22, 28 August 2016 agree should be redirected to Liquid_diet#Clear Contested deletion OZ no prior article engagement, DJ and OZ are the only two participants
Talk:Vaginal yeast infection [49] 19:34, 11 May 2015 19:42, 11 May 2015 not convinced this is needed [Disagreeing with James] Requested move OZ no prior article engagement. Only one of two instances found where OZ disagrees with James
Talk:Akathisia [50] 20:14, 1 December 2018 22:13, 1 December 2018 agree w/ Doc James, it is a better source Sourcing OZ no prior article engagement
Talk:Ivermectin [51] 11:35, 8 September 2019 (UTC) 01:03, 27 September 2019 agree w/ Doc James, pricing should be included Drug pricing dispute OZ no prior article engagement. DJ conflict with Ronz over drug pricing, later Seraphimblade, later QuackGuru. Example of 4O Fait accompli, reasoning provided was that other drugs have prices
Talk:Study 329 [52] 18:23, 6 May 2015 18:32, 6 May 2015 i think DocJames is correct with the needed wording of the article...(BTW...i also believe the "further reading " section of the article needs better organization) Content dispute between Jytdog and Sarah OZ no prior article engagement
Talk:MDMA [53] 13:33, 2 April 2016 15:15, 2 April 2016 Support per reason given above [referring to James] [54]) James either-or RFC OZ no prior article engagement
Talk:Ménière's disease Multiple Various Oz only prior engagement to alter sections ordering [55] In this case, OZ actually engaged discussion on talk multiple times.
Talk:Pregabalin [56] 13:05, 23 October 2015 13:34, 23 October 2015 perhaps [7] ? Sourcing OZ no prior engagement at article. OZ suggests another source. DJ says “For pain I would not describe its onset as rapid. Its onset is over weeks. Half life is 5 to 7 hours for gabapentin while it is 6.3 hours for pregabalin. Hardly a difference.” WhatamIdoing points out to DJ that “Wikipedia isn't a guide for clinicians. ‘Not clinically important’ is not an excuse for blanking material that you know is accurate.”
Talk:Aneuploidy [57] 20:19, 28 April 2015 20:30, 28 April 2015 provides a source to back James’ position Lead OZ no prior article engagement. He later alters MEDMOS sections
Talk:Hearing loss [58] 19:06, 3 March 2016 19:17, 3 March 2016 WHO is a very good source [referencing James’ preferred source] Sourcing dispute OZ no prior article engagement. WhatamIdoing later points out the contradiction in James’ position (WHO is a preferred source of James) [59]
Talk:Aripiprazole [60] 11:04, 10 May 2019 11:22, 10 May 2019 agree w/ Doc James... [and repeats James’ words: Putting this mass of receptor details in the lead is not an improvement-} Lead dispute, where IP editor making the edits explains problems with James’ interpretations, James responds he can start an RFC, OZ appears. OZ no prior article engagement.
Talk:List of suicide crisis lines [61] 01:49, 8 May 2019 00:45, 8 May 2019 Disagrees with James Community-wide RFC, not a James-OZ only interaction OZ no prior article engagement.
Talk:Endometriosis [62] 14:40, 15 October 2018 14:52, 15 October 2018 agree w/ Doc James Content dispute, further reading (where, IMO James and OZ are wrong in deleting a book that is relevant to the topic) OZ no prior article engagement.
Talk:Alcoholism [63] 13:18, 16 May 2015 13:33, 16 May 2015 I concur with Doc James (repeating James’ wording just above) Hatnote dispute OZ no prior article engagement.
Talk:Corneotherapy n[64] 03:53, 26 February 2018 15:14, 26 February 2018 agree w/ Doc James Redirect OZ no prior article engagement.
Talk:Phimosis [65] 22:42, 15 June 2015 22:57, 15 June 2015 they are non-MEDRS compliant (in being dated, primary source,) [agreeing with James] Sourcing dispute OZ no prior article engagement.
Talk:Cysticercosis [66] 21:38, 4 June 2015 21:59, 4 June 2015 I think simpler language helps the general population,( complicated wording can be used later in the article) [Agreeing with James] Lead dispute A lead “dumbing down” dispute, [67]
Talk:Amphetamine [68] 12:52, 4 June 2015 13:09, 4 June 2015 concur with DocJames, logic indicates it should go under research section Content dispute OZ no prior article engagement.
Talk:Trigeminal neuralgia [69] 18:21, 11 December 2016 21:06, 11 December 2016 we don't Wikipedia:Advocacy(as Doc James pointed out) Content dispute (neither James nor Oz point out that these links can be added via Curlie) OZ no prior article engagement (did engage article during this dispute)
Talk:Tonsillectomy [70] 21:16, 11 February 2019 21:33, 11 February 2019 agree w/ Doc James, should use MEDRS Sourcing dispute OZ no prior article engagement
Talk:Pax Labs [71] 15:15, 16 May 2017 17:35, 16 May 2017 *support per proposers rationale [proposer being James] Merge/Notability dispute that degenerates in civility OZ no prior article engagement
Talk:Factitious disorder imposed on self [72] Requested move, by RexxS OZ no prior article engagement, pretty much everyone in agreement, but WhatamIdoing had to remind them all to behave
Talk:Chronic obstructive pulmonary disease [73] [74] multiple multiple agree, support Various OZ no prior article engagement, ever
Talk:Chronic prostatitis/chronic pelvic pain syndrome [75] 08:05, 9 March 2019 12:02, 9 March 2019 agree w/ Doc James on Meta/analysis Sourcing dispute, in which James is treating a good faith but fairly inexperienced user rather poorly, not explaining issues sufficiently, leading to an either-or RFC after much frustration where the user implores James to explain himself better.[76] Features James edit warring, while warning the other party for edit warring, [77] with OZ reverting to James’ position as well [78] RFC closed by Thyrdulff, other user is gone.

Case study in frustration: Chronic prostatitis/chronic pelvic pain syndrome, Ozzie10aaaa and James with an inexperienced user[edit]

At times, Ozzie appears unclear what he is reverting or why, or whether he has engaged and digested the discussion. At Talk:Chronic prostatitis/chronic pelvic pain syndrome in this discussion and this RFC a relatively inexperienced user, User:Thomas pow s, attempts to discuss with James. (It appears to have been a good faith discussion on Thomas' part, met with stonewalling, contradictory information, and Ozzie intervention.)

Article and talk interaction at Chronic prostatitis/chronic pelvic pain syndrome
  • 20:23, March 7, 2019 Thomas adds text cited to a dubious source.
  • 09:06, March 8, 2019 James reverts, edit summary, "source is poor"
  • 18:35, March 8, 2019 Thomas reverts, edit summary, "How is the source poor? One of the authors is a leading researcher in this area at Stanford. See talk."
23:21, March 8, 2019 Thomas starts talk discussion, saying the source is ... a reliable secondary source ... written by one of the leading researchers in this area at Stanford University [about] a major theory of CPPS causation which was scarcely mentioned in the page until now. ... There are other theories of causation in the article now [with] little or no academic support. If we delete this section, then the most prominent and well-supported theories of causation will be removed from the article when fringe or unsupported theories remain. The reliable sources policy appears to favor citing secondary sources, which is why I included that one. WP:MEDRS does not stipulate that the source must be a primary source.
  • 04:33, March 9, 2019 James reverts, moving to talk
04:35 March 9, 2019 James moves text to talk saying the book is not a medical textbook
  • 05:58, March 9, 2019 Thomas reverts
  • 06:06, March 9, 2019 James reverts
06:07, March 9, 2019 James responds with "you need to use proper sources and get consensus."
06:17, March 9, 2019 In a long post, Thomas points out that James has not answered his questions, again asks for clarification, and says the article is full of fringe theories.
06:29 March 9, 2019 James responds with, As the person who wishes to add the content in question, you need to come forwards with a decent reference. You have not done so. You have not even supplied sufficient details in the current reference to verify it.
06:33, March 9, 2019 James (with three reverts) warns Thomas about edit warring
06:34, March 9, 2019 James adds (without answering the questions) about sourcing, You need to use proper references per WP:MEDRS.
06:39 March 9, 2019 Thomas says let's take it one step at a time, trying to understand why the source is not reliable, and says that James is “offering flippant responses, while not responding at all to what was just said to you. If I included a bunch of primary sources as well, as per above, would that be acceptable to you?
08:06, March 9, 2019 Further discussion of the meta-analysis added, with James concluding "that source is much better".
10:02, March 9, 2019 Thomas asks if he should include the book as well as the meta-analysis: RexxS responds affirmatively.

But Ozzie failed to engage that discussion:

  • 11:46, March 9, 2019 Ozzie reverts, "agree w/ Doc James"
  • 11:56, March 9, 2019 Ozzie restores, ten minutes later, as he somehow realizes he has reverted a meta-analysis.
12:02, March 9, 2019 Ozzie belatedly enters talk for the first time ever, with agree w/ Doc James on Meta/analysis.
More talk ensues, with Thomas trying to get clarification from James and Ozzie.
03:11, March 10, 2019 James disagrees with the advice RexxS gave previously about the book
Ratel pointed this out, as does Thomas.
07:28 March 10, 2019 Thomas again attempts to get less than terse responses from James asking several questions about sourcing.
19:49 March 10, 2019 WhatamIdoing attempts to help Thomas format the book citation
22:45, March 11, 2019 Thomas points out that James is misquoting him, and says more people need to get involved.
09:56, March 14, 2019 much discussion later, Thomas still trying to understand James' objections
  • 11:56, March 14, 2019 James adjusts
14:45, March 14, 2019 Ozzie agrees with Doc James that primary sources should not be added (in a case that is not at all clear that the primary sources would not be helpful when added to secondary sources)
10:22, March 15, 2019 James launches RFC and more of same continues for weeks.

After what looks like an excruciating encounter for a relatively new user, some content that could have been sourced was cut, and some theories were added because of this editor's persistence. This editor is gone.

Ozzie10aaaa does not resolve conflicts directly with editors[edit]

In December 2019, during a long back-and-forth between James and Colin, James asked Colin to stop pinging him. (This could be interpreted to mean pinging only to that discussion.) There was no comment about the pingie-thingie from other editors who were participating in the discussion, nor any request on Colin's talk; Colin initially refused to accept this request.

Less than three days later—having made no attempt to address or resolve or clarify the "pinging" matter on talk directly with Colin, and in spite of multiple instances of previous reminders to do just that—Ozzie escalated the incident in an ANI about Colin. (Colin agreed not to ping James anymore as soon as that was requested on the ANI.) At ANI, grudges came out of the woodwork, with many editors taking the opportunity to lodge baseless allegations about Colin.

Ozzie has a history of problems in this area: May 2015 reminder from several to discuss first; June 2015 concerns about Ozzie10aaaa's editing raised at ANI; July 2015 Ozzie brought a most odd AN3; March 2017 reminder "to fully understand the issues involved, before taking a side ... and read through the arguments and examples, and them vote"; and April 2018 reminder to speak directly to the editor before escalating.

Ozzie10aaaa has difficulties editing complex topics[edit]

Ozzie has some difficulties editing complex topics:

A good portion of Ozzie's many edits are citation-bot assisted, updating epidemic data, and MEDMOS section heading adjustments. Most of them have no edit summaries. Otherwise, he seems to be at times editing above his comfort level and needing a lot of guidance.

Case study: Dyslexia, James exempts Ozzie GA from MEDRS[edit]

Dyslexia Dyslexia provides an example of my concerns about deteriorating content on Wikipedia and promotion/semi-protection of deficient medical GAs. Evo’s post about the gynormous peer review templates parked in the References section—a template which has nothing to do with References for this article and should be in External links—brought me to the Dyslexia situation.

See the full description and diffs of a troubling situation here.

Full description and diffs of a troubling situation
  • In March 2015, Dyslexia is promoted to GA on support from Bluerasberry, considerable and valid issues identified by Jytdog (with Ozzie threatening to take Jytdog to ANI [84] after asking him to review), concerns reiterated by Gordonofcartoon, and finally passed by DoctorJoeE.
  • In July 2015, only four months later, User:Keilana initiates a Good article reassessment, identifying numerous and considerable problems, which are endorsed by CFCF as "should probably never have passed GAN".
  • But James says, "The article is not that bad in my opinion." 16:09, 23 August 2015
  • James says, "I would classify this as a non actively researched area of medicine. While I agree that we should update primary sources with reviews a little leeway WRT WP:MEDDATE should be given." 16:15, 23 August 2015 (emphasis mine: PubMed returns 140 secondary reviews for the last five years alone and Google scholar returns 23,000 results for Dyxlexia review between 2010 and 2015.) This is not an inactive area of research, and we would never apply that standard to woo and alt-quackery.
  • James suggests closing the review on 03:41, 4 November 2015.
  • User:Looie496 (a trusted editor in neuropsych content) brings up more serious problems. 15:41, 4 November 2015 (UTC)[reply]
  • Keilana closes the review on 15 November.
The article is twice promoted GA, with obvious prose deficiencies, support from Bluerasberry, and exemption from MEDRS standards from James.
The peer review template parked incorrectly in the References section takes us to Wikiversity, where the article was nominated for review in October 2018, and passed a year later in October 2019, after considerable sourcing problems identified and a substantail rewrite by multiple editors responsible for a quarter of 15% of the article (corrected per link to article—previous was talk.)
  • The article at Wikiversity on Dyslexia has an adequate, well-written and professional lead with narrative that flows. The Wikipedia article has an inferior lead, but the rest of the article appears to be a copy of the article that was rewritten at Wikiversity.
End result: a GA that is inferior to the same article on Wikiversity, twice passed GA when not in compliance with standards, still using non-MEDRS sources, with writing on Wikipedia attributed to Ozzie10aaaa when the article was mostly partially (except the lead) written by others at Wikiversity, copied to Wikipedia without attribution.
And, seven months later, May 4, 2020, someone notices the mess created in the lead last October..
May 10, perhaps this will just pass into archives as did the last unaddressed problem with non-MEDRS sourcing in the article, backing inaccurate claims.

Added content from User:SandyGeorgia/Dyslexia GA diffs, Der Wohltemperierte Fuchs talk 14:15, 11 June 2020 (UTC)[reply]

In a Medicine Project where alt-quack editors are routinely whacked for not strictly adhering to MEDRS and MEDDATE, we have at GA Dyxlexia being spread across the internet via WPMEDF apps, and James advocating for an exemption from MEDRS for his Wikifriend Ozzie, with:

  • non-MEDRS-compliant sourcing,
  • and inferior primary sources supporting the text in the article for the font referenced above,
  • in a GA written by others at Wikiversity but attributed to Ozzie10aaaa on Wikipedia,
  • with an inferior lead on Wikipedia relative to Wikiversity,
  • and a deficient GA promoted twice, once with support from Wikifriend Bluerasberry, and the second time with James specifically saying that this article should be exempt from MEDRS for reasons that do not hold water, and would not be accepted in any other article.

QuackGuru: Anti-woo culture and quid-pro-quo at WP:MED furthers disruptive editing[edit]

See Barkeep's evidence on Quackguru history

A bad dynamic has overtaken medical editing, and has become a role model for other editors. The notion that bullying and editwarring is necessary to combatting woo, trolls, quacks, and POV pushers is prevalent, and yet there is plenty of editwarring that has little to do with anti-woo. (Samples: general edit warring, Schizophrenia, Down syndrome, chronic prostatitis, drug pricing dispute, and general.)

That MEDRS has become an anti-woo bludgeon is a source of discomfort for some who helped write that guideline (myself included). Bullying and MEDRS bludgeoning has alienated several experienced medical editors.

Arbcom (Jytdog) and arb enforcement (QuackGuru) have recently made inroads towards changing this dynamic. A minority of medical editors (including James) expressed support,[85] or found no problem with the behaviors that led to arbcom action, defended the behaviors, or expressed dissatisfaction with arb actions. (Roxy the dog, Seppi333, Ozzie10aaaa, Boghog) James said: "we could technically over ride arbcom".

The cultural change is explained by WAID in December 2019:

SandyGeorgia's comment about the long-term changes in the group resonates with me. We used to be focused on writing brilliant articles filled with precisely delimited claims and superb sources. Then we went through an anti-woo phase: almost anything's okay, as long as it hurts the spammers and alt-med proponents ... Now we seem to be talking more about issues of health policy, which is a more approximate subject area with a focus on practicalities, like approximate prices.

Another way to deal with woo is to re-write articles to a higher standard, addressing the woo components directly, as I did years ago at MMR vaccine and autism, and have tried to do at the battleground pages of delusional parasitosis and Morgellons. The attitude that prevails in medical editing is seen in this discussion, where editors who possibly have a delusional disorder are called LUNATICS, and both Jimbo and a sysop are used as role models, and bludgeoning techniques are used to keep out perceived woo. In this perennial issue at Morgellons, I did the research to add content addressing the frequent questions.

With that as background:

Reviewing the history of editors involved in editwarring threads, and the multiple other case studies presented on this page, a quid-pro-quo appears to be an issue. Some editors mutually defend each other at ANI, AN3 and other dispute resolution fora, preventing community consensus on dealing with disruptive behavior.

WP:MED History[edit]

Timeline of the development of the Medicine Project, Reliable sources in medicine guideline, and Medicine manual of style

Whether by coincidence, commitment, or something else, almost all of the early contributors to the Medicine Project who are still active are also producers of featured content (the only exception being WAID):

with all of us having contributed together towards most of the medical Featured articles (and even the very controversial Water fluoridation with Eubulides—evidence that a well-written article is the anti-woo protection!

These editors are accustomed to sustained and lengthy discussion and collaboration towards developing top content (qualities typified by Colin's editing, thoroughness, incisive analysis and comprehensive review, see here, here, here, here, and here for but a few samples and Colin's encouragement here to participate. Simply stated, the best route to a medical Featured article is to engage Colin for comprehensive analysis of content and prose and flow with incisive critique that always includes an examination of the sources. Number of bytes posted, and number of posts made is not part of the formula. Nor is frequent reverting. We don't always agree, we are accustomed to disagreeing, we are even accustomed to heated exchanges, but we are always headed the same direction (top content), and rarely resort to quick measures to sort out differences. It should not be surprising, then, that there is now a cultural clash at WPMED.

WPMED has moved away from a culture where sustained and collaborative interaction and engagement on talk towards precision and accuracy in writing have been replaced by a hurried, attention-deficit, revert, revert, revert, "RFC to win", whack-a-mole culture. In the current environment, limited talk page engagement is characteristic, hasty RFCs are preferred over sustained discussion, and those who engage in sustained discussion are accused of "bludgeoning" and "walls of text".

Effect of WPMEDF change on WPMED[edit]

This cultural change coincided with the uptick in WPMEDF activity, and the decline in FA-related activity, as a culture of "push as much content out the door via apps as we can" took over, in place of a sustained commitment to overall quality.

Wikipedia:WikiProject Military history is a very successful WikiProject; its project page reveals its focus on generating top internal content, with a project page that highlights coordinators, goals, assessment, an A-class review, open tasks, how you can help, and core work areas.

In contrast to its focus when its core guidelines were developed, Wikipedia:WikiProject Medicine's project page is now dominated by external WPMEDF partners, translations, apps and other non-en.Wikipedia projects, while it is short on information and encouragement about contributing to the English Wikipedia medical content upon which those apps and projects depend.

Many of the still-active editors who were involved in the early development of the Medicine guidelines have an interest in seeing the project guidelines well maintained, in sync with Wikipedia-wide guidelines, and reflecting best practice. This is partly because best practice must be followed by Featured articles, and Featured articles can't be produced if Project guidelines are in disarray. And we can see in the evidence on this page that most of these editors are in varying states of disillusionment or conflict with the Medicine Project. This is a red flag.

The alternate explanation I offer to Rexx's narrative is that it is NOT the case that one more-or-less camp is opposed to innovation: they are opposed to the methods used to implement these WPMEDF projects. The crux of the conflict is:

  • concern that these projects are promoting sub-standard content, as focus has shifted away from quality of content per se, towards propagating ill-maintained content via apps, while
  • shifting the Medicine Project focus away from maintaining timely accurate content in that very information they are spreading, while
  • having no measure of medical outcome to indicate that diverting resources from content towards content propagation improves health, while
  • using less than desirable techniques to implement the content goals sought by WPMEDF. These methods include: one or two people achieving fait accompli (often via edit warring) in multiple areas-- altering the order of every medical article, altering the lead of every medical article, doing this often without edit summaries so the activity goes undetected, alerting WTMED to changes only after they have been accomplished, dumbing down leads sometimes to the point of inaccuracy (even Featured articles), inserting videos into the leads when the videos contain inaccuracies that cannot be corrected (even Featured articles), and putting up roadblocks at WT:MED when editors seek collaboration to restore deteriorating Featured articles to status (eg the discussion here, so that several of us have had to develop a network outside of the Medicine Project to work together to produce and restore medical Featured articles.)

Elitism and cultural changes at WPMED[edit]

Ozzie describes James as an "elite editor", and uses editcountitis to justify his (Ozzie's) frequent appearances to back James on articles where Ozzie has never before appeared. James uses the same justification, on more than one occasion.

Further, in contrast to the meme, On the Internet, nobody knows you're a dog, in medical editing, we confront ill-conceived commentary implying that "Doc" James has a better command of policy and medical sourcing (even on topics where he is less experienced) than other editors. Those "lesser important" (non-MDs) are inaccurately charged with poor timing for this arbcase, while the impact of an arbcase (forced by James' behavior) on our time (samples, [98] [99] [100] [101]) is discounted because we aren't saving the world from a pandemic.

I don't believe the "elitism" factor has an easy or apparent solution, and it is something we must live with, but the solution to the editcountitis problem might be less difficult.

  • See User:SandyGeorgia/WPMED editcountitis:
WPMED editcountitis

The culture at WPMED since around 2013 has chased off other editors, and turned from an environment of collaborative discussion to a culture of revert, revert, revert, solve disputes with a hastily-formulated RFC.

In the list of top medical editors Ozzie supplies[102], I was at #14 in 2013, falling to #280 by 2016, and gone in 2017. In 2018—Dementia with Lewy bodies rewrite—I came back to #24. Of note, I was at #14 in spite of a) no automated editing, and b) extensive edits in non-medical areas (FA-related and Venezuela); in other words, WPMED lost a fairly prolific medical contributor.
My editing is characterized by a ratio of talk to article edits about five times higher than either James or Ozzie; that is, sustained engagement on talk is a feature. I compared mine, James and Ozzie's talk/article ration to that of a fourth medical editor who puts his nose down, gets the work done, and isn't often seen in conflict (User:Alexbrn) and found him also at about a 50% ratio to my 45%, with James and Ozzie at 14% and 11%. With such limited engagement on talk, from two excessively prolific editors, conflict is not surprising.
Name Year
2015
Article/Talk
2016
Article/Talk
2017
Article/Talk
2018
Article/Talk
2019
Article/Talk
Total
Article/Talk
Ratio
Talk/Article
Alexbrn 2805 / 1510 2363 / 1404 2487 / 950 1908 / 809 2664 / 1148 12,227 / 5,821 48%
James 23377 / 3001 26801 / 2809 28780 / 5186 16454 / 2877 26368 / 2800 121,780 / 16,673 14%
Ozzie 7260 / 848 10147 / 1231 15728 / 1610 19635 / 2130 20157 / 2068 72,927 / 7,887 11%
SandyGeorgia A 2171 / 943 152 / 156 B 231 /0 2248 / 971 C 6894 / 3251 D 11,696 / 5,321 45%
Note A: Mostly years I was not editing, as I backed out around 2013
Note B: Stopped editing
Note C: Tried WPMED collaboration on Dementia with Lewy bodies
Note D: Mostly Venezuela editing, re-engaged medical in November after I returned for ArbCom elections

(Added contents from User:SandyGeorgia/WPMED editcountitis, Der Wohltemperierte Fuchs talk 14:16, 11 June 2020 (UTC))[reply]

These numbers reinforce several issues, seen elsewhere in discussion on this Evidence page:

  • The amount of editing by Ozzie and James is extreme, averaging about 100 edits per day from James, and 175 edits on one 9-hour editing session.
  • Ozzie and James rarely engage on talk, relative to other editors.
  • Both Ozzie and James are editing too much, too fast, and without adequately engaging on talk with careful attention to detail or sustained collaborative discussion.
  • Ozzie follows James' edits to endorse James' positions without adequately engaging, which reinforces the overall cycle of non-engagement, replacing discussion with hastily-formulated RFCs.
  • In contrast, those editors who do engage sustained discussion with incisive and policy-based analyses will see aspersions cast their direction and their reputations on Wikipedia destroyed.

Problems to be solved; I don't know how. I only know this culture alienated me from medical editing.

Effect on editor recruitment, retainment and content[edit]

Lead restructuring[edit]

WP:OWN#Featured articles (policy) says:

Editors are asked to take particular care when editing a Featured article; it is considerate to discuss significant changes of text or images on the talk page first.

Here is the level of writing about Tourette syndrome from the CDC: https://www.cdc.gov/ncbddd/tourette/facts.html

User:SUM1 points out we are at that low level, describing James' leads as inducing headaches, saying What I do know is that any medical article maintained by Doc James has far too many short sentences in the lead and is incredibly disjointed to read. I wish I could change it to be more in line with basically every other article on the entire Wikipedia.

SUM1 gives an example of choppy, disjointed prose in a lead written by James at Harlequin-type ichthyosis:

"There is no cure. Early in life constant supportive care is typically required. Treatments may include moisturizing cream, antibiotics, etretinate, or retinoids. It affects about 1 per 300,000 births. There is no difference in rate of occurrence between sexes. Long-term problems are common. Death in the first month is relatively common. The condition was first documented in 1750."

Medical Featured article production has ended because James' imposes such leads on every article, and that kind of lead cannot pass FAC. (Meaning, I, for example, can no longer do what I do on Wikipedia, and basically gave up and stopped editing.)

While writing for the purposes of translation is a laudable goal, we must first aim for accuracy and precision in our English-language content. I experienced the lead rewrite at Tourette's in 2016.

  • On October 15, 2016 (well after James had reordered the leads of many articles, see Fait accompli section) and with no prior request or discussion on talk, James rewrote the lead, ending here at 03:25. At 19:45, I started repair:
  • [104] "Vocal" tics are distinguished from "phonic" tics in the literature, and the distinction is important and a frequent source of confusion.
  • [105] "worsen and improve" is prejudicial language that is avoided, and does not accurately encompass the many ways tics fluctuate, described in almost all reviews as "waxing and waning". [106] "Waxing and waning" encompasses much more than the prejudicial "worsen and improve", and is terminology encountered in most TS literature.
  • [107] "briefly" is just an inaccurate choice of words here; sometimes tics are suppressed all day while a child is at school
  • [108] premonitory urges do not have to be "strong"; they can be a feeling like an itch
  • [109] James completely dropped one sentence.

At that point, James begins discussion on talk for the first time. I then had to spend several days explaining all the errors he had introduced, and trying to get the article back to some semblance of accuracy. A lengthy discussion ensues, and I ultimately am obligated to accept James' re-ordering, having seen how the history has unfolded in other cases (editwar --> RFC --> several editors unfamiliar with the topic or sources come in to "agree w/Doc James", means it is easier to go along with James to avoid trouble).

James' goals were to a) simplify the language for translation (which was not revealed until well into the discussion) and b) reorder the lead according to his preference. The preferred order of narrative is not optimal for Tourette syndrome. And in trying to simplify wording, James introduced inaccuracies. He attempted to rewrite the lead of a topic he is not familiar with, without the courtesy of a notification first. Had James approached this collaboratively—that is, had he simply put a list of words he wanted to simplify, and allowed editors knowledgeable in the topic to work through them—the process would have been much more effective. And I would not have given up on maintaining all medical Featured articles. James is not a neurologist, or a urologist, or a psychiatrist, and this pattern repeats across articles that are not in his area of practice, contributing to ongoing conflict.

In 2018, I attempted a WPMED collaboration: I approached a complete rewrite of a dismal Dementia with Lewy bodies (DLB) after an exciting new consensus report was published in 2017, hoping the effort would re-unite WPMED in the kind of collaboration it once excelled at. I gave up after experiencing the dysfunction that had overtaken WPMED.

The first phase of that effort (beginning at the "Outdated" section, and including the rest of talk Archive 1) was dealing with extremely dated info in the lead, sourced to NIH, and lengthy discussions about what appeared to be James not understanding the new diagnostic criteria. So I realized I was going to have to rewrite the entire article all at once, or incur endless discussion to explain the new consensus. Between March 28 and April 8, I rewrote the entire article, and the next phase began (intended to be a productive collaboration). The second phase (all of Archive 2) shows Wikipedia at its finest: considerable productive discussion between both medical editors and experienced FA copyeditors. But then, having not yet dealt with James' personal preferences on leads (I believe in writing leads last), a separate issue occurred at the meta-level, in which every editor with an opinion tried to explain the faulty reasoning of yet another medical editor who threatened to vehemently oppose a FAC [110] (in bright flashy highlighted text) over his idiosyncratic personal preferences about the word "should". I began drafting an RFC, which I abandoned because that editor's views did not gain support from anyone. Meanwhile, yet a third medical editor was rude to an FA writer who showed up to help copyedit my typically dreadful prose.[111] [112] Also, Colin's attempt to explain the way we usually worked together on collaboration towards FAC was misinterpreted by Tryptofish as "condescending", after Trypto inserted unsourced text in two places. All factors considered, I lost hope, and stopped editing, realizing that the type of collaboration that was routine and customary at other FACs was not probably going to happen at DLB.

So, with now four separate problems, I decided to abandon the possibility of taking DLB to its best level.

But the pattern in the lead at Tourette's and elsewhere repeated at DLB when James appeared unfamiliar with recent journal literature.

  • At Talk:Dementia with Lewy bodies/Archive 1#Infobox inaccuracies, I had to spend a good bit of time convincing James that he was using old sources, when the 2017 DLB Consortium had completely changed the diagnostic criteria, such that text he wanted in the lead was inaccurate; he didn't appear to understand or be aware of the significance of the new findings.
  • I reluctantly accepted James' piping of "lack of interest" to apathy, although I disagree that description is accurate or precise enough for medical writing, knowing it is expedient to go along with James rather than incur an RFC over a word. (Just as I reluctantly removed "wax and wane" from the lead at Tourette's.) Precision is lost for the purpose of translation, and apathy is not difficult to understand or translate. (Disclaimer: I work as a volunteer interpreter in a free clinic for Hispanic migrant workers.)
  • All of this led to a lengthy discussion with James, where I pleaded with him to understand the impact his editing was having, in a discussion encompassing all of the issues in one. I pointed out James' dishonesty at intentionally linking to a dated, archived NIH source to justify his position, when newer sources and information were available; today, I retract that as dishonesty and assert it is more likely a reflection of James editing too much, too fast, in areas he does not know thoroughly, and not fully reading, engaging or digesting talk page discussions. (Discussed many times with James, for example here.) Hasty RFCs allow him a faster way of proceeding than actual discussion.
  • In October 2019, an editor made good-faith improvements to the lead of DLB, resulting in smoother prose, but was reverted by James.

DLB ended up with such a poor lead that I disengaged and could not take it to FAC. (I re-engaged this year, precisely because and after some of the WPMED bullying has been dealt with by arb actions, and I am hoping to progress to FAC.)

A frequent problem is that James edits article leads only, and does not edit the body of the article to keep it in sync with the lead. After the 2016 experience at Tourette's, I unwatched most medical Featured articles, only checking on them occasionally. While I was absent, enough damage was done to Asperger syndrome that it was defeatured this week. (Similar problems exist in almost all medical featured articles, where the body is not kept in sync when the lead is edited, and they are almost universally outdated.)

  • In March 2016, James restructured the lead, introducing considerable prose problems:

    While there is likely a genetic basis it has not been determined. Environmental factors are also believed to play a role. Brain imaging have not identified a common underlying problem. The diagnosis of Asperger's was gotten rid of in the 2013 fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) and people with these symptoms are now included within the autism spectrum disorder along with autism and pervasive developmental disorder not otherwise specified. It remains within the tenth edition of the International Classification of Diseases (ICD-10) as of 2015.

  • There is some evidence that children with AS may see a lessening of symptoms; up to 20% of children may no longer meet the diagnostic criteria as adults ...
  • In this edit to the lead only, James adds contradictory information
  • "typically last for a person's entire life" without adjusting the text in the body or adding that to the body, and
  • adds that "females are typically diagnosed at a latter (sic) age" which is not in the body of the article.

These are samples only of the kind of editing I have seen at every Featured article, where focus on the lead only takes the lead out of sync with the body, neglects the overall content, and ultimately leads to Featured articles falling into such a state of disrepair that they must be defeatured, as Asperger’s was this week.

In all of these cases, James is editing outside of his area of practice, yet imposing his preferences in the lead, for the apparent purposes of translation. My concern is that, with a focus on producing leads for external apps, overall content is neglected and even degraded, and that James is simply editing too much, too fast, and in a way that leads to alienation of other editors. It has proven difficult to get James or his supporters to recognize this. The new WPMED pattern is revert, revert, revert, then conduct an ill-formed RFC "to win", rather than engage, discuss, understand, respect, apply policy-based reasoning and collaborate.

Drug pricing dispute[edit]

Fait accompli[edit]

At Ivermectin, in this September 2019 discussion, Hipal/Ronz and Doc James are in a drug price dispute. Ozzie10aaaa enters an "agree w/ Doc James", Seraphimblade disagrees, Quack Guru supports James. The only two independent opinions, who come from Wikipedia:Third opinion are:

Participation in RFC formulation[edit]

After the 7 December 2019 ANI close remitted all discussion of drug pricing to a single forum to formulate an RFC, between that time and 23 January 2020 when the RFC was launched, James engaged on 9, 10 and 16 December, and not again until 3 January. [113]

RFC participation affected by canvassing and WPMEDF entering “drive-by” commentary[edit]

( See also Down syndrome case study on WPMEDF "driveby" supports)

The second RFC on drug pricing attracted 40 editors (43 total in page history includes the three sysops adminning the process).

Of those 40 editors, 10% (4) were canvassed or were WPMEDF colleagues who did not engage the core of the issue, rather entered "drive by" commentary:

User:Axem Titanium was canvassed from the Video project [114] (see Bluerasberry canvassing section)
User:Avicenno (WPMEDF) entered a 6 February no policy-based reasoning, ILIKEIT opinion.
User:AbhiSuryawanshi (WPMEDF) entered a 3 February no policy-based reasoning, OTHERSTUFFEXISTS
User:Pratik.pks (WPMEDF- videos) entered a 3 February no reasoning at all—Pratik has five article edits on Wikipedia as of 15 April [115] and has mostly edited the Dengue fever video (a video that “Not anyone can edit”, based on outdated text, and yet installed in the lead of a Featured article)

The RFC was open fox six weeks (23 January to 7 March); three WPMEDF members who had no previous engagement entered "driveby" positions within three days of each other.

Simvastatin RFC

The second RFC on drug pricing closed on 27 March. Colin initiated discussion at WT:MED on 28 March. Differences in interpretation and how to implement surfaced quickly. On 29 March, WhatamIdoing took one of the clearest examples of non-compliant drug price text, at Simvastatin, and removed the text from the lead, while adjusting the text in the body. Edit war discussed in other evidence ensued, with James and Ozzie together reverting five other editors on 30 March.

With insufficient discussion on talk, and no discussion about how to correctly frame an RFC, James unilaterally launched another RFC only three days after the community-wide RFC closed. Similarly, he unilaterally launched another RFC at Talk:Ethosuximide.

  • James set up the RFC as a "yes-no" !vote format and disallowed threaded discussion. (This is after months of RFC formulating, and two other RFCs, where WhatamIdoing many times outlined the problems with yes-no RFCs, but James didn't hear that.)
  • James removed attempts by others to hold threaded discussions, and altered the posts of others, running the page like an ArbCom clerk, with no threaded discussions allowed.[116] [117] [118] [119] [120]

Most of the editors opining do not appear to have read or understood what the actual issue is (because it's buried below), but WPMEDF officers and members, having limited previous engagement, support:

With a just-closed community-wide RFC finding no consensus to breach WP:LEAD or WP:NOT for drug prices in the lead, local consensus is overriding global consensus based on WPMEDF support.

SG: Response to Tryptofish allegations[edit]

Brings old baggage to discussion

For very old (and limited) reasons, Trypto seems to hold a grudge against Colin, relating to one issue where Trypto followed Colin to Commons and misreported an issue there, leading Trypto to ban Colin from their talk page after one post; another where Colin used the word "guys", and Trypto responded, “I will certainly remember this”; and another where Colin accurately described how I felt when confronting the behaviors now in evidence on this page, and being told I would just "have to deal with it as is". It seems this baggage may have led to Tryptofish reading into a post from Colin intent that was not there in the DLB incident. I tried my best to stay out of that, but was relieved that someone (Colin) understood how it felt to be treated that way, when trying to resolve content issues with a colleague, and having another editor interfere. Tryptofish's evidence seems to blame Colin for issues that occurred at Dementia with Lewy bodies, without reason, as Colin only explained to Tryptofish the problems with adding text without consulting sources. I don't yet understand why Tryptofish took offense to that.

Caused consternation during RFC formulation

During the formulation of the RFC,

I was off-Wiki when much of this occurred, and posted my expression of regret to Tryptofish on January 5.

Stirred the pot, urging an arbcase, even while others were hoping for conflict resolution

and then unnecessarily stirred the arbcom pot with James, while we were seeking resolution, saying "they are clearly looking to make a case against you", and "That's important 'insurance' in the event that this goes to ArbCom." The appearance is that Tryptofish always wanted these issues to end up before the arbs, rather than resolved amongst ourselves.

Tryptofish continued these behaviors, and Colin took Tryptofish's persistent failure to AGF to Barkeep's talk page, where I again implored Tryptofish to cease urging an arbcase. Patiently enduring all of this and more, and without taking sides whatsoever, Barkeep49 merely suggested that the problems between Colin and Tryptofish might go to Arbitration Enforcement. That simple suggestion provoked Tryptofish to retire. Because Trypto repeatedly suggested he wanted to fully retire, at Barkeep's talk page, when I asked Tryptofish if he wanted to be a named party in the case (as Hipal/Ronz had requested in the same discussion), Tryptofish fails to AGF, accuses me of "intimidation" and "battleground" (???????), so I refrained from adding him as a party, even though his actions led to a deteriorating climate for dispute resolution.

Inadequate use of edit summaries contributing to tension[edit]

There are concerns thoughout the evidence of reverts being made without edit summaries, and changes that are known to be controversial being made without adequate summaries. The edit summary issue has contributed to the tension at WPMED, as it lends a "stealth" appearance to the edits and makes it hard for other editors to be aware that controversial changes are being made.

  • complete with personalization by CFCF ("this seems like conspiratorial thinking on your part in order to justify this inane discussion. Carl Fredrik talk 12:59, 28 March 2018") and an
  • agree w/ CF--Ozzie10aaaa (talk) 13:07, 28 March 2018

After discussion at WT:MED about using edit summaries on controversial drug price edits,[122] which was adopted by others,[123] [124] [125] [126] James continues without (see as an example edits at Simvastatin and his contribs

Ozzie indicated he would try (without providing an edit summary :) Ozzie is still not using edit summaries consistently or helpfully, although I explained to him that he can set a reminder in preferences.

SG: responses to other evidence[edit]

Regarding James evidence, [127] he had never before asked me not to ping him. After he first asked on 31 March, he had an acknowledgment from me within 13 minutes. James misrepresents my statement about "arrogance" and fails to AGF. It would be arrogant of me to demand people not to ping me because it makes extra work for my arthritic hands; I can change my preferences if needed.

The vaccine section at Dengue fever was updated a month after I tagged the section, and the Research section remains dated, while the References section reflects some WP:MEDDATE issues, and the Epidemiology section needs an update.

James says "The claims around dengue are false." I don't want to continue a content dispute here, but the "false claims" should be addressed. This is the lead I tagged in January 2019. "The vaccine, however, is only recommended in those who have been previously infected" is inaccurate. The current lead says: "As of 2018, the vaccine is only recommended in individuals who have been previously infected or, in populations with a high rate of prior infection by age nine." The update was made at my instigation; the body of the article is still out of sync with the lead, and there are still tagged updates needed. My concern (as indicated in this primary study) is that during the Crisis in Venezuela this article should be timely and accurate. Inaccurate statements about vaccines impact people where Dengue has and will escalate. Others might say, SOFIXIT: in the past, I have been accused of COI and threatened with topic ban by a now-banned editor; I had dengue fever when I lived in Venezuela, so am concerned I will be similarly charged if I make substantive edits to this article. SandyGeorgia (Talk) 15:11, 22 April 2020 (UTC)[reply]

James' response lists vandalism that well pre-dates the semi-protection at Gastroenteritis.

James' response about Gout shows a misunderstanding about good-faith misinterpretation of a source, versus vandalism.

Update: As James points out, one of the edits interpreted as vandalism (and the semi-protection) occurred in January 2012, while the source was accepted for publication in March 2012 and published in July 2012. We cannot know if the IP (who has no other contribs) had advance knowledge of the publication, and interpretation of that edit as vandalism at that time could not have been avoided. The overall conclusion remains: there doesn't seem to be enough indication for indefinite semi-protection in any of these cases, and I am happy to see that James is willing to adjust these. SandyGeorgia (Talk) 14:14, 22 April 2020 (UTC)[reply]

FeydHuxtable, thank you for the considered evidence (I don't believe I ever saw that "leading light" reference). I turned my attention prematurely to the Workshop page because it has been impossible to pull up diffs for several days due to something going on with the server, so I was trying to make use of my time. I am aware that Workshop proposals are for generating ideas and discussion; please take note of what kinds of remedies I am not suggesting. Bespoke remedies to a novel situation will be needed for us to return WPMED to its former standing, my evidence is aimed at showing why the standard measures may not work, generating ideas for what will work, and I doubt that any of us want to lose any of the few valued medical editors we have. We all just want to be able to edit: for almost five years, I haven't been able to. I also agree that S Marshall has it about right; well-intentioned people trying to do too much, too fast, and not realizing how they are impacting the editing of others. I hope my-- and everyone's-- contributions are equally valued. Best regards, SandyGeorgia (Talk) 22:57, 16 April 2020 (UTC)[reply]

Also, regarding the timing to "launch attacks on Doc James", the timing was James' choice. Barkeep49 initiated this case after James appeared to ignore a community-wide RFC, edit warred, and launched two more local RFCs. Noting that James had time for 175 edits in a 9.5-hour editing session on 16 to 17 April. SandyGeorgia (Talk) 17:53, 17 April 2020 (UTC)[reply]

Regarding Ozzie’s statement, the arbs can pass judgment on whether such "harassment" ever occurred (particularly since that block was removed quite quickly, before I even knew it happened).[128] SandyGeorgia (Talk) 18:10, 21 April 2020 (UTC)[reply]

Ozzie, regarding this statement, Colin and I have been involved at WPMED from its earliest days, in the development of MEDMOS, MEDRS, and at multiple FACs, FARs and Featured articles. Which of those interactions concerns you? Perhaps this one, which is not in the normal suite of articles we edit, and where Colin disagrees with me? SandyGeorgia (Talk) 16:56, 26 April 2020 (UTC)[reply]

Regarding Ian Furst’s statement about Down's syndrome, I began editing Down syndrome on 2006-12-02 00:16 and Colin on 2006-12-08 23:36 (related to the peer review and Featured article candidacy); James began editing DS on 2009-06-14.[129] The disputed text was present at every stage of content review, according to the Article milestones.

  • 2006 Peer review [130]
  • 2006 Featured article candidate [131]
  • 2010 Featured article review [132]
  • 2012 Peer review [133]
  • 2014 Good article [134]

and was only removed by James in 2016,[135] when he began inserting his views of leads on every medical article. SandyGeorgia (Talk) 19:43, 21 April 2020 (UTC)[reply]


Where T.Shafee(Evo&Evo) describes as "unconstructive friction", the full discussion is omitted from their link, and is at Wikipedia talk:WikiProject Medicine/Archive 134#Featured article removal candidates. What started as a post to solicit help maintaining FAs (where there was a good deal of helpful commentary from MILHIST members), turned to addressing inaccurate and discouraging commentary from CFCF.[136] Specifically, the statement, "FA … lacks understanding of what concessions need to be made for medical articles" is odd, considering two former FAC delegates (SandyGeorgia, Graham Beards) and one current FAR Coordinator (Casliber) are medical editors. I point out the inaccuracies,[137] and that CFCF is not in a position to criticize how the process works as he hasn't participated there,[138] and CFCF calls that an "ad hominem".[139] With now two statements that WPMEDF members are not concerned to keep medical FAs up to date,[140][141] and with these roadblocks thrown up when Featured article reviews are mentioned at WTMED, the effort has had to move off of the Medicine project page, to a grassroots effort which has seen good results (example Wikipedia:Featured article review/Chagas disease/archive1, with editors also willing to begin repairs to Dengue fever).

I have have stricken the statement that the template is a WPMEDF project. SandyGeorgia (Talk) 14:04, 24 April 2020 (UTC)[reply]


The fallacies of tone policing explained at the ANI to Bluerasberry. SandyGeorgia (Talk) 23:53, 28 April 2020 (UTC)[reply]

SG: Response to editcountitis[edit]

Statements have been made on this Evidence page and elsewhere impugning the motives of those who fully engage dispute resolution. In relation to the amount of text contributed by editors who scarcely engage at all, [142] [143] [144] [145] the percent contributed by those who do appears inflated. EDITCOUNTITIS charges that WhatamIdoing, Colin and SG contributed 60% of the RFC do not account for a) WAID drafted the RFC, so had KB due to the orginal writing; b) Colin provided almost all of the (incisive, policy-based) price analysis; and c) I (SG) re-posted to the page at someone else's request a copy of a long quote from the formulation phase. (Which doesn't mean I am not known for a long history of apparently genetic verbosity, contrasted with WAID's and Colin's incisive and precise analyses.) Further:

At WhatamIdoing's urging, the principals in the dispute and formulation of the RFC held off until later in the process, so as not to impede or influence commentary from others.

In my case:

  • At that point, the trends were already clear and 38 of the 40 respondents had already opined. The RFC closed on 7 March, so there was ample time for people to respond to my comments.

The RFC was formulated over seven weeks (7 December to 23 January), and discussion encompasses three archives. Formulation was made difficult because of the time spent in trying to find a single sample (from the over 500 inserted) of drug price text that met all other policies (WP:V, WP:OR, WP:WEIGHT), so a strong example could be used to ask a neutral question about whether that price info met WP:NOT and should be included per WP:LEAD. Much time was lost because not one example could be found that did not appear to have multiple other policy-based or source-to-text-integrity problems. For that reason, how to position an RFC had to be re-cast several times, and discussion of two RFCs occurred (that is, how can we determine if NOT and LEAD are met, if we don't have a sample that is otherwise policy compliant, so we will have to deal with that first).

Many medical editors weighed in on the Simvastatin RFC, and the Ethosuximide RFC, yet never participated either in the formulation of the broader RFC, or the broader RFC itself, and now appear to want to overturn it. Those include: JenOttawa, Whispyhistory, CFCF, Myoglobin, RexxS and Flyer22 Reborn. Ozzie10aaaa did not participate in the formulation, but did add one brief comment to the RFC.[147] Although Ian Furst did not participate in either, he did indicate multiple times that he was following and reading.

Evidence presented by Doc James[edit]

Agree that the issues at WPMED have been ongoing for years. A fair bit of it involve incivility, efforts to silence voices though intimidation, and to close down discussion. We are seeing this in the most recent round of discussions around prices but it is not new.Doc James (talk · contribs · email) 20:43, 7 April 2020 (UTC)[reply]

Inappropriate behavior by Colin and Sandy[edit]

Some discussed at this ANI in Dec of 2019 with respect to Colin. On Dec 2nd I requested that Colin stop pinging me.(Dec 2nd at 19:04) I had previously requested, a number of years back that they not post on my talk page, which they also did not follow. Colin replied to this request "James As long as you won't drop this issue, you'll get pinged whenever I mention your name." and he not only pinged me in the reply but continued pinging.[148]

After being brought to ANI and being threatened with a block they backed down. SandyGeorgia was the first one to respond and did not appear to have any concerns with their behavior. They have continued on the pinging tradition with 6 pings on March 30th, all to bring my attention to a single discussion I was obviously watching.[149][150][151][152][153][154] Sandy has criticized me multiple times for requesting unwanted pings to stop, Mar 31st stating "you disallowed pings and were not keeping up with discussion". On Apr 7th they calls those who make such requests "arrogant".

When the harassment team initial stated they were developing a tool to silence unwanted pings, I did not think such a thing was needed as I assumed all one would ever have to do was politely ask. I have now changed my position on this and fully support the development of such a tool.

Consensus being misinterpreted[edit]

A 2016 RfC concluded "Except in the cases where the sources note the significance of the pricing (which did have consensus), there is no consensus to add the pricing to the articles." We have plenty of sources that note significance. Plus there was no consensus for removal of prices.

There have also been efforts to shut down develop of consensus through RfCs such as here "Wrong RFC."

General audience[edit]

Many editors at WP:MED have spent a significant amount of time improving the readability of the leads of medical articles. A published analysis found that the reading levels changed from grade 15.7 in 2008 down to grade 12.7 in 2018.

The work is supported by guidelines such as “Strive to make each part of every article as understandable as possible to the widest audience of readers who are likely to be interested in that material.

WP:MEDMOS has summarized this as “The lead of an article, if not the entire article, should be written as simply as possible without introducing errors or ambiguity.” since 2015.[155]

There however was attempts by Colin and Sandy to remove this wording in 2019 without discussion.[156][157] And a push to use more complicated wording though a compromise was reached.[158] This involved small adjustments like using “loss of interest” rather than “apathy” added here [159] adjusted here [160]

Colin stated Mar 2018 “I have seen too many times Doc James pervert our article content to suit his pet projects, which are not aligned with English Wikipedia. Four years ago I saw him spend his time dumbing down our leads to baby language in the assumption that this made it easier to translate or with the idea that this was Simple English wikipedia, for those who find English hard to read.” And this insulting of writing for a general audience continues to Apr 23 2020 with "Doc James does not write about cost, he adds factoids".

Here is a list of more than 1,300 leads I have worked on and I would invite people to decide for themselves if these are inappropriately dumbed down or written in baby language.

Consistent organization[edit]

There have been efforts to improve the consistency of the layout of disease and medication related articles over the last 10 years. This makes the WP easier to use, especially by those who do so frequently. It also makes our content easier to maintain. The suggested ordering is present at WP:MEDMOS and is supported by the majority of the community. Yes there can be exceptions but these generally need justification.

Collaborating between languages[edit]

Sandy attempted to remove the fact that there is no rule against citations in the leads of articles from MEDMOS in 2018.[161] Translation between languages, a project being working on since 2012, would not be possible without references in the lead. These efforts have resulted in the translation of more than 6 million works of text by the Wikipedia:WikiProject_Medicine/Translation_task_force Efforts have concentrated on translating the leads of articles due to feedback from a number of languages. The attempt to remove this text occurred despite this having been discussed multiple times.[162]

Making our content more global[edit]

Wikipedia’s content is often US / EU centric. In collaboration with the World Health Organization WP:MED/WPMEDF worked to improve our coverage of all medicines listed in the WHO Model List of Essential Medicines. This is a list of medications that should be present in all health systems due in part their efficacy, safety, and cost. As part of these efforts the WHO released the 2017 list under a CC BY SA 3.0 IGO license. These efforts worked to add a decent summary, including details on use during pregnancy and discussion of cost. The latter of course bringing us here. Well there appears to be consensus on including the numerical prices of medications in the leads of articles when those medications are expensive in the United States such as pyrimethamine and onasemnogene abeparvovec, some appear unwilling to allow prices of any sort in LMIC anywhere in the article despite 1) plenty of sources discussing costs of essential medicines generally 2) a book published by the WHO which has these details. I am happy to consider changes; the details in question can be presented without interpretation and within the body of the article rather than the lead, and I hope that the other people involved will accept this also. I am also happy to put the question to the community. Also many have suggested improving our coverage of costs of medications including User:Nbauman back in 2014.[163] Yes it is more difficult to include coverage pertaining to LMIC as high quality sources are harder to find, but when such sources are available Wikipedia should not actively avoid providing appropriate details. The population of LMIC is 6.4 billion (85%) out of 7.5 billion people as of 2018. https://data.worldbank.org/income-level/low-and-middle-income That I editing via consensus and working to develop consensus can be clearly shown in this RfC and other RfCs.

Other formats[edit]

Wikipedia needs to be not only in a language that people can understand but also a format that they can use. We do and can adjust our content rules to make enWP universal, and we have from the very start. The goal was to make a free encyclopedia, free for anyone to adapt, and enWP and the foundation have always kept the other purposes of society in mind.

I have collaborated to develop offline apps in various languages and offline distribution systems. We are not just writing enWP for online use, we are also writing enWP for offline use. And the changes that make enWP better for offline users also makes enWP better for online users.

I have supported multiple video collaborations including with the Khan Academy,[164] HealthPhone,[165] Osmosis,[166] and WP:Videowiki. Rich content, such as video, was the second most requested improvement in the 2015 readers survey.[167]

Comments such as “VideoWiki, as an attempt to get editors to create and edit videos for Wikipedia, is a failure. The videos are rubbish too.“ [168] Sure the efforts are a work in progress but so is all of Wikipedia.

Other collaborators[edit]

Yes WPMEDF has collaborations with the World Health Organization, the National Institutes of Health, the Center for Disease Control and Prevention, Our World in Data, Cochrane, the University of California School of Medicine, HealthPhone, Internet-in-a-Box, Kiwix (Wikimedia Switzerland), Translators Without Borders, ECGepedia, VideoWiki, Turnitin (copyright detection tool), and Radiopedia, among other organizations. These have led to release of content under open licenses and positive recognition for our movement. The goals of WPMEDF are inline with those of the Wikipedia editing community and these efforts have generally advanced our mission. We are not going to succeed at collecting the sum of all human knowledge by ourselves.

Response to other evidence[edit]

With respect to the semi protection of gout, this was in 2012 following a brief episode of semi-protection not being effective. The good "faith edit" to gout that SG described added the text to the "cause" section of the article "gout may also cause the sex organ to shrink in men and render the sex organ inoperable if left untreated". The source they found that supposedly supports this does not mention shrinkage and was published after the edit in question.[169] That SG is trying to present this edit as good faith is strange. I do not clearly remember all the details from 8 years ago, but we did have a pharmaceutical company trying to promote their medication for gout User:Gout2012. I have removed protection from the pages in question.

With respect to gastroenteritis, replacing the name of a disease with that of a probable living person is vandalism.[170] Other IP vandalism.[171][172][173][174][175][176][177][178][179]

The claims around dengue are false. When a vaccine came out in Dec 2015 it was added that month.[180] When concerns about the vaccine came out in 2017 they were rapidly added that month.[181] When Sandy tagged the article Jan 28 2020 claiming that the most recent WHO article on the dengue vaccine was old they were simple mistaken.[182] What was there was a Sept 2018 paper by WHO.[183] which is still the most authoritative source on the topic. Yes there is a closed source analysis of the paper by Elsevier which does not really say anything different.[184]

We have an entire section on the Down_syndrome#Name. Most of our medical articles only contain one of these minor spelling variations. I started the RfC in question. The majority disagree with my position and the new version is now in place. This is how Wikipedia works, not seeing the big deal.

With respect to Graham Beards concerns about my edit summary in this edit on March 30th 21:58.[185] This was preceded by a discussion on their talk page March 30th 2020 at 19:21 to which they never responded.[186] They had previously removed all details of cost March 30th at 16:37 from simvastatin.[187]

Graham’s comments make it appear like I either added or supported the addition of Twitter and FB as references. I did neither. In fact I have removed such links.[188] GB did not feel WPMED deserved credit for work done on COVID19 despite User:Whispyhistory working a lot on the topic.[189] With respect to the claim that I do not see him as a peer, I did recommend that the journalist who wrote this piece reach out to him due to their involvement. Simple put I do view them as a peer.

Per the rotavirus vaccine this account in 2016 added further details regarding price to the body of the article.[190] Sure the details in the lead should have been updated as well and I have done so based on the newer and more details reference. Yes I used "is" instead of "are".[191] in Oct of 2019, sure I made a minor grammatical error. Yes this map does represent the frequency of the disease in the populations in question and yes frequency can be used in this case synonymous with prevalence.[192] (with the frequency being high, intermediate, and low). The definition of frequency is "the rate at which something occurs within a given sample". This map lists the explicit percentages.[193][194]

Evidence presented by Colin[edit]

Doc James, Blue Rasberry and QuackGuru are advocacy-editing over drug prices[edit]

The community has since 2007 required prices to be exceptional, not routine; to reject the "ephemeral trivia" of "street prices" "that can vary widely from place to place and over time" and not be "a price guide to be used to compare the prices of competing products, or the prices of a single product across different countries or regions". This policy statement came from two lengthy discussions (here and here).

The earliest medical discussion on drug prices is this one from 2010. There was very much support "to remove such information on sight" and reaffirming policy requirement for notable issues concerning price. This prompts User:WhatamIdoing to add prices to the MEDMOS list of things (along with dose and titration) that should not be included in articles "except when they are extensively discussed by secondary sources". The MEDMOS change is swiftly synchronised with the Wikipedia:WikiProject Pharmacology/Style guide by User:Anypodetos. This view requiring prices to be exceptional and notable is repeated at this discussion in 2014 on the Pharmacology Style guide.

The advocacy to include drug prices in all articles begins in this discussion at WT:MED from June 2015 started by User:Bluerasberry, who wants a "List price for month supply (US)" infobox field. This idea is strongly rejected by several users. James picks up the idea with this discussion in August 2015 which is on the talk-page of the {{Infobox drug}} template and is about the infobox and wikidata, not article leads. Ozzie10aaaa supports, though is short on justification. Bluerasberry, on the other hand, is effusive with advocacy reasons to include prices. There is strongly held opposition and no consensus to add prices to wikidata, infoboxes and never once is there a suggestion to add price sentences to the lead.

In August 2015, James begins adding MSH Price Guide based prices to the leads of drug articles. After inserting prices in 30 articles, James removes "pricing" from the "do not include" list at both style guides: here and here. He justifies the edit by citing the 2014 Pharmacology Style guide discussion. That discussion was very much against routine prices. The discussion resumes, provoked by opposition to James's change to the style guide, and BlueRasberry continues advocating for prices.

After adding prices to 100 drug articles by May 2016, James informs WP:MED of what he has been doing by starting a poll-style RFC. It is somewhat unclear what the RFC is actually proposing, other than a vague confirmation of what James has done, which isn't described in any detail. Ozzie10aaaa offers James his support, without any rationale. BlueRasbery joins in with his advocacy. James notes "Doctors Without Borders has done a fair bit of work to increase price transparency [195] and this is something they are interested in collaborating on." About 40 participants discuss and are numerically split evenly.

Admin User:Jc37 closes the RFC in July 2016: "Except in the cases where the sources note the significance of the pricing (which did have consensus), there is no consensus to add the pricing to the articles." Despite a lack of consensus to add prices, and an explicitly requirement for the sources to "note the significance of the pricing", James continues to add prices solely sourced to product price databases, which contain no commentary on the price at all. By the end of the 2016, over 300 drug articles have MSH Price-guide "developing world" prices, and currently 530 drug articles have explicit price statements in their lead (User:Colin/ExistingPrices). As User:Colin/PriceEdits shows, the vast majority of the edits to insert prices have no edit summary or the vague "added".

There is an edit war at Ivermectin in September 2019 over prices. In the talk page discussion, James notes industry lobby/censorship, lawsuits about TV commercials and industry hiding costs. At WP:NOT's talk page, James notes industry transparency issues and makes a comment about his personal experience. At WikiProject Pharmacology, James makes further advocacy comments. At WP:NOT, James says (without providing evidence) that "Every essential medicine has extensive coverage / discussion of its pricing by reliable independent sources" (there are 500 WHO essential medicines).

In October 2019 QuackGuru edits MEDMOS in support of James's article-lead pricing, and edit wars over this (see Barkeep's timeline). A long discussion begins WT:MED, mostly involving James and Colin. CFCF makes a personal attack on Colin. James posts about the pharmaceutical industry suppressing medication price information and then accuses Colin: "That you are pushing the industry position to try to WP:CENZOR Wikipedia is concerning." James goes on to create a subheading "Knowledge equity" where he expands his advocacy case. . The discussion continues on the MEDMOS talk page. Here QuackGuru says "NOT does not apply to medical content." (presumably referring to WP:NOT). James argues that relying on "the popular press" would lead to a US bias (presumably referring to WP:NOTPRICES policy requirement for mainstream media sources). JzG raises a concern about making the RFC conclusion watertight.

After over a month's gestation and much discussion, the RFC opens on 23 January 2020. James argues that prices are critical to human health and hyperlinks to an advocacy organisation's story: "Secret medicine prices cost lives". James tries to dismiss that WP:NOTPRICE ever had consensus. James selectively quotes WP:NOTPRICE. QuackGuru says readers may want to compare prices to other similar drugs. BlueRasberry argues that WP:NOT does not apply here and that he is not concerned about current article content. Later he makes a further dismissal of WP:NOT. BlueRasberry notes his previous employment relationship with Consumer Reports.

The RFC closes after two months on 27 March. A few editors remove price content from a few articles. The prices are restored by James, and edit warring occurs (see Barkeep's timeline). On 13 April, James criticises the RFC and those who drafted it.

Doc James reverts and edit wars on drug prices[edit]

User:Colin/PriceEdits contains all edits on drug prices on 530 articles since 2015. They were all added by Doc James. Attempts to remove prices are swiftly reverted by Doc James, occasionally aided by Ozzie10aaa and QuackGuru.

Response to evidence by Ian Furst[edit]

Ian Furst, I cannot find a single time when I have been critical of you personally. I have been critical of VideoWiki, which has largely been promoted by James, but that is content plus a set of tools, and we clearly disagree on its merits. My only personal interaction with you I can recall is when we crossed paths in 2013 over an issue (with another editor) at Water fluoridation, an article that I played a minor role in aiding Eubulides to get to FA. I gave you some friendly advice about potential COI in an article you were drafting and you thanked me for helping a newbie.

Wrt VideoWiki criticism, here are just a few examples of issues in articles today.

  • Each of the following videos have <font> tags visible in the Closed Captions, and have done since they were created a year ago: HIV/AIDS, Cholera, Cystic fibrosis, Polio, Hypertension, Influenza, Malaria, Multiple sclerosis, Sepsis, Urinary tract infection. [Note: this was fixed by James after my post. An example of the problematic timed-text can be found at commons:TimedText:Wikipedia-VideoWiki-Hypertension.webm.en.srt.]
  • Any images included in the video that are square or portrait-shaped, are squashed to 16:9 landscape. Examples at 2:18 of HIV, 1:24 of Cholera, 2:28 Cystic fibrosis, the first two frames of Polio, a very squashed pregnant lady with Hypertension at 2:34 who also has Malaria at 2:04. The archive footage at 0:32 of Multiple sclerosis is so vertically distorted as to appear barely human. The worst is really the poor little lad at 2:23 of Sepsis. [Note: this was somewhat fixed by James after my post. The video now contains images in the correct aspect ratio, but behind them is a blurred stretched version of the image which is often quite distracting, for example the lead frame at Sepsis. ]
  • Major_depressive_disorder has an upside-down photo. You can even see it on the script page. [Note: this was fixed by James after my post.]
  • There is a video, which I won't name here, that in the very first frame identifies by name a person with a socially stigmatising disease. The source image was taken down on Commons with a DMCA notice after lawyers contacted WMF, citing the distress it was causing their client. James commented at Commons on the case, and patched up the article lead image after its removal. The image was removed by Commons-delinker from the VideoWiki script. However, the VideoWiki video still contains it seven months later, and is still present on a major article that gets about 5000 hits every day (I can email diffs/links to arbs)

WP:NOTYOUTUBE warns about the problems that occur because the scripts and videos have nearly nobody watchlisting them. They clearly also have nearly nobody watching them either. The above presentation errors would all have been quickly spotted and resolved if they had occurred in articles or with still images, yet are still present a year later. Ian accuses me of "hyper-critical remarks about the quality". Judge for yourself. Would we accept HTML tags all over article content, or thumbnails with terribly squashed people in them, or images that even after they are legally removed from the wiki text, are still rendered to viewers of the page seven months later? -- Colin°Talk 21:43, 21 April 2020 (UTC)[reply]

Wrt Simvastatin, Ian Furst says pricing long preceded Doc James and was "Always with allowed sources". Partly true. The diff Ian supplies shows that User:Rod57 added the price unsourced in 2008. In fact, it took Rod57 four years to get around to adding the reference! Simvastatin in 2008 represents the very normal and policy-compliant situation where Wikipedians comment on the tiny minority of drugs with notable cost. As the first major statin to come off-patent in 2006, it was a very attractive generic, especially compared to the blockbuster atorvastatin, the biggest selling medicine of all time, which was still expensively under patent. Atorvastatin's patent expired in 2011 and today it is (in the UK) almost identical in price to simvastatin. So for those few years between 2006 and 2011, the relative cost difference between the two drugs was notable and did indeed get coverage in "mainstream media", which WP:NOTPRICES requires. Today, though, simvastatin is just another generic statin. The cost/benefit arguments of having a percentage of the population on prophylactic medication is true of all such statins, and not specific to that one drug. The argument for Wikipedia specifically discussing the (relative/absolute) price of simvastatin is today hugely weaker than it was in 2008.

The real change that James, encouraged by Blue Rasberry, introduced and enacted alone, was to routinely add prices to all drug articles, to do so at length in the article lead, and to conduct original research and cherry-picking of product database records to invent a treatment cost that no secondary source mentions. -- Colin°Talk 16:53, 23 April 2020 (UTC)[reply]

Doc James does not write about cost, he adds factoids[edit]

When James removed the constraint on adding price from both medical style guides (see above), User:Johnbod objected, saying "I'm in favour of discussing it where it is exceptionally high, & discussed as such in sources (see above), but we do not want people adding the (inevitably) USD prices of standard cheapish out-of-patent drugs, & proposing their favourite sources etc. Or international tables... Something needs to be added to say so." and warned "I don't think we should just remove all MOS controls on the topic. Inappropriate factoids often get added by well-meaning editors, & editors need a simple MOS reference to quote when removing them.". How precient. After the most recent RFC a couple of test edits were made to remove some database-sourced prices from two articles (see Barkeep's evidence). James restored those prices and expanded on the cost section in the body with yet more prices: Simvastatin and Ethosuximide. I shall discuss cost text in the workshop/analysis. James's edits demonstrate not only a disregard for consensus but a poor and ultimately harmful approach to adding content to Wikipedia, which frequently brings him into conflict with editors. This isn't article writing, it is just factoid insertion.

Response to evidence by RexxS[edit]

  • While we all agree a "price" is a numerical value in some currency, RexxS suggests that "pricing information" means "general prose descriptions like 'relatively inexpensive'" There is no evidence presented that any editor has considered that meaning before, and it seems unlikely to catch on since "information" can be presented in many ways, verbally or numerically. Strictly, "pricing" is a verb, and refers to the process by which companies and health systems agree on a price to charge and pay. But editors have clearly used both words to refer to numerical prices in articles. As a general topic, we all agree that drug pricing merits articles. The conflict, until very recently, has been nearly exclusively over the inclusion of numerical prices in articles, and I suggest the RFC and its closure was primarily interested in such prices. I suggest that if there is uncertainty about what an editor or closing admin meant by their choice of words, that they be asked. The issue of using adjectives or relative prices has received comparably little discussion, and the hasty addition of such clauses into article leads by James, followed by the creation of two poll-style RFCs, is part of the reason why this Arbcom was instigated. The issue of describing drug costs verbally needs further work.
  • RexxS offers only two NOTPRICE interpretations, but does not supply any evidence that any editor holds them. I am not aware of any editor who thinks "no prices or pricing information relating to drugs should be in Wikipedia". Nor am I aware of any editor who has suggested or protested against the kind of price comparison service RexxS describes. One editor has proposed adding an external link to GoodRX in the infobox, but not gone as far as to suggest Wikipedia offer that service today. BlueRasberry, James and QuackGuru have all strongly advocated that Wikipedia should be a price comparison service between drugs: that American readers may discover that WonderStatin is cheaper than SuperStatin and be empowered to ask their doctor for a cheaper prescription.
  • RexxS's description of editor-interpretations of NOTPRICE is significantly lacking in the aspects that many editors have felt to be vital. Cherry-picking of only some of this policy, or at times the denial it even exists (as James, Ozzie and BlueRasberry have all done), is what brings us to Arbcom.
  • Wrt the 2016 closing statement, RexxS appears to make a fundamental error of logic. I shall expand on this in the Workshop, but essentially WP:NOT is about not doing things, and one cannot use it to suggest we are therefore compelled to do some things. There are further obstacles to including text on Wikipedia, not least WP:WEIGHT.
  • Wrt the 2020 closing statement, RexxS quotes only a minority of points. In addition to the removal of prices from the lead, the closing statements made it clear (first and second bullet points) that prices derived solely from drug product database are not permitted -- they need to come from secondary sources that include commentary on the significance of that price. This, at a stroke, means nearly all the prices James has added to drug article leads should be removed, and not transferred to the body as James did. Since the main focus of that RFC was on prices derived solely from a drug product database, it is notable that this key finding is being overlooked by some.
  • The statement "Since the 2020 RfC closed, prices have been systematically removed from the lead of articles" is not supported by any evidence. I am aware of four articles where editors removed prices from the lead, shortly after the RFC closed. There are 540+ articles with such prices.

Atorvastatin[edit]

  • 30 March. User:Graham Beards removes prices from the lead, edit summary: "deleted drug "cost" from the Lead as per RfC". This RFC closed saying prices should not be in the lead and prices should not be solely sourced to drug product databases, which two prices here (US and UK) were.
  • 30 March. User:Doc James restores the prices to the body, and adds a statement "Atorvastatin is relatively inexpensive" to both the body and lead, citing a textbook. The edit summary "adjusted" is the same one James used in conflict to restore prices to Ethosuximide and Simvastatin. The database-sourced prices should not have been restored.
  • 1 April. User:Hipal asks on talk "How about removing all mention of pricing from the lede per the RfC and the content policies cited there?"
  • 2 April. User:Hipal asks again "Any objections to my removing it from the lede per RfC and policies?"
  • 4 April. User:Hipal removes "and is relatively inexpensive" from the lead, edit summary: "per recent RfC, pricing information in lede is almost never appropriate - nothing here demonstrates it is one of the few exceptions"
  • 4 April. User:Hipal notes his removal on talk.
  • 4 April. User:Doc James reverts Hipal with Twinkle, edit summary "No support for this". Admin Doc James is now edit warring.
  • 4 April. User:Doc James comments at talk "Of course plenty of objection and we have a RfC here Talk:Simvastatin#Clarification_of_RfC were support is overwhelming."
  • 22 April. User:Seraphimblade reverts James, edit summary "WP:NOPRICES as well as an explicit RfC." Admin Seraphimblade is now edit warring.
  • 22 April. User:RexxS reverts Seraphimblade, edit summary "revert removal of sourced information per Wikipedia talk:WikiProject Medicine/Archive 84 #Price of medications. This is not a price". Admin RexxS is now edit warring.
  • 22 April. User:RexxS writes on talk "Following a unilateral decision to remove the phrase "and is relatively inexpensive", I have restored it." Rexx introduces his novel distinction between "price" and "pricing information" (the former being numerical and the latter textual, according to RexxS).
  • 22 April. User:Seraphimblade reverts RexxS, edit summary "Mentions of cost are price, and are covered by the 2020, not 2016, RfC. "Inexpensive" is mentioned only in passing by one source in a brief blurb. That is not the type of in-depth coverage the new RfC requires for lead inclusion, which is why it has repeatedly been removed. It stays out". Admin Seraphimblade continues to edit war.
  • 22 April. User:RexxS reverts Seraphimblade, edit summary "Don't edit war - there is an open talk page discussion that you have not engaged in". Admin RexxS continues to edit war.
  • 22 April. User:Hipal says on talk "RexxS, you're edit-warring. Your interpretation of the RfC has no consensus."
  • 22 April. User:RexxS says on talk "Hipal your partisan stance is already well-known. The edit warring was begun by Seraphimblade when they redid their bold removal of content which was reverted. I am editing in accordance with consensus; they are not. I already know what belongs in lead sections."
  • 22 April. User:Hipal on talk objects to being dismissed.
  • 22 April. User:RexxS on talk RexxS appears frustrated that Hipal does not accept RexxS's terminology, which he says originated with Hipal: "The differentiation between prices and pricing is absolutely clear, and you're the one who made it." RexxS says to Hipal: "I no longer believe you are making a good-faith attempt to resolve differences". RexxS warns: "I'll continue to edit according to policy."

Doc James: Solo Performer[edit]

The areas where James brings himself into greatest conflict are where he makes widespread controversial edits, without seeking or gaining consensus, by stealth and editing alone rather than in collaboration with others.

Osmosis videos[edit]

James, in his evidence, states that "Rich content, such as video, was the second most requested improvement in the 2015 readers survey" What we don't know, because they weren't asked, is if this rich content is "The article subject as a seven minute video in a lecture format aimed at Canadian medical students, top and tailed with promotional logos and links for a subscription learning platform." It could instead be readers wanted interactive features (BMI calculator), animated diagrams or short video clips, something all of us agree on. User:Colin/OsmosisEdits documents the edits made to add or remove the Osmosis videos to 308 articles. Only 21 additions (7%) had the meaningful edit summary "added video"; 152 (50%) have the meaningless "added"; 124 (41%) are blank and 9 (3%) suggested other activity. These videos were added by James without community approval and by stealth.

If you need a reminder of how awful they were, try File:Candidal infections.webm, where it opens with a !hilarious joke about Candida vs Canada. Oh, yeast infections are always a great source of much needed humour in an encyclopaedia. Or try File:Breastfeeding.webm, where it opens with the claim that breast milk has all the nutrients a baby needs for the first year of life. In fact, all medical authorities state solid foods should be weaned from 6 months. Or try File:Tic Disorders.webm, where listeners are introduced to the DSM-5 tic disorders and told individuals with these disorders all suffer from tics. But DSM-4's "suffer from" was dropped like a hot potato from later editions after an outcry from experts, researchers and patient groups.

These videos were not there to supplement our articles with illustrative clips, but to entirely replace the need to read them, justified by the pseudo-scientific woo that some people are "visual learners". They were not scripted by or composed by a community of editors working on an online platform open for anyone to edit. They were created by a private company who want to sell subscriptions to their training videos. As RexxS notes in his evidence, when editors started trimming off the promotional top and tail, relations with Osmosis soured. Wikipedia has always been firmly against sponsored content and advertisements; James introduced it to over 300 high profile articles without asking.

Translation task force[edit]

The English-Wikipedia part of the Translation Task Force is James. It has been a source of conflict with English Wikipedia for many years. It mainly affects article leads, for that is all that gets translated. Conflicts include an early push for all medical articles to use the same few citation templates (other Wikis don't have our variety), the forcing of excess citations into the leads, the dumbing down of our leads to make translation easier (apparently), or the insertion of material into the leads alone (e.g. drug prices).

As James notes in his evidence, James has simplified more than 1300 leads. This task-force page has been used by James, from June 2014 to the present day, to tick off each article as he works on it. To see what goes on, you need to look at the date of the "Simplified" link. Carbamazepine was simplified on 28 March 2015. If you look in the history of Carbamazepine on this day, you see James began editing at 23:02 and stopped at 23:52. He then copied the lead over to the Simple Carbamazepine page that gets translated. The steps follow this pattern:

  • The paragraphs in the lead are re-ordered per James's preferred order.
  • Sections missing from the lead are summarised and included.
  • Citations are added to the lead even though they aren't needed. Occasionally sources updated.
  • The language is simplified or dumbed down, depending on your POV.

You'll find this for every simplified version. The Wikipedia article lead is adjusted by James to conform to the needs of the Translation Task Force and then forked to produce a petrified Doc-James-approved version that is later translated.

Drug prices in leads[edit]

This is well documented elsewhere in the evidence. User:Colin/PriceEdits lists 530 articles with prices in the lead. With hardly any exception, all the prices in leads were added by James, sourced to drug product price databases. He began this task without asking anyone if adding the prices to the lead met community approval, and when in 2016, after adding 100, he did ask, he didn't get consensus to continue adding them. Yet he still did. And here we are at Arbcom.

Other[edit]

There are 500 medicines in the WHO Essential Medicines list. This binary fact was added by James to every such drug lead as: "It is on the World Health Organization's List of Essential Medicines, the safest and most effective medicines needed in a health system."

The Top 300 Drugs from ClinCalc.com have had their US sales rank and prescription totals added by James to the end of the lead with the sentence "In 201_, it was the ____th most [commonly] prescribed medication in the United States, with over ___ prescriptions". These two data values, if of note, seem more appropriate for an infobox than in prose. In the lead, it should surely have to be more notable (e.g. in the top 20, or the biggest seller of its class of medicine).

Doc James: Dumbing down Wikipedia[edit]

Examples[edit]

  • "is an anticonvulsant and mood-stabilizing drug" changed to "is a medication".
  • "was discovered by chemist Walter Schindler at J.R. Geigy AG (now part of Novartis) in Basel, Switzerland, in 1953" (body text) added to lead as "Carbamazepine was found in 1953 by the Walter Schindler".
  • Infobox "routes_of_administration - Oral (capsules, oral solution)" changed to "routes_of_administration - by mouth (capsules, solution)"
  • "is a succinimide anticonvulsant" changed to "is a medication" + "Ethosuximide is in the succinimide family of medications."
  • Short stubby sentences: "Side effects are generally minimal." -- "Ethosuximide is taken by mouth." -- "How exactly it works is unclear." -- "Ethosuximide is avaliable as a generic medication."
  • "is an acidic organic compound that has found clinical use as an anticonvulsant and mood-stabilizing drug" changed to "is a medication"
  • Short stubby sentences: "Long acting formulations exist." -- "It is unclear how valproate works."
  • "Valproic acid was first synthesized in 1882...In 1962, the French researcher Pierre Eymard serendipitously discovered the anticonvulsant properties of valproic acid...It was approved as an antiepileptic drug in 1967 in France..." (body text) is condensed for the lead to "Valproate was first made in 1881 and come into medical use in 1962".
  • After the opening sentence, James added a series of sentences about NSAIDs and ibuprofen's side effects which are not a summary of the body, but come from a new source: "About 60% of people improve with any given NSAID and it is recommended that if one does not work that another should be tried, Ibuprofen may be a weaker anti-inflammatory than other NSAIDs. Compared to other NSAIDs it may have less side effects such as gastrointestinal bleeding. At low doses it does not appear to increase the risk of myocardial infarction; however, at higher doses it may. It may result in worsened asthma." The source (BNF) says patients "respond" rather than personally "improve" as the article claims. There's a lot of "may" here. The source says its "anti-inflammatory properties are weaker", not "may be". The source says "fewer side-effects" and we have "less side-effects", which grammar pedants won't like. Wrt risk of myocardial infarction, it is odd here that James has not substituted "heart attack". For higher doses we are told "it may [increase the risk of MI]". A "risk of" is already a "may" situation, and the source is in no doubt of the association with increased risk. The final sentence is stubby and is a good example of the vague use of "it" throughout this paragraph. Ibuprofen doesn't cause heart attacks and make your asthma worse sitting on your bathroom shelf. This is a pill many of us will take occasionally, whereas some people will take it regularly, for arthritis, say, and here the reader could do with knowing what "it" might give you a heart attack.
  • "synthesised" changed to "made".
  • In the second edit, the lead paragraph gains "It may also be used to close a patent ductus arteriosus in a premature baby." Most readers won't have the first clue what a patent ductus arteriosus is, it doesn't have a reader-friendly name, and it is complex to explain how ibuprofen (given IV) might help close this. This factoid really doesn't belong here.
  • Short stubby sentences: "It can be used by mouth or intravenously. It typically begins working within an hour." Here we have the weird "used by mouth" rather than the idiomatic English "taken orally".
  • The Epidemiology section concludes with a statement, added by James, that "In the United States about 19,000 new cases occurred in 2011 down nearly 90% from 1990". This makes the confident claim that these cases actually occurred and that 19,000 is an approximation to the real figure. The source gives a figure of 18,800 so it is a reasonable approximation. But crucially, it is actually an estimated value. The actual number of cases reported to the CDC in 2011 was only 2,890. They then take into account underreporting of cases and asymptomatic infection to mathematically calculate and estimate the likely true incidence. The latest figures for 2017 give the number of reported cases as 3,409 and the estimated number of infections as 22,200 and importantly their confidence interval is 12,600 to 54,200. That's a big range: it could be half this or over twice this. This lack of correlation with what our sources really say, is unfortunately a common feature of James's edits, and naturally is a source of conflict among editors trying to make sense of the Covid19 pandemic. We also saw it with the drug prices, where figures were claimed to be approximates but were actually given in four figures to the cent, and the method of calculation, involving cherry-picking records, meant they were effectively just random numbers.
  • The two terms that any readers of an encyclopaedia section on disease epidemiology have to understand are incidence and prevalence. We cannot shy away from those words. The careful writer uses them in a way that the reader can infer their meaning, even if they are unfamiliar with them or get them confused. James's edit removed both words from image captions. "Prevalence" was replaced by "Frequency" and "Incidence rate" with "New cases of". Not only have we now got captions that use different terminology to the body text, but they are simply wrong. Both incidence and prevalence are measures of frequency (the frequency of new cases occurring over a time period and the frequency of current cases respectively) so this replacement muddies what measure the map is telling the reader. Both are typically expressed as a rate (e.g., per 100,000 people) rather than a total figure for an entire country. Therefore the substitution of "incidence rate" with "new cases of" is completely incorrect.

Observations[edit]

In James's evidence, he cites "a published analysis" on the "Readability of English Wikipedia's health information over time". What James neglects to mention is that this paper was co-written by James himself and published at our own WikiJournal of Medicine. The paper relies on readability formulas, which are a peculiarly American pseudo science. Naively simple algorithms, designed before A.I. was a thing, count long words and sentence length and perform some dubious maths to concoct a score corresponding with an American school grade. The article Readability Formulas: 7 Reasons to Avoid Them and What to Do Instead by Jarrett and Redish provides a good overview of their problems and how good writers focus on something other than a grade score generated by a computer. Even if we accept the claim that easy and difficult texts are correlated with lower and higher scores, it does not follow that lowering the score means the text is easier to read and understand or that is engaging in any way.

Wikipedia, as a hyperlinked encyclopaedia is different from text that must simply be understandable or enjoyable: it is primarily educational. Part of that educational role is to teach readers or give them confidence with words they don't know or are unsure about. We can do this with definitions like a dictionary, but the primary way people learn words and learn how to use words is to see them used in context in high quality writing. Writing accessibly about complex subjects, as many areas of medicine are, in a way that draws the reader in and holds them requires some talent and skill. What can you do if you lack these? You can improve the readability score in several mechanical ways: remove or replace words or concepts you think are hard, write short stubby sentences, and dilute the difficult stuff with more text. James does all of these.

  • In Carbamazepine, Ethosuximide and Valproate articles, the class-of-drugs -- "anticonvulsant drug" or "mood-stabilizing drug" -- is just removed and we are only told it is "a medication". We are simply no longer teaching the reader something that had a multi-syllable word.
  • In hundreds of Wikipedia articles, the idiomatic English "taken orally" has been replaced by James with "is used by mouth". This is such a weird expression. Oral might not be an everyday word, but it isn't university-level either. Any parent will have used an "oral syringe" to give a child Calpol. It isn't a "mouth syringe". Our readers expect us to use the proper words, and not be patronised: "oral medication" is a thing.
  • In the leads, new chemicals are no longer "first synthesized", they are "first made". But chemical synthesis is a thing. It is a specific kind of making. New drugs are no longer "discovered", they are "found". Like a chemist just came across them in the street, or perhaps had lost them the day before. But drug discovery is a thing. You cannot learn about chemicals and drugs without appreciating these terms.
  • When preparing the leads for the translation effort, James may expand the lead by summarising article content. He doesn't research the topic and improve the body -- the body isn't touched. This is low-hanging fruit: summarise what is already there.
  • The leads are then augmented with boilerplate sentences about WHO Essential Medicines, US sales rank and prices in several regions of the world. The reading age of the lead goes down because none of this extra padding is teaching you any new concepts.

The article I linked earlier gives a good example of the flaws of naively simplifying words just because they appear technical or advanced. The authors decided to replace the official term "Security Deposit" (we even have a wiki article on it) with "Promise Money", thinking this was easier for their audience of "low-income, low-literacy tenants". But these adults knew the term "Security Deposit" already, even if individually the words "Security" and "Deposit" are financial jargon; they were perplexed by "Promise Money", even though "promise" and "money" are simple words.

Ethosuximide[edit]

James refuses to accept RFC close[edit]

  • 29 March. Colin removes the numerical prices from the lead. Edit summary: "per Wikipedia:Manual of Style/Medicine-related articles/RFC on pharmaceutical drug prices". James restores these prices to the body. The edit summary "adjusted" is the same one James used in conflict to restore prices to Atorvastatin and Simvastatin. The database-sourced prices should not have been restored.
  • 30 March. James expands the cost text to include the statement in the lead and the body that "As of 2008 it was generally affordable in most areas of the world" citing a textbook. James posts on talk a new section on Affordability. His source is a Google Book result for the search 'Ethosuximide cost'. As with many books freely readable at Google Books, the textbook is an ancient second-edition from 2004, not 2008 as the article claims. The third and fourth editions of this textbook drop "ethosuximide" from the list of generally affordable medicines.
  • 31 March. SandyGeorgia removes this additional body and lead text. Edit summary "revert per discussion post-RFC here, will separately reinstate infobox changes as needed". James reverts Sandy with edit summary "Not what the RfC says". Admin James is now edit warring. SandyGeorgia tags the text as "disputed". James begins an RFC asking for votes in support of the sentence he added to the lead. He says "we have textbook by a well respect medical publisher" but neglects to mention it is 16 years old, and there are two more recent editions, both of which demonstrate the statement James added is not true. SandyGeorgia objects to the voting and "yet another RFC to dispute the already held RFC" and "the use of 2001 data from one country to support price statements" James offers another source. This is a Google Books result for the search 'Ethosuximide inexpensive' and is from 2005. SandyGeorgia complains the source is two decades old. WhatamIdoing opposes the voting-style RFC and asks for a discussion instead.
  • 1 April. Hipal says "I don't see the point of responding to these biased RfC's. They're clearly efforts at IDHT and CONLOCAL. The ArbCom case should sort these behavioural problems out"
  • 3 April. Ozzie10aaaa supports "I support based on sources, just to clarify as I never write this much it should be noted that references speak for themselves, I hope this matter can be solved, thank you".
  • 5 April. WhatamIdoing points out that the price Colin removed and James restored "a couple of hours later" was in fact text James agreed during the RFC was unacceptable. James makes further changes to add availability info to the lead, to change "developing world" to "from an NGO in the Democratic Republic of Congo" and to and an Italian retail price from 2001 (though James writes 2011). WhatamIdoing writes that the RFC close clearly made the MSH Price Guide an unacceptable sole source and suggests James asks the closing admins for clarification. James writes (wrt the closing admins) "They also say "database which covers some ground and does not require interpretation... should be discussed at the talk page". We could write "[...]" That requires no interpretation as required." WhatamIdoing responds: "I'm really surprised and dismayed that you left out so much of the sentence you quote there. James, that's "selective" to the point of seeming dishonest" and goes on to quote the whole sentence and "The sentence you (mis-)quote is about hypothetical other databases, not about MSH's IMPPG database. And it doesn't say that these other databases are acceptable; it only says that there's a possibility that some hypothetical and heretofore undiscussed database might not have the same fatal problems."
  • 6 April. Wugapodes (a closing admin) responds that the RFC was clear about the sentence using the MSH price being unacceptable. WhatamIdoing posts I think that, given Wugapodes' statement at 03:23, 6 April 2020 above, that this sentence will be removed as soon as Doc James has had a moment to catch up on his watchlist". James says Sure and the sentence discussing in the RfC is no longer in the article. WhatamIdoing is unconvinced: But, it does still seem to be in the article?" Wugapodes responds again that James's change to the article text is still problematic, but shies from declaring "a blanket ban on the MSH IMPPG database". James responds "WAID I think given Wugapodes' statement at 21:43, 6 April 2020 their is not justification to remove this sentence."

RexxS reboots RFC on obscure article talk page and attacks Colin[edit]

  • 6 April. After several editors have already complained about multiple new RFCs on article talk pages, RexxS posts a set of nine new questions "to look at the bigger picture". Six of these are general questions about any drug and cost, such as "Do we agree that drug articles can have a section on Cost?" Colin objects to the location of this new nine-pointer discussion on an article talk page that not even been used till this dispute: I don't think it is helpful to contemplate further areas of agreement/disagreement on drug prices in this Ethosuximide talk page. This is an article surely that until a few days ago was likely on a couple of people's watchlist. It is clear that RexxS misunderstands and thinks Colin is trying to shut down debate: "If you are genuinely interested in finding areas of compromise, rather than insisting that your own view should prevail, then I would have hoped you would have welcomed attempts to isolate the disagreements. Later he complains "you don't seem to have done us the courtesy of indicating the sources that support your assertion, and that really isn't helpful" (Colin has, in fact, given sources earlier). RexxS adds "If you were to try to find some common ground, you would find that over-egging a reasonable argument (20-year-old prices) merely serves to diminish it."
Colin then posts to Barkeep's talk page, complaining about RexxS's hostile comments. RexxS responds "As usual Colin presents a distorted picture of his interactions with other editors, and with me in particular....It is quite disingenuous of him to...If he goes trolling for a reaction, he mustn't be surprised when he gets one....I am afraid that I cannot assume good faith with Colin.". RexxS complains again of difficulty following the conversation: "He knows what and where he posted earlier today, but leaves other editors with the puzzle of trying to figure out from his contributions what that was and chase around to find it. That's unacceptable game-playing, and you'll note that I scrupulously quote my sources in every interaction. That's the sort of courtesy I expect from other editors who are trying to help each other to find common ground, and I've have consistently found that an impossibility with Colin." The bad faith continues "When you begin your post with a statement whose only purpose is to provoke a reaction, I'll call you out on it. I'm not going to be bullied by you." Later RexxS posts a sort of non-apology followed by a threat: Given the degree of unpleasantness I've received in my interactions with you over the years, I'm afraid that I have difficulty in continuing to assume good faith when debating with you. I trust you won't want me to list examples of our prior interactions."
  • 7 April. RexxS continues re-running the main RFC arguments all over again and his comments include many misunderstandings and confusion about what has already been said by other parties. He accuses Colin of personal attacks, states I misunderstood nothing. You have chosen not to address the points I made on NPOV and NOTPRICES, and I think that speaks volumes to the shaky foundations that you base you arguments on. He then demands Colin responds to several new questions. But Colin has had enough: "I don't think this conversation is working" and "I said what I wanted to say about "low cost" at 09:18, 1 April 2020". Note that Colin is referring to an earlier post on this page, using the same timestamp method as James and WhatamIdoing did earlier above. RexxS complains Why do I have to go searching through your contributions to find something you could have linked. Is 09:18, 1 April 2020 in EST, GMT, BST, CET? What? Simple basic courtesy to other editors is needed if you're going to avoid accusations of deliberate obstructiveness.
  • 8 April. Colin posts to RexxS's talk page, that his method of referring to an earlier post was identical to that done by James and WhatamIdoing. RexxS responds "...then I realised you were playing games again...The simplest basic piece of courtesy is to link to something if you want to refer to it. I do that scrupulously in my contributions, and for you to make me play detective work again is contemptible. When you're prepared to debate in a constructive and collegiate manner with a view to finding some common ground, I'll have reason to start assuming good faith. But with stunts from you like yesterday's why should I ever assume you act in good faith toward me? I'm not here to harm Wikipedia, but I'm not here to be treated with contempt by you, either."

Remitted to one venue only - Clerking leads to hostility from Rexx[edit]

As part of the ANI close restrictions wrt drug prices, discussion on the topic was remitted to one venue only: the MEDMOS talk page. Barkeep encouraged editors to use his talk page if they want to complain about other editors, rather than posting such complaints at the MEDMOS discussion. WhatamIdoing created a draft RFC at Wikipedia:Manual of Style/Medicine-related articles/RFC on pharmaceutical drug prices.

  • 2 Jan. SandyGeorgia posted on the draft's talk page a thanks to WAID and asked Colin a question.
  • 2 Jan. Colin responded.
  • 2 Jan. WhatamIdoing continues the discussion. She even moves some of Colin's text about and into a sub-heading.
  • 2 Jan. Colin asks Barkeep if the post at the draft talk page was a wrong venue.
  • 2 Jane. Barkeep replies that yes discussion should only be at WT:MEDMOS.
  • 2 Jan. WhatamIdoing, blanks the draft-talk discussion and pastes it into WT:MEDMOS. She responds to Barkeep to say that the text is moved.
  • 20 Jan. Rexx posts a comment to the draft talk page criticising WhatamIdoing: "This is a clear indication that you're counting angels dancing on pinheads: your arithmetic is as bad as James' and your assumptions cause a bigger error than the one that you were calling "incorrect"".
  • 20 Jan. Colin responds defending WhatamIdoing.
  • 20 Jan. SandyGeorgia reminds us that "there is one venue for pricing discussions, and this is not it." while pinging RexxS, Colin and Barkeep.
  • 20 Jan. Colin blanks the draft-talk discussion with edit summary "moved to WT:MED talk" (which is a typo, it should be WT:MEDMOS) and pastes it into WT:MEDMOS, with edit summary "move from RFC talk".
  • 20 Jan. RexxS reverts the blanking with edit summary "Don't mess with my posts - This is a commentary on an edit summaryfrom THIS page - not any other" and reverts the pasting at WT:MEDMOS with edit summary "I didn't post this here, and moving it here is misleading, as well as discourteous to those who received notifications. If you forge my signature again, I'll take direct action to prevent a repeat."
  • 20 Jan. Colin complains to Barkeep about RexxS's hostility and bad-faith allegations about forging signatures.
  • 20 Jan. RexxS replies: "Colin...seems to have gained the impression that he can dictate where other editors post. He can't. I did not give him permission to copy my signature onto a page that I didn't post to. It's deceptive and runs contrary to our CC-BY-SA licence. It's about time somebody reined in Colin's bludgeoning tactics, and if he tries that sort of heavy-handed trick with me again, I'll seek sanctions against him. It's not friendly, I agree, but then neither is Colin's behaviour, and it needs to stop.".
  • 20 Jan. Barkeep recommends "Keeping discussion of the RfC at one place would always be a bit of a challenge and the occasional slip is to be expected. It's best in such situations that an uninvolved sysop (of which there are now two on the scene? 1.5 at least?) be the one to do such clerking rather than active participants in the content discussion.".
  • 20 Jan. RexxS says he was unaware of the single-venue restriction. Note: Sandy did ping RexxS about the single venue restriction, prior to Colin moving the text.
  • 21 Jan. RexxS comments "looking at it from Sandy and Colin's point of view (who have been immersed in the process), I must have seemed to be a complete klutz for posting in the wrong location.".
  • 21 Jan. Colin comments that he is unhappy at being treated differently to WhatamIdoing, who performed an identical clerking move, and who is neither an admin nor uninvolved. He says "I do object to admin's thinking that certain edit actions require a level of privilege: it rather goes against the "Encyclopaedia anyone can edit" community values"
  • 21 Jan. RexxS responds "You still have to butt in, don't you Colin?" Colin opened the discussion on Barkeep's page, and so you might think he is entitled to participate in it. RexxS continues: "yet another PA. I have at no time used any admin tools in this RfC, nor do I intend to." RexxS has got wrong end of the stick on this. " I didn't make that post to that page, and you misled others into believing that I did. We don't allow that kind of deception on Wikipedia, and had I taken you to ANI for review by independent admins, you would have stood a good chance of being sanctioned. Don't do it again." He continues "Your pretending that somehow you are the victim of my justified annoyance fools nobody. The community functioned perfectly well in your absence for years, and the problems arising now stem principally from your crusade to remould our accepted guidance and practice into your own image of what it should be without compromise."
  • 21 Jan. Colin replies and is particularly upset about the "The community functioned perfectly well in your absence for years" comment.
  • 22 Jan. Barkeep replies that this comment does indeed "land on the personal attack side of things". He goes on "Colin, I agree with you that sysops aren't special on the whole." and "You and WAID are being treated differently, I concede, and neither of you are sysops".

Two episodes here where my actions (clerking) and text (referring to previous posts on a page) were near identical to other editors, yet RexxS brings quite an astonishing degree of hostility. The red mist descends, and every problem RexxS has following the conversation is Colin's deliberate fault, setting traps and playing tricks. I am at a loss as to how this can be acceptable from an admin.

Evidence presented by Ozzie10aaaa[edit]

Good faith effort/discussion[edit]

SG[edit]

  • 1.response to SandyGeorgia,.....yes I often keep an eye on Doc James due to his Wikipedia:WikiProject_Medicine/Stats/Top_medical_editors_2019_(all), as a consequence I try to chime in on any medical articles he may be on (AFTER READING, AND DECIDING WHAT IS BEST FOR ARTICLE), he is an elite editor and therefore I try to learn as much as possible from him. However I do not always agree w/ Doc James as SG noted on their post or on many occasions I simply do not give an opinion, thank you--Ozzie10aaaa (talk) 19:42, 20 April 2020 (UTC)[reply]
2.SandyGeorgia has been BLOCKED before for Personal attacks/Harassment...is something that should be taken into consideration--Ozzie10aaaa (talk) 17:33, 21 April 2020 (UTC)[reply]
Hi Sandy, I've just blocked you for this edit. Accusing others of sockpuppetry without providing evidence is a personal attack. You have been warned not to do this in the past on multiple occasions ([196][197]). If you wish to retract the allegation or provide evidence, I will be happy to life the block. Mark Arsten (talk) 16:17, 25 June 2013 (UTC)[198]--Ozzie10aaaa (talk) 21:51, 27 April 2020 (UTC)[reply]
3.Per SG...GA written by others at Wikiversity but attributed to Ozzie10aaaa on Wikipedia...I would answer this however???(this is an example of the above comment #2 personal attack/harassment), thank you--Ozzie10aaaa (talk) 21:27, 27 April 2020 (UTC)[reply]

Colin[edit]

  • 1.reponse to Colin,...…(see above answer to SG, thank you)--Ozzie10aaaa (talk) 19:47, 20 April 2020 (UTC)[reply]
2.copied from the Main page response...... (With regard to Colin's indication ...I agree w/ Doc James, it should be checked in my edits that 1. I have on several occasions "agreed w/ WAID [WhatAmIDoing]" (on other articles/matters) , 2. as well as many other editors...I don't/never will write a "wall of text", I usually keep it simple, 3. and most important I don't always agree w/ Doc James, therefore I do not support/do not comment on the article/matter whatever it might be, thank you--Ozzie10aaaa (talk) 13:43, 2 April 2020 (UTC))--Ozzie10aaaa (talk) 20:29, 20 April 2020 (UTC)[reply]
3.Wikipedia:Administrators'_noticeboard/IncidentArchive1025#User:ColinWikipedia:Administrators'_noticeboard/IncidentArchive1025#User:Colin On 12/5/19 I opened ANI for incivility--Ozzie10aaaa (talk) 00:56, 26 April 2020 (UTC)[reply]
4.SG/Colin interaction...as you may note (in the above #3), SandyGeorgia responded in defense of Colin within 30/40 minutes of my ANI post, furthermore the committee may be interested in interaction timeline between the two, going back some time, thank you--Ozzie10aaaa (talk) 16:06, 26 April 2020 (UTC)[reply]

Evidence presented by bluerasberry[edit]

Sandygeorgia's misconduct is the continuous use of negative tone[edit]

Sandygeorgia routinely speaks with a negative tone. In the RFC on pharmaceutical drug prices this user tells me what they think of my contributions to Wikipedia.

  • off-putting
  • blatant violation
  • soundly rejected
  • I shudder to think
  • no meaningful content or analysis,
  • (bluerasberry's participation causes) The loss of valuable editor time
  • exhausting and demoralizing
  • a strange argument indeed
  • have used (misused) the data
  • Examples are mostly irrelevant
  • this much time on what was a "pilot" is alarming
  • meaningless
  • People are dying
  • meaningless gibberish
  • taken too much time away from real content creation
  • meaningless information
  • can't turn this sow's ear into a silk purse

Here is Sandy talking about another of my proposals at Wikipedia talk:Prices:

  • blatantly misleading
  • entire essay is a mess
  • waste time trying to fix something that has no value
  • Sheesh, wouldn't it be nice
  • This writing gives me a headache
  • I don't think effort should be expended on it
  • Fixing this essay would be a time-sink
  • this is perhaps the most egregious edit
  • It is especially shocking that
  • leave to Bluerasberry to perform as a show of good faith
  • This is blatantly deceptive
  • so blatantly deceptive

Colin's misconduct is the continuous use of negative tone[edit]

Colin routinely speaks with a negative tone. In the RFC on pharmaceutical drug prices this user tells me what they think of my contributions to Wikipedia.

  • Godwin's law
  • colossal quantities of meaningless and misleading data
  • you've lost. Game over
  • doesn't make sense on a wiki
  • nor does it correspond with facts
  • ridiculous idea
  • repeat false claims
  • not only impractical but simply a cop-out
  • misleading our readers
  • that's what makes us look like chumps
  • I think you need to stop

Here is a list I made in a previous behavior complaint about Colin. This is not about me but it is from one conversation.

  • just plain incorrect
  • problems with our use
  • wrong on so many levels
  • rather embarrassing to WP:MED
  • This is your problem
  • I think you have forgotten
  • James is misusing
  • it is just nonsense
  • wrongly claims
  • usually inappropriate to use
  • the sort of thing we shouldn't do
  • The problem
  • you are just acusing me
  • It wasn't intended
  • nobody else does this
  • there is no consistency
  • falsely claims
  • more complicated than you want
  • your statements are very unclear.
  • If you won't accept this
  • over-simplified like you do
  • no reasonable way
  • I know you wished
  • you are being wilfully obtuse
  • You ignore
  • you are not acknowledging
  • you cherry-pick
  • you had an agenda
  • WP:MED intends to silence any criticism
  • It doesn't work
  • which is wrong
  • it would be good for you to admit you made a mistake
  • You still haven't found any
  • falsely claims
  • isn't what I asked for
  • you don't understand database copyright
  • are not allowed to do that
  • failing to present anything coherent

Colin and Sandy engage in a pattern of misconduct[edit]

Routinely and with regularity, Colin and Sandy have been opposed to WikiProject Medicine proposals. Friendly criticism is not the issue. The problem is excessive focus on WikiProject Medicine with negativity. This behavior is hounding, stalking, harassment, flaming, trolling, griefing, or misconduct by any name. Per Wikipedia:WikiProject, a "WikiProject" is a group of people who want to work together to improve Wikipedia. Colin and Sandy do not travel to WikiProject Medicine to seek collaboration, but rather to engage in a pattern of disruption. Their objections to WikiProject Medicine activities, whether reasonable or unreasonable, are no justification for the continuous negativity.

The pattern is as follows:

  1. Someone at WikiProject Medicine makes a proposal
  2. Colin and Sandy learn of these projects by observing WikiProject Medicine's talk page
  3. Colin and Sandy oppose these proposals
  4. Colin and Sandy express their opposition to these proposals with negative tone

WikiProject Medicine participants get harassed for making proposals[edit]

A "Wikipedia proposal" is any new idea, workflow, tool, endeavor, partnership, or subproject in which a group of people publicly share and develop plans to engage in some collaborative activity with the Wikipedia community. Some proposals are good, some are bad, and most are so-so. Regardless of the quality of a proposal, everyone who presents one deserves civil behavior.

The following proposals have all of the following in common:

  • they all found consideration at WikiProject Medicine
  • all of these proposals got opposition which was sometimes reasonable and sometimes unreasonable; opposition to the proposals is not the issue
  • In all of these at least one of Colin or Sandy use the pattern of misconduct to disrupt collaboration
proposals
  1. Wikipedia community outreach including to medical schools for student editing
    1. Sandy complains that WikiProject Medicine endeavors since 2012 are "away from development of English Wikipedia", "no longer focused on quality"
    2. SandyGeorgia in 2018 calls the medical school outreach program a nightmare
  2. Osmosis, a donation of professionally produced, medical-school targeted health videos for Wikipedia
    1. Administrators' noticeboard/IncidentArchive979#Colin and The Videos
  3. Videowiki, the development of MediaWiki software to edit videos online
    1. Archive 126#Write up in Slate about our video efforts
  4. Internet in a Box, an international effort to package Wikipedia for distribution as an offline resource
    1. Wikipedia_talk:WikiProject_Medicine/Archive_110
    2. "These are perhaps goals of some in WikiMedia Foundation generally… not obviously and naturally goals for English Wikipedia"
  5. Translation Task Force, an effort to translate English Wikipedia's medical articles into other languages
    1. Wikipedia talk:WikiProject Medicine/Archive 110
  6. pilots in automated support on talk pages
    1. Wikipedia talk:WikiProject Medicine/Archive 37#Template:Reliable sources for medical articles
  7. onlyoffline template - Template_talk:OnlyOffline

Sandy, Colin, and WhatamIdoing spoiled the prices RfC[edit]

Top edits to English Wikipedia drug prices RfC 2020

The RFC on pharmaceutical drug prices was illegitimate due to excessive bad conduct.

Sandy, Colin and WhatamIdoing were the top 3 editors to the RfC with 51% of the total edits and 60% of the total text added. Aside from that they took leadership in designing the RfC question while declining to compromise with suggestions from the other side. Their majority participation and the negative conduct are a problematic combination.

Condoning misconduct in the RfC was a problem also[edit]

In the context of the RfC I complained of SandyGeorgia's behavior. It was my error that I agreed to tolerate the toxic behavior and focus on Sandy and Colin's ideas. Now I feel that toxic behavior is never worth condoning.

I share this to show that I spoke out, but somehow, I was unable to find relief.

Role of Wiki Project Med Foundation[edit]

Wiki Project Med Foundation is not relevant to this case because it is not a block of votes to influence the issues in this case. I mention the organization here because it gets mention in this case. Wiki Project Med Foundation is a registered Wikimedia movement affiliate in good standing with the Wikimedia Foundation. It does programs as described in its annual reports on Meta Wiki at meta:Wiki Project Med.

In an attempt to describe the organization's power, I will share that the reports on the meta page show that since 2012 the organization has raised less than US$20,000. I feel that this amount of money is an indication that the organization does not have power to use in issues of this case.

Evidence presented by Hipal/Ronz[edit]

Doc James has added pricing information to the lead of hundreds of articles[edit]

Judging from my own sampling (User:Hipal/scope), as well as that of Colin (User:Colin/ExistingPrices and User:Colin/PriceEdits, included in his evidence), Doc James has been adding pricing information to hundreds of medicine articles. It appears to include all of Category:World Health Organization essential medicines (currently 463 entries), minus the few (nine?) entries that are not specifically medicines). My sampling has found articles not Colin's list (Artesunate/mefloquine (edit | talk | history | protect | delete | links | watch | logs | views) and Artesunate/pyronaridine (edit | talk | history | protect | delete | links | watch | logs | views)).

Doc James has added pricing information only to the lead of most of these articles[edit]

Doc James, with extremely few exceptions, has placed pricing information only into the article lead.

Content problems in pricing information added by Doc James[edit]

As seen in User:Colin/ExistingPrices, User:Colin/PriceEdits, User:Colin/PriceMistakes, and in the WP:MEDMOS2020 RfC; the pricing information added by Doc James is rife with content violations. There are widespread WP:V/WP:OR problems in the way data has been used, interpreted, and presented. Pricing information is being given undue weight. Cherry-picking of information is common, mostly for RECENTISM purposes. Doc James' focus is to present recent pricing information, without regard to pricing history.

Content dispute in Ivermectin[edit]

The dispute at Ivermectin started as concerns over including pricing information in the lead of the article:

  • [199] removed on 6 September 2019 by Hipal with edit summary: "NOPRICES, especially in lede - maybe in article body with proper context? Please avoid linkspam refs"
  • [200] This material was initially added on 16 January 2016 by Doc James with the edit summary "added"
  • [201] The content expanded by Doc James the same day with no edit summary

Behavioral problems at Ivermectin[edit]

The edit-warring and other problems at Ivermectin are well documented. I want to highlight my first interaction with Doc James in this dispute:

  • I start the discussion by focusing on policies (NOT, POV, and MOSLEAD) [202]
  • Doc James' response is to revert with the edit summary "It was fine"[203] and comment that price is important for medicines in general, and that there are efforts to censor such information [204]
  • I ask for it to be removed from the lead if sources are not available. I ask for any wide consensus for such edits to be identified. [205]
  • Doc James' response is to ignore my requests and to instead mention industry lawsuits about pricing in commercials for medicines in general. [206]
  • I ask for sources, but the ones provided in response do not mention Ivermectin
  • I respond, If you are trying to have an exception to NOT and POV so we start adding prices for medication articles in general, this is a poor way to try to do so. Better if you started with a medication that's notable for it's pricing
  • After getting no further response, I ask for a third opinion.

This small interaction demonstrates what appears to be typical behavior by Doc James:

  • Poor edit summaries, dismissive of any discussion or dispute
  • Lack of response to requests
  • Avoiding mention of related discussions and consensus, even when specifically called to do so
  • A general lack of understanding of policies, guidelines, and general consensus as it applies to the situation
  • Advocating for pricing information for medicines in general, without regard to relevant policies, guidelines, or general consensus
  • A battleground mentality toward efforts to apply policies and guidelines to the situation

Related behavioral problems at IPhone 11[edit]

An RfC was starting, resulting in "Consensus is against including a chart that includes pricing information of the iPhone 11 in various countries." [210] In the discussion, Doc James once again cites an essay for the inclusion of the information while ignoring policy. [211]

The behavior here demonstrates that Doc James, QuackGuru [212], Ozzie10aaaa [213], and Bluerasberry [214][215][216][217] take their behavior beyond medical articles to support their pov about pricing information.

Related behavioral problems at User talk:Doc James[edit]

Related behavioral problems at Wikipedia talk:What Wikipedia is not[edit]

Wikipedia_talk:What_Wikipedia_is_not/Archive_57#Clarification_requested_for_product_pricing_(Sales_catalogues)

  • Doc James starts with, "The prices of medicines and transparency around them is key to public health per NGOs such as UNICEF[221] and MSF[222]. These groups are working to improve transparency in this area. Many within the pharmaceutical industry are trying to decrease transparency around medication prices with lawsuits currently ongoing in the US.[223] We are not censored obviously. " [224]
  • "Further concerns with respect to attempts to suppress this information, an account that was pushing to remove medication prices from buprenorphine/naloxone has just been blocked for undisclosed paid editing" [225]
  • He ends with, "Every essential medicine has extensive coverage / discussion of its pricing by reliable independent sources." [226]

Again, Doc James expresses a BATTLEGROUND mentality, and the need to RIGHTGREATWRONGS. His solution is to declare that every essential medicine has the necessary sources for the inclusion of pricing information.

Disputes upon closure of MEDMOS2020 RfC[edit]

The MEDMOS2020 RfC identified original research and pov problems across hundreds of articles. In the follow discussions at Wikipedia_talk:WikiProject_Medicine#RFC_on_pharmaceutical_drug_prices_/currently_at_ArbCom Doc James stated that the RfC only applies to numerical prices, then used it to support more edit-warring across multiple articles:

  • "That is not a numerical price. Anyway I guess we have our next RfC." [227]
  • "This is not a proposal to include numerical prices."[228]
  • "Yes the RfC concluded that numerical prices should generally not go in the lead." [229]

Doc James starts an RfC at Atorvastatin [230] with the title "Clarification of RfC" without mention of any relevant discussions, RfCs, or policies. Nor does he mention that this is apparently his attempt to address the "numerical price" issue.

Doc James starts an RfC the following day at Ethosuximide [231] again without reference to relevant discussions, RfCs, or policies.

At Talk:Atorvastatin, Doc James makes a misleading and illogical statement in support of his revert to that article: "The consensus of the RfC was not to scrub all pricing information from Wikipedia." [232]

Now that Doc James has a single RfC going his way, he refers to it as being relevant to the discussions in other articles: "Of course plenty of objection and we have a RfC here Talk:Simvastatin#Clarification_of_RfC were support is overwhelming." [233]

Despite the conclusions of the MOSMED2020 RfC, Doc James still insists on using poor sources for content that has WP:V/WP:OR problems, for content that appears undue and of questionable encyclopedic value (Talk:Ethosuximide#Price_in_one_country_misrepresented_as_the_price_in_the_developing_world).

Discussions at Talk:Pyrimethamine#Multiple_problems brought up similar problems, though with other sources. Again, there's insistence on excessive pricing detail, this time over clearly notable pricing issues.

Doc James has continued to add pricing information during this arbitration[edit]

  • Addition to Sulfasalazine on 13 April [234]
  • Expansion at Febuxostat on the 15th [235], Salbutamol on the 12th [236]
  • Rework and expansion in Methocarbamol on the 14th [237]

Evidence presented by {D A Patriarche}[edit]

Against including any pricing info[edit]

I was not aware of edit warring; I am glad to have it drawn to my attention. I had assumed the widespread insertion of pricing info was evidence of GF & WP consensus, & bowed to what I took to be policy. However, I am strongly against including this information, most especially in the lead. Some of my arguments were published on the Methocarbamol Talk page: Talk:Methocarbamol#Marketing - cost in 2018-19, but received no response from Doc James or any other editor.

Methocarbamol is a drug of particular interest to me, partly because it's a "poor sister" to contemporaneous drugs such as the benzos. It's very widely prescribed and taken OTC but comparatively little research has been published. Because of its enormously wide use OTC, especially in analgesic compounds for back pain, the "pricing" information seemed particularly egregiously misleading to me. I am a former medical biophysics researcher with a continuing interest in the field. --D Anthony Patriarche, BSc (talk) 05:03, 13 April 2020 (UTC)[reply]


Evidence presented by Jorge_Stolfi[edit]

Distortion of Wikipedia's goals[edit]

I have clashed with DocJames on several articles.
For one thing, he seems to have decided that he "owns" articles on pharmaceuticals, and proceeded to edit them according to specific idiosyncratic rules, with a rigid layout for the head section; and shows little tolerance for views of other editors. Most pharmaceuticals are also chemical substances, however he insists that the corresponding articles be cast as "pharmaceutical articles", in his standard "pharmaceutical" format and with a "Drug" infobox instead of a "Chemical" infobox. In at least one case, ascorbic acid, the article had to be split in two, one about vitamin C as a drug, and another one as chemistry of ascorbic acid -- instead of placing that contents as separate sections of the same article.
Another problem is that he has sought to organize the articles on medical drugs according to the WHO list of essential medicines. In vain I tried to explain that Wikipedia is not meant to mirror the content or organization of external databases, even if authoritative (which that list is definitely not).
Finally, he insists on listing the market price in the head section of every drug article. While that information does not seem to have commercial motives, it is inappropriate for Wikipedia because it is ephemeral, may vary a lot from country to country, and is better obtained directly from external sources rather than from Wikipedia. My attempts to remove those lines were promptly reverted by DocJames, ignoring my justifications.
More than a complaint about DocJames's behavior, this comment of mine should be read as a complaint about the attempts of many editors to turn Wikipedia into a federation of partial encyclopedias, each managed by a clique of editors of one specific WikiProject, who assert "ownership" of those articles and thus act as if their preferences had priority over those of other editors.
Wikipedia would be infinitely better if all WikiProjects were closed and their guidelines deleted, if every topical sidebar or navbox like {{Template:Thermodynamics sidebar}} was eliminated from individual articles and turned an index section in the main article of the topic.
Also, every infobox like {{Template:Infobox drug}} should be reduced to a button that the reader had to click to expand into the full box. Then an article on something that is both a chemical, a drug, a fuel, and a foodstuff could have all four infoboxes -- instead of only one, arbitrarily chosen.
However, there does not seem to be a space in Wikipedia where those systemic diseases could be discussed...
--Jorge Stolfi (talk) 07:41, 13 April 2020 (UTC)[reply]

S Marshall's evidence[edit]

On another RfC within the scope of WP:MED[edit]

On electronic cigarette: Doc James reverts my changes and suggests I could try RfC. I began the RfC Doc James suggested on the same day. Doc James expressed confusion about what the RfC was asking. I explained, and please will Arbcom also note from that diff where I specifically asked Doc James to slow down and read attentively (emphasis in the original diff). Cunard closed the RfC with consensus for the changes I proposed. Doc James then claimed (on my talk page) and claimed (on the article talk page) that he thought the RfC that I'd begun at his suggestion was about a pipe link.

Analysis[edit]

Doc James isn't basically an obstructive editor, although he does display an awful lot of confidence in his own judgment. And this isn't a deliberate tactic to exert control and ownership of article content. His behaviour does have that effect, but it's not intentional. It's because his attention is spread so thin. His watchlist is so big, and he's active on so many pages, and he makes so many edits per day, that he can't follow the sequences. Therefore he doesn't make the connections that would be obvious to someone more focused.

With hindsight, my RfC could have been more clearly-worded, although nobody else who participated experienced any confusion.

Evidence presented by FeydHuxtable[edit]

SandyGeorgia, Colin & Doc James are serious editors, we're extremely lucky to have them. So it's distressing to see them squaring up on a board that traditionally see's a decisive winner. A clear win for either side could be highly detrimental to the encyclopaedia.

Sub optimal time to launch attacks on Doc James[edit]

As others have noted, this can be seen as a conduct dispute. Given the nature of submissions so far, this case is no longer just about drug prices. The outcome has a bearing on the Docs future participation in senior roles.

Granted, theres much valid criticism that could be levelled at the Doc and his crew, S Marshall's point is an excellent example. Yet medicine is an especially challenging area. Articles have an above average potential for harm, aggravated by motivated editing from cranks & shrills. So little wonder a group of "good" editors with clique like qualities emerged. It's not easy to diff, but on balance the current MEDS team seem a huge net positive – and article quality likely to suffer if they're taken down.

What can be easily demonstrated is that Covid is causing abnormal stress to editors with the most relevant real world expertise. This mirrors real life where nurses have took their own lives due to the stress. At least two editors with RL expertise in infectious disease recently expressed a desire for a permaban or courtesy vanishing, which the young doctor later clarified as partly due to Sandy & Colin.

Some have said if folk have time to edit war over prices in articles, they have time to discuss. That would be fine if this was just about prices, but as above the fate of outstanding editors seem at stake. Even though she's a party to this case, Sandy has already laid out 8 remedies for Doc James and his crew, which in context seem severe. Talk about being previous, the evidence phase hasn't even closed, the Doc might change his position. Sandy's multiple edits to the case these last few hours suggest she's on a mission. Jytdog may have been overly aggressive, but his resignation to the community at his Arb case was angel like in comparison. Granted, knowing some of the history, Colin and Sandy's recent actions may be justified. There's literally > 1000x to this than there was to the portal case, so it's hard to form an accurate opinion. Hence not posting many diffs against them, though it would be easy to cherry pick a submission suggesting they're more at fault than Doc James. IMO it's currently not realistic to expect the community to carefully attend to this. It's to be hoped the side too busy saving lives to properly defend themselves isn't rewarded with severe sanctions.

The perfect v the good[edit]

Colin indicated this conflict has a "Quantity vs quality" dimension to it. He's right. Yet it may be more useful to see this as a case of the prefect is the enemy of the good.

SandyGeorgia and Colin were amazing MEDS editors[edit]

Back in Jan 2019 I noted it would be good if Sandy & Colin returned to being "leading lights on the MEDS project. " . That was based on considerable attention to their work (as explained here.) On reflection, while I still look back at the years leading up to 2012 as a golden age, with a standard of FA writing that may never be surpassed, I'm no longer sure it would be desirable for folk like Colin to displace the current leadership of the MEDS team. We weren't clearly in a post truth age back in 2012. The world has moved on, and it's likely for the best that a new generation of MEDS editors have become prominent.

The Doc's approach more suited to defend mainstream science[edit]

Wikipedia has about 50,000 MEDS articles, many of which are attractive to quacks, pov pushers, and/or corporate shills. It seems unrealistic to expect a small number good editors to defend such a wide attack surface with the perfectionist approach. As good doctor Furst clearly explains, there's a need for "quicker edits". It's great to have examples of perfectionist editors serving up three course meals Yet realistically , the "fast food" approach is also needed. Unless our risk appetite accepts the chance of industrial bleach being added to a large portion of med articles that the perfectionist aren't currently improving with their "Brilliant Prose".

Doc James often exemplifies collegial conduct[edit]

As others have noted, the Doc is typically a "polite" editor, who will engage with anyone willing to discus and is encouraging of other opinions. Here's a recent example, where Doc James helped out an editor who very recently was a leading adversary on how to present our most high profile Covid articles. Back in mid Feb, editor Almaty asked me to check out his "diplomacy", which in context I understood to mean his debating against the Doc re Covid, so I kept an eye on the situation. While it led me to personally intervene with a couple of little nudges to ensure Almaty prevailed in a key RfC, that was only due to social factors favouring the Doc. On the scholarship dimension, it was pretty much no contest, as you'd expect when even the brightest generalist AE doc trys to debate with a specialist on their own field. But despite the hammering the Doc took from Almaty, he was the first to step in to support ending Almaty's Covid topic ban and even awarded them a barnstar. I always knew the Doc would react like that, rather than push his advantage, as it's the sort of fine character the Doc is all about. Yet it's rather exceptional, we all know that when even your typical good editor has a wiki adversary over a barrel, they don't often show exactly that sort of love for their enemy.

We can trust Doc James to stand for impartial mainstream science[edit]

Editors have argued that the Doc has violated RGW/advocacy with his position re prices. This seems correct. Even years back the Doc saw prices as "a critically important aspect of global health" which they echoed this January. While a little naive, this is largely a positive; it indicates the Doc is not in the pockets of big pharma. Much as I believe big pharma/biotech is overall a huge net positive for humanity, it can't be denied they spend hundreds of millions on +ve PR, which one cant always trust to accurately reflect the best available science, as explained here. Good editors appreaciate the threat from fringe pushers, yet many seem less aware of the insidious risk from corporate shills, who are adept at posing as genuine scientists, & who can often easilly find corporately funded systematic reviews to support their pov. It was useful for Doc James attackers to help show the Doc can be fully trusted to stand for neautral science.

What is WAID doing?[edit]

WAID states they don't think they've "entirely figured" out what this case is all about. I'd say that's accurate. So not sure why they're warning us to be suspicious of "us-versus-them statements" . As Barkeep has stated, WAID seems to be respected by all – they're clearly a very good natured and intelligent editor who obviously knows a lot about medicine. But they seem too peaceful to understand the contours of conflict here. To clarify, drug prices are largely just as Casus belli for a power struggle with at least 8 years of history, with Colin & Co on one side, and Doc James and his crew on the other. WAID is on Colin's side, even if they're too good natured to know it, while Tryptofish stands with the Doc.

Summary[edit]

This appears to be by far the most perilous Arb case Ive ever seen. A clear win for the Doc seems unconscionable. It might demotivate some of the few editors who can produce truly beautiful & exceptionally accurate encyclopaedic content. And at the end of the day, policy is policy. On technical grounds, overall it does appear to be Docs' crew who were the more non compliant. While the new evidence added in the last few hours does show un-collegiality by Colin, especially Trypto's demonstration that he's been known to double down with his hyper criticism, it's unclear that recent conduct is at a level where an admonishment is warranted.

On the other hand, severe sanctions for the Doc or his crew could be disastrous. Our whole civilisation is on a rocker; it could go up or down. We need the reliable guidance of mainstream science. The perfectionist approach is not suited for maintaining the reliability of our thousands of MEDs artciles – not unless Colin & Co can make themselves hundreds of clones. Also, editing Wikipedia is supposed to be fun. Few want to held to a near impossibly perfectionist standard, which even a senior consultant like Graham Beards admits he found challenging. A check of Colins contribs doesn't yield many cases where he awards barnstars or even complements others. Whereas obviously there is with the Doc. I'd suggest that a few minor admonishments may be warranted for some members of the Doc's crew (obvously not including the more consistently collegial ones like Trypto or Dr Furst), but no sanctions as such even for the most passionate editors. (Unless there's no sign of the air clearing by the end of the Workshop, in which case maybe a no fault 2-way iBan between Colin & the Doc could be considered.)

PS I fully endorse the summary of the situation that Literaturegeek provides in the first sentance of their submission. FeydHuxtable (talk) 21:58, 28 April 2020 (UTC)[reply]

Evidence presented by AlmostFrancis[edit]

Response to evidence by SandtGeorgia (SG)[edit]

SG claims that their is a direct conflict of interest between Wikipedia and WPMEDF as it pertains to encouraging colleges to give academic credit to Wikipedia work. SG then gives a list of reasons that would seem to fit better with the Feautured Article process, which as far as I know has never been considered a COI. SG give no evidence to support her assertion about WPMEDF and as far as I an tell the assumption would be that the article would be edited in the standard way.


Evidence presented by Barkeep49[edit]

Timeline of MOS Dispute[edit]

  • July 28, 2006 WP:MEDMOS created as a proposed guideline
  • April 29, 2007 MEDMOS becomes a guideline with Colin and Sandy Georgia each having contributed substantially to the writing.
  • April 8, 2008 First mention of drug cost/pricing on the guideline talk page (discussing what scenarios it would be included)
  • July 16, 2010 WhatamIdoing introduces language about not including drug pricing following a discussion at WikiProject Pharmacology
  • September 4, 2015 Doc James removes the prohibition in MEDMOS on including drug pricing linking to a discussion at the Pharmacology WikiProject
  • May 15, 2016 Doc James starts an RfC at WikiProject Medicine to include pricing in medication articles. References three prior discussions: [238] [239] [240]
    • July 9, 2016 jc37 closes the RfC with the close of Except in the cases where the sources note the significance of the pricing (which did have consensus), there is no consensus to add the pricing to the articles. There were several ways to present this information proposed in the discussion (such as wikidata). Please feel free to start a follow-up discussion regarding that.
  • September 30, 2019 Doc James makes a change to the guideline saying pricing/costs may be included if reliably sourced
  • October 1, 2019 QuackGuru creates a new section on product pricing in MEDMOS expanding on James' language.
    • A series of edits [241] [242] [243] [244] by Doc James and QuackGuru ensue about placement and wording.
    • October 11 WAID further adjusts the wording and formatting of the pricing section
  • November 14, 2019, after not having edited the guideline for just over 6 years, Colin makes a series of edits that changes multiple sections of the guideline including article titles, LEAD, and product pricing.
    • QuackGuru reverts Colin's change to product pricing minutes later.
    • Over the next 5 days QuackGuru makes a series of further changes in response to Colin's edits, including one to product pricing whose edit summary is Add neutral worded content. See WP:CIR.
    • November 21, 2019 DocJames further reverts some of Colin's changes.
  • November 21, 2019 QuackGuru opens a discusson at Talk page for WikiProject Medicine about MEDMOS.
  • December 5, 2019 01:15 Ozzie10aaaa opens an ANI thread reporting Colin for incivility and excessive pinging of Doc James.
    • December 5, 2019 09:08 NilEinne proposes an indef block of Colin. There is some support but a majority oppose.
    • December 5, 2019 10:50 Colin proposes a TBAN on Doc James from drug pricing. There is a little support but a strong majority oppose.
    • December 6, 2019 10:33 Guy proposes a four point plan for moving forward. There is nearly unanimous support.
    • December 7, 2019 19:53 Barkeep49 closes thread enacting Guy's proposal and adding two implementation notes as closer.
  • December 8, 2019 Kashmiri removes the product pricing section.
  • December 21, 2019 Tryptofish creates a proposed 2020 RfC format
    • December 26, 2019 Tryptofish creates a second 2020 RfC format draft which is publicly shared January 2nd.
  • December 22, 2019 SandyGeorgia launches an RfC on the guidelines for the lead
  • January 1, 2020 WhatamIdoing proposes an 2020 RfC structure
    • After discussion and revision this would be the template for the 2020 RfC which is launched
  • January 7, 2020 Barkeep49 updates AN on the dispute both on the 2020 RfC and conduct. This includes asking for closers.
    • Over the next few weeks, Ymblanter and Wugapodes volunteer to be closers.
    • January 20, 2020 Rosguill responds to a plea from WhatamIdoing to be the sysop to certify the 2020 RfC is neutral
  • January 7, 2020 Casliber launches an RfC about the order of sections in the guideline
  • January 23, 2020 Barkeep49 launches the 2020 RfC on pricing
    • March 7, 2020 Ymblanter marks the 2020 RfC as closing
    • March 27, 2020 Wugapodes closes the 2020 RfC
Closing statement
* Editors are generally opposed to inclusion of prices in the lede. While basic calculations are not considered original research, the pricing statements in the examples require interpretation of primary sources that may not be straightforward. This makes the editorial claims difficult to verify, and especially so for drugs whose prices are not widely discussed in published sources. In addition, there are concerns that proper explanation of the situation for the indicated price would give the price undue weight.
  • There is no consensus on whether drug prices should be included in articles at all. Where secondary sources discuss pricing extensively (insulin being a frequently cited example), that information may be worth including in the article; where there is little discussion of pricing in secondary sources, it generally should not be included. Drugs which fall into the grey area between these extremes should be discussed on a case-by-case basis. Where pricing information is included, claims should be sourced to reliable, secondary sources and not solely primary source data from price databases.
  • Whether to include prices in the infobox was not widely discussed but is unlikely to find consensus. Arguments against inclusion in the lede would similarly apply to inclusion in the infobox, and editors should be aware that inclusion of prices in the infobox is likely to be opposed in most cases.


Thank you to everyone who participated!

    • The closing would end up with several clarifying statements by the two closers
  • January 24, 2020 Barkeep49 removes full protection from the guideline.
  • January 25, 2020 Barkeep49 topic bans AlmostFrancis under discretionary sanctions from all Medical MEDMOS discussions broadly construed for this comment.
  • March 28, 2020 Colin opens a discussion about the 2020 RfC at the WikiMedicine Project
    • Discussion remains ongoing
Post RfC Case Study: Simvastatin
  • March 28, 2020 WhatamIdoing removes information from Simvastatin citing the RfC
    • March 29 Doc James in a series of edits adds information about the drug being low cost cited to a new source and also starts a talk page discussion about the new source
    • March 30 Graham Beards reverts citing the RfC
    • About 3 hours later Doc James reinstates the revert and further adjusts in a series of edits
    • 25 minutes later Hipal partially reverts Doc James
    • 5 minutes later Hipal starts a discussion at WikiProject Medicine about Doc James addition
    • 5 minutes later Doc James adds new pricing information
    • 55 minutes later WhatamIdoing replies to the talk page discussion disagreeing with Doc James
    • 12 minutes later Doc James replies
    • 14 minutes later Doc James opens an RfC about the disagreement
    • Just over an hour later Seraphimblade reverts citing NOPRICES and information unsupported by the reference
    • 15 minutes later Ozzie10aaaa reverts Serphaimblade
    • 4 minutes later Sandy Georgia requests page protection at WP:RFPP
    • 1 minute later Sandy Georgia reverts Ozzie10aaaa citing the RfC
    • 13 minutes later Ozzie10aaaa reverts Sandy Georgia
    • 7 minutes later Sandy Georgia tags the disputed information
    • A couple hours later Whywhenwhohow adds additional price information
    • 40 minutes later Ymblanter fully protects for three days
  • March 30, 2020 Barkeep49 requests an ArbCom Case be opened
    • April 7, 2020 the case is formally opened
  • April 12, 2020 Doc James removes the disputed tag around the LEAD in the guideline
    • 43 minutes later Sandy Georgia reverts
    • 4 minutes later Doc James restores and opens a discussion on the guideline talk page
    • April 13 Colin removes a sentence
    • 41 minutes later Sandy Georgia makes further changes to the section
    • April 14 Sandy Georgia adds a citation needed tag
    • April 15 Doc James adds a reference to address the citation needed tag

QuackGuru History[edit]

  • Block log includes:
    • 5 editwarring blocks
    • 3 disruptive editing blocks
      • 1 additional disruptive editing blocks where the block sysop accepted an unblock request
    • 2 Personal attacks or harassment: continued disruptive editing, edit warring, harassing other editors blocks
    • 3 Arbitration enforcement blocks
    • 1 overturned indef block
  • July 23, 2011 topic banned from pseudoscience and chiropractic, broadly construed, for one year.
  • October 6, 2015 topic banned from acupuncture
  • November 17, 2015 warned by ArbCom about e-cigs
  • April 19, 2016 topic banned from Vani Hari and the talk page for 3 months
  • August 23, 2017 topic banned from all articles and edits related to religion, broadly construed by the community

Observations[edit]

For a case with 14 parties ultimately we're here because of Doc James' insistence that pricing belongs in the articles of hundreds of drugs. On its own this isn’t a problem. What is a problem is that he has taken what can, in the reading most sympathetic to his point of view, be read as a lack of consensus from two different RfCs (2016 and 2020) and used that to justify his actions. I am also not aware of any incidents where Doc James respected a removal of the information. Every instance I am aware of, when information has been removed the removal has been reverted frequently but not always by Doc James. Plainly speaking over the years of this dispute the group of editors that have wanted to see this information included has been more aggressive in their stance than those who don't think it should be included (or at least not included as widely as it has been). This group is also larger numerically among the "regulars" of WikiProject Medicine than those who oppose its inclusion. This had, in my opinion, the effect of making those opposed to its inclusion more aggressive in discussion which has had its own negative side effects I'll discuss later.

Since the 2020 RfC ended I am unaware of James, and others favoring inclusion, adding it to new articles and am aware of those who think it should be removed attempting to do so (see Atorvastatin, Ethosuximide, Pyrimethamine, Simvastatin). However, when following these limited removals - all by different editors -  there was no engagement or discussion. It was revert and then when/where discussion was opened a bit of a rush to an RfC.

I found this rush to the RfC particularly troubling for a couple of reasons. First James had not really engaged in any meaningful way with the formulation of the 2020 RfC. Now I think this could be defended because editors who did object to the way the RfC was being formulated were brushed aside or were unwilling to hold-up the RfC and also tended to come into the conversation one at a time rather than ever being present as a "group". So to the extent James finds fault with the RfC, substantial participation, outside of comments on January 6, in formulating it could have meant a lot. It's frustrating to read him complain after the fact, despite entreaties for participation beforehand.

The rush to RfC at two of those areas is also troubling because it seems to suggest that RfCs are a substitute for discussion which, as our Dispute Resolution policy reminds us, is Talking to other parties is not a mere formality, but an integral part of writing the encyclopedia. Discussing heatedly or poorly – or not at all – will make other editors less sympathetic to your position, and prevent you from effectively using later stages in dispute resolution. (emphasis added) Except there really isn't a way that later stages, in this case RfC, are prevented by not discussing. Instead after a widely attended and commented on RfC, centrally notified, was closed having two local RfCs, while overall discussion was underway about what the centralized RfC meant, was not an effective method of dispute resolution. Especially when the RfCs opened were so explicitly set up to encourage voting rather than discussion (which thankfully and to his credit, Doc James did walk back). Having multiple simultaneous RfCs is, as WAID has noted, troubling in its own way and something for which there is some history here.

However this seems to be a reaction to the style chosen by those opposing price inclusion. Lacking in numbers among the regulars they have turned to discussion. This works fine for some editors - WhatamIdoing seems to be respected by all and engage in useful conversation with all. But it works less well for other editors; namely Colin. Colin rightly prides himself on having been a driving force behind the creation of MEDRS and an important editor in the creation of MEDMOS. He also prides himself on never reverting a second time. He can also rub editors the wrong way (diffs introduced to show for Doc James, Tryptofish, and RexxS). On the whole Colin is willing to walk back comments that cross the line of incivility. In fact in my experience when asked every editor in this dispute was willing to do so (examples: [1] [2]).

I think there is a fair comment to be made that Colin can bludgeon a discussion (3 4). However, WP:BLUDGEON is an essay. So despite being commonly used, so common it became part of the December 2019 ANI consensus and close, there's not actually well developed behavioral practices around it. So telling someone how to bludgeon is easy (say less in fewer edits) but showing when they've cross the line is something I cannot do with any confidence and I don't think any sysop can beyond a "I know it when I see it" criteria which again doesn't help an editor know when they've crossed a line between helpful participation and bludgeoning. Case in point: the second BLUDGEON diff I offered above shows that WAID was closely behind Colin in terms of bytes and ahead of him in number of edits but no accusations of bludgeon has been directed towards them. Why is this? I have my theories but they're just that. So to the extent that Colin causes consternation with bludgeoning I think it's on the community to refine that term if they want to see BLUDGEONing sanctioned.

Beyond the points about Colin and Doc James I haven't really observed anything that rises to the level of an ArbCom FoF or remedy from any of the involved editors individually.

Evidence presented by Graham Beards[edit]

Doc James acts as though he his exempt from our policies[edit]

Here is an extract of a comment I wrote in 2018 [245] and it is sad to note that nothing has changed.

"He (James) has a cavalier attitude to the core principles of Wikipedia and collaborative contributing. He seems to think consensus means agreeing with him and never considers for a second that he might be wrong. His arrogance knows no bounds. He is difficult to work with and often doesn't bother with edit summaries. It seems to me that James strives to dumb down Wikipedia when others strive to improve it as a solidly reliable source. Our policies on verification and so forth have done us proud. James's hard work and apparent popularity must not be used undermine and negate our core principles".

All of this is still happening. The lack of edit summaries, or worse, the untruthful ones are a particular concern. He reverts edits with the summary "adjusted". As he did here [246] when I deleted a vague comment about the cost of atorvastatin (a drug I have to take every day and turned to our article for other information).

With regard to our coverage of the coronavirus pandemic, which to be frank was worse than poor to begin with, I had to point out to the Medicine Project that a pandemic was actually happening and that our less experienced editors were alone at the helm! When James and other Med Project members finally came to help all regard for WP:MEDRS was left behind and Facebook and Twitter were being allowed as sources.[247]

James seems to think that he is above his peers (e.g. me) in a (non-existent) Wikipedia editors pecking order. Graham Beards (talk) 18:24, 19 April 2020 (UTC)[reply]

James' oversimplified prose[edit]

James has invited us on this page to comment on his writing style. He includes Rotavirus vaccine on a list of articles he has "improved". I started this article and many of you will know that the virus is of special interest to me. The Lead of this article is a paradigm of James' excessive dumbing down. It consists of piecemeal factoids and has no flow. And here's a diff with typical fundamental grammatical error. [248] (quote "the current versions is not").

For another example, here's a direct quote from an uninvolved editor writing at Talk:Coronavirus disease 2019/Archive 1#Doc James obsession with oversimplifying these articles to the point there are unreadable:

"User:Doc James seems to have an obsession with over-simplifying articles to the point that the majority of English speaks find these articles unreadable and stupid...The facts of the matter are that anyone who doesn't speak fluent English isn't going to seek medical advice or information in English, they will seek information in their own language. Please stop over-simplifying these articles to the point that they are becoming useless for the majority of the population."

And another editor here Talk:Coronavirus_disease_2019/Archive_2#The_standard_of_English_being_used_in_these_articles:

"Trying to read in simple English is cumbersome and doesn't flow easily. It conveys too little information across more words and is generally more vague. We are presuming that any reader of normal Wikipedia would have reasonable literacy skills and would have come across healthcare information before, so there's no reason to remove "normal" words from this article...I think that anyone who is unable to read in normal English should be guided to the Simple English Wikipedia."

I am also interested in hepatitis B – which I worked up to GA many years ago and is still on my watchlist. Presumably in the belief that an understanding of two fundamental concepts, "incidence" and "prevalence", in epidemiology, are not needed by our readers, James "simplifies" them to "frequency" and "new cases" [249], which is completely incorrect. They are proportions and are usually given with a population denominator (e.g. per 1000 people). James then says he understands the terms on the talk page [250] but the evidence is to the contrary in my mind. Whenever James' name appears on my watchlist, I have to check what he has done.

Added misleading cost prices to Rotavirus vaccine[edit]

In this edit [251], James added the prices of rotavirus vaccines. These were incorrect. He wrote "The wholesale cost is between 6.96 and 20.66 USD as of 2014." But in 2014, the cost of the Rotavac vaccine course of three doses in India was Rs. 162 (about 2 USD). What was worse was James' addition changed the focus of the article to cost prices and numerous later additions by others to the article were of questionable neutrality in this regard. When one editor added that the costs were widely variable, James reverted with a dishonest edit summary [252]. The cost-benefit analysis of vaccine programs is complex to say the least. (See for example: Pecenka C, Debellut F, Bar-Zeev N, Anwari P, Nonvignon J, Shamsuzzaman M, Clark A (November 2018). "Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines". Vaccine. 36 (49): 7472–7478. doi:10.1016/j.vaccine.2018.10.068. PMC 6238205. PMID 30420039.). To add prices to this article (based on a source that is not WP:MEDRS compliant) was irresponsible.

(Since writing this, James has updated the article, but the "prices" are still given. [253])

In vaccination programs and schedules the cost of the vaccine is just one, often minor, component of the overall cost. There is the cost of administration and whether or not it can be given in combination with other vaccines, storage and the strict maintenance of a cold chain, shelf-life and other practicalities that have to taken into account. These all vary with location, which can be village-to-village in remote areas. It is impossible to quote an accurate cost, even as range, in an encyclopedia.

Colin[edit]

By far Colin has been the toughest critic of my contributions to Wikipedia. As early as 2007, he made it clear to me that my prose was not up to FA standard. Here's a ruthless critique of an early draft of the lead of Virus [254]. In 2008, he gave me a very tough time when reviewing a version of Rotavirus, where he commented on almost every single sentence.[255]. When I nominated an article on the history of viruses and virology at WP:FAC in 2010 [256], Colin opposed outright. He criticised the very concept. I withdrew the nomination. In 2009, he gave another long thorough review of Phagocyte [257]. What a grilling! Colin can come across as extremely annoying, but when I calmed down it became clear to me that he was often right. On the occasions when he wasn't, we managed to reach an understanding and move on. A tough critic indeed. Virus, Social history of viruses, Rotavirus and Phagocyte are now all Featured Articles. This would not have been the case without Colin's reviews. He taught me that it is simply not enough to know your subject and that there's loads more to producing quality content. I have never met Colin. We do exchange the occasional email, but often years pass when we don't. On reflection, the most rewarding times I have spent working here is when Colin was ruthlessly pushing me to do better.

Evidence presented by RexxS[edit]

The disputes need to be seen as philosophical, not behavioural[edit]

Unusually, I'd like to present narrative testimony, rather than a series of assertions about behaviour. I do this because I continue to believe that attempts by ArbCom to understand the issues will be distorted if they view the case solely through the lens of a behavioural dispute. I also believe that a better understanding of the proper scope of this case case requires a full understanding of its history and context.

First of all, I contend that the vast majority of parties to this case are respected, long-term editors who have made considerable contributions to the field of medicine on Wikipedia over many years. It should be taken as a given that every single party's foremost aim is to improve Wikipedia, although there exists a wide range of opinion on how that is best achieved. I'll supply metrics on editor contributions if anyone wishes to challenge my initial contention.

Secondly, I contend that there is a broad philosophical difference on the question of innovation on Wikipedia. There are not two distinct camps, but there is a spectrum of affinity to two distinct positions: one which wishes to preserve the established encyclopedic conventions of highest quality, sourced, textual content, supplemented by images; and another which wishes to experiment with new formats, new outlets for content, and new sources of information. For what it's worth, I see that same difference of philosophy not just in the medical field, but I'll confine my evidence here to medicine.

Finally, I contend that where some editors push hard to innovate on a particular issue, a flash-point often occurs where other editors resist the changes involved. This is partly due to differing philosophical leanings, and partly due to problematical personal interactions, and I acknowledge my own inability to work with some editors, where I just seem to "rub them up the wrong way". I'll adduce examples of where these flash-points have occurred over several years, and I'll give my understanding of what was happening.

Background[edit]

I'd like to make clear my own background: I've been editing for more than 12 years. I have some expertise in technical issues and hyperbaric medicine. I am a founder member of WikiProject Med Foundation, now known as Wikimedia Medicine (WMMED) since it was granted thematic organisation status as an international affiliate to the Wikimedia Foundation (WMF). I have served as secretary to WMMED and now am privileged to serve as its chair. For six years, I've also been a trustee of Wikimedia UK (WMUK), the UK chapter affiliated to the WMF. I maintain that I have no conflict of interest between either of those affiliates and my contributions to the English Wikipedia, because the affiliates' aims are aligned by their constitution with those of the Wikimedia movement. Nevertheless, the members of WMMED are international, and represent many different countries and languages. That predisposes them to taking a different view on innovation from editors working principally on a single Wikipedia.

Translations[edit]

One of the first tasks undertaken by WMMED was to identify a number of vital health articles, and then to translate them into as many different languages as was possible. An organisation called "Translators Without Borders" partnered with WMMED to do translations, both on a rolling programme and on demand whenever a medical emergency occurred in a region where there was little Wikipedia health information available in the local languages. The first target was to translate the lead section of those vital articles as widely as possible.

That presented consequences such as the problems caused by a lack of sourcing in the lead of articles, which needed to be carried over to the short translated articles being created in multiple language Wikipedias. That lead directly to initiatives to source the lead section of medical articles and the advice in WP:MEDLEAD to provide citations. Similarly, the advice to keep language simple and to make sure that the lead contained a comprehensive overview of the topic were partially driven by a desire to make the translations as rapid, accurate and comprehensive as possible.

That naturally created a tension with other editors who wanted to see the guidance in MEDLEAD match that in MOS:LEAD. That has recently produced edit wars over the wording, multiple debates on the talk pages and eventually an RfC.

Internet-in-a-box[edit]

Another initiative by WMMED was a partnership with Internet-in-a-box (more detail at meta:Internet-in-a-box), which aimed to make available Wikipedia's medical content in a number of languages to areas where no internet access existed. A device was produced that used a tiny computer working as a wireless access point and serving all of the medical content via Kiwix (a WMF sponsored project to distribute content offline on small memory cards). That was used in many places throughout the third-world, and found use as part of emergency response to disasters where the infrastructure had been destroyed.

While working on VideoWiki last year (see next section), we were presented with evidence that multimedia presentations such as videos had far better results in communicating health information for people who could understand spoken English, but not read it. Hardly surprising, of course, but it lead several of us to conclude that there would be extra value in including videos in content delivered offline (where the target audience is often poor in reading English), even when consensus was against placing such videos on the English Wikipedia. As a compromise, I created Template:OnlyOffline which excluded its content from the online Wikipedia, but allowed it to be read and delivered offline by readers like Kiwix. Believing that the template would have general use, I requested a CSS class be created at

The use of the template was challenged at its talk page. It started cordially, but descended into unpleasantness, spilling over into criticism of the VideoWiki project and the Internet-in-a-box project in general:

That lead to a lengthy and rather acerbic proposal to delete the template:

Videos[edit]

As stated above, WMMED looked at evidence indicating that readers who don't have English as their first language often respond better to short video clips to summarise key medical information. At present, YouTube is the biggest publisher of such clips and it's a jungle, with fringe medicine and dangerous advice being afforded equal footing with evidence-based medicine. That lead to an attempt to source good quality short video clips that gave an overview of various conditions.

As far back as 2013, there was an exploration of the possibility of using Khan Academy's videos in a collaborative venture, but it came to nothing as we couldn't overcome the copyright problems.

Osmosis[edit]

A commercial company called "Osmosis" produced about 300 video clips and released them in April 2017 under a CC-BY-SA licence suitable for Commons. They can be found at c:Category:Videos from Osmosis. When some of these were used in Wikipedia articles, objections were raised in March 2018:

The initial complaints were that the Wikipedians were unable to edit the videos, that the facts were not verifiable, and that the videos contained an advert for Osmosis at the start and end. I did my best to answer these objections by editing some of the videos and removing the first few and last few seconds. Compare File:Abscesses.webm and File:Abscesses 1.webm, for example. Osmosis were unhappy with the derivatives and it soured relations.

Eventually an RfC was started, which resulted in the decision to terminate the collaboration. James removed all of the videos used on Wikipedia.

VideoWiki[edit]

The issues identified with the Osmosis initiative led James to look for a collaboration that could deliver videos that could be created by Wikimedians from a script. The idea was that the script would be editable by anybody to update and add references. By July 2018 a working version of a tool was added to wmflabs and a documentation page created on Meta. The latest versions are at:

In November 2018, a WikiProject was set up, dedicated to working on collaboratively created videos:

This was announced at WTMED in February 2019 and received considerable feedback, particularly concerning the accessibility of subtitles, but sadly the discussion descended into acerbic dialogue.

A post talking about the New England Journal of Medicine's increasing use of videos also sparked a negative response:

In January 2020 a complaint was made about the small number of editors actively engaged in creating videos:

Drug pricing[edit]

There is considerable friction between editors on the questions surrounding the inclusion of the pricing of drugs on Wikipedia. This extends to basic issues such as terminology, where some editors make a clear distinction between "price" (meaning a numerical value like "$0.25 per mg") and "pricing information" (meaning general prose descriptions like 'relatively inexpensive"); while other editors believe these terms to be completely interchangeable.

NOTPRICE[edit]

Wikipedia has a policy, often referred to as WP:NOTPRICE, which is part of part of Wikipedia:What Wikipedia is not, that states:

Wikipedia articles are not ... Sales catalogues. An article should not include product pricing or availability information unless there is an independent source and a justified reason for the mention. Encyclopedic significance may be indicated if mainstream media sources (not just product reviews) provide commentary on these details instead of just passing mention. Prices and product availability can vary widely from place to place and over time. Wikipedia is not a price comparison service to compare the prices of competing products, or the prices and availability of a single product from different vendors or retailers.

This has been taken by some editors to mean that no prices or pricing information relating to drugs should be in Wikipedia, because databases of prices don't indicate significance, and prices vary over time and location.

Other editors believe that this section is to prevent Wikipedia becoming a price comparison service where the article on Acme Manufacturing Inc lists all the prices of the widgets that it sells; or from content where an editor tabulates the prices of widgets offered by numerous different manufacturers. The assertion there is that the cost of a drug is an encyclopedic topic relevant to the drug and should be included in the article when reliable sources discuss it.

RfC 2016[edit]

To address some of the conflict surrounding drug pricing, an RfC was created by James in May 2016 to examine consensus for the inclusion of pricing in medical articles, and he gave examples of where prices could be found:

I have been including pricing information in medication articles. We have a good source here that gives the price range found internationally and in a number of countries in the developing world. Often the variation between prices is less than 5 fold. I have also been providing the US price as presented in this book but there are other good options. The US is not only a large portion of the EN speaking population but a large percentage of our readership. Also most other countries are somewhere between the global price and the US price.

The Rfc was well attended. Opinions differed very strongly, and discussion was extended. The close by Jc37 concluded:

Except in the cases where the sources note the significance of the pricing (which did have consensus), there is no consensus to add the pricing to the articles. There were several ways to present this information proposed in the discussion (such as wikidata).

This notes a consensus to add pricing to articles where the sources note the significance of the pricing.

Many editors (myself included) believe this is the consensus that governs the issue of drug pricing (as opposed to prices) in Wikipedia articles. This is very much in line with the sort of sourcing that applies to any aspect of a medical topic on Wikipedia.

Current interpretations of this RfC range from a belief that it has been entirely superseded by a later RfC to a belief that it allows drug prices in articles whenever a secondary source discuses the significance of the drug's pricing.

RfC 2020[edit]

The breadth of interpretation of the 2016 RfC left detailed questions unresolved, in particular the issue of having drug prices in the lead of articles. The drafting process of the RfC was extensive and not all editors were happy with the wording. Eventually Whatamidoing created a draft, which was edited between 2 January 2020 and 23 January 2020 when Barkeep49 launched it as an active RfC. Links to details can be found at

The RfC settled on a format of a question, followed by a commentary on the International Medical Products Price Guide, and three examples of drug articles which contained wholesale prices (per month or per day or per dose) in the lead. The question posed was :

These examples of drug prices for generic pharmaceutical drugs have been taken from the leads of articles. Do you think that this content complies with Wikipedia's standards for verifiability, due weight, no original research, what Wikipedia is not, and how to write a lead section?

The Rfc was well attended (although personally, I was unhappy about the manner in which the debate was conducted and chose not to participate). Opinions differed very strongly, and discussion was very extended. The close by Wugapodes and Ymblanter has three principal conclusions:

Editors are generally opposed to inclusion of prices in the lede ... There is no consensus on whether drug prices should be included in articles at all ... Whether to include prices in the infobox was not widely discussed but is unlikely to find consensus.

Since then, there has been conflict over interpretations of the close and several questions asked of the closers.

Some editors have taken the decision to remove all mention of pricing from the lead of medical articles, and that has met resistance from editors who believe the RfC only addressed the question of prices in the lead.

RfC at Simvastatin[edit]

Since the 2020 RfC closed, prices have been systematically removed from the lead of articles.

In some cases, the RfC has been used as a justification for removal of any pricing information from the lead also, and in at least one case, the removal of an entire section on Cost from the body of an article.

Early on 30 March 2020, James began a discussion at Talk:Simvastatin #In depth discussion to establish that Simvastatin was a relatively low cost drug. Only Whatamidoing engaged in discussion with him. Later that day, the Cost; section was removed entirely from the body of the Simvastatin article. This section was restored and amended, and removed and restored by a variety of editors until fully protected. (for anyone reading the history: LMIC = low and middle income countries; ACA = Affordable Care Act.) Disagreement remained.

At the same time, the phrase "It is relatively low cost" was removed from the lead of Simvastatin. As a result, late on 30 March 2020, James opened an RfC at the talk page, asking the question

Should we state " Simvastatin is relatively low cost." at the end of the 4 paragraph of the simvastatin article?

There was considerable consternation over James' initial request for each commentator to keep to their own section, and he was convinced to withdraw that stipulation.

The RfC is still open. It has attracted a good range of participants and there is considerable discourse, some of which is productive, but much of which consists of editors stating or restating a fixed position. Of course it is difficult to find a compromise with a binary question that requires a yes or no answer, but that has been a feature of the most recent RfCs.

For what it's worth the RfC is currently showing a sizeable majority of editors in favour of including that phrase in the lead. I believe that indicates that the majority of editors find the general topic of drug pricing encyclopedic, and that the previous RfC which addressed prices should not be used to remove a phrase like "It is relatively low cost" from the lead of articles. In my humble opinion, inclusion depends only on the due weight that the discussion in the body of the article gives to summarising that discussion in the lead (as it is for the summary of any other discussion in the article). If my opinion proves to gain acceptance, that will mean a decision would have to be taken on an article-by-article basis, but it will mean that the 2020 RfC can't be used to blanket-ban pricing information from the lead. It may be that acceptance that the 2020 RfC can't be extrapolated beyond its remit will go some way to reducing flash-points by focusing debate on the underlying principles and policies, such as WP:DUE and MOS:LEAD. I sincerely hope so.

Evidence presented by Ian Furst[edit]

Timing of this is horrible[edit]

Myself, and many others in HC, are deep in mitigation and management of COVID. I would participate more but my energy is needed elsewhere. Time for a meaningful debate is just not available even if we find time to comment on talk pages. The lack of a word limit makes this doubly-hard. Also, tensions are high for everyone right now due to COVID which may influence passions and positions.

Conflict:Content[edit]

I do not perceive the conflict on WP:MED any worse than other pages. In fact, I find it less partisan, more evidence based, and generally civil. Especially with the number of articles we collaborate on. I have no means to measure the conflict:content ratio but my perception is it's low.

WPMEDF[edit]

The Wikiproject Medicine Foundation’s mission is “To make clear, reliable, comprehensive, up-to-date educational resources and information in the biomedical and related social sciences freely available to all people in the language of their choice on and off line.”[258] not to somehow subvert the purpose of Wikipedia to an alternate path. Last year, we made an application through Gates to bring Wikipedia to war ravaged areas with Internet in a box. That is the work of WPMEDF (among many others). The WPMEDF has made no claims to MEDMOS, the goals of Wikipedia, and “WP:MED founding members” should have no claim on WPMEDF or it’s membership. I find it troubling that experienced editors, with a long history of editing without COI, should have to defend their charitable affiliations over what is, largely, a content dispute. I also worry about the precedent set if this line of argument is entertained.

Conflict scope is relatively narrow[edit]

The conflict is isolated to a few very niche areas of WP:MED. For instance, an edit and then the question, "Should we state " Simvastatin is relatively low cost." at the end of the 4 paragraph of the simvastatin article?" resulted in the current conflict. Yes, it's around pricing but if we accept that there is no community consensus for this, the statement itself (with a reference) is nothing compared to many of the topics dealt with in WPMED. Of the ?thousands of edits that are made and managed on WP:MED monitored articles, we do pretty well at building consensus. This interaction between James and Sandy from just 3 days ago is civil and closer to the normal[259].

Simvastatin case[edit]

With respect to current content conflict: pricing in the Simvastatin article has been present since 2008 [260] and long before Doc James. First as a cost/benefit issue then as an essential medicine issue. Always with allowed sources. The attribution to Doc James as the source of conflict are misleading in my opinion.

edit>>revert>>edit>>discuss>>RfC when other guidance fails[edit]

Regarding the broader content issue of discussing relative pricing; there is no consensus among WP:MED editors despite the RfCs, therefore, page discussions and RfC's have resulted. The path of edit>>revert>>edit>>discuss>>RfC is the prescribed process and Doc James (and many others) has followed it. See example in previous section; more available. Without community consensus this is the appropriate pathway to resolution of content issues imo.

Doc James will engage with anyone willing to discuss[edit]

I see a lot of blame being thrown at Doc James for not resolving conflict but he is following the rules and is an active content contributor to all of these articles. He does not claim ownership nor does he roll over when he disagrees with an edit. He has saved medical content from conflict of interest editing with bold edits. On the other hand, other editors, who have never contributed to a page make unsourced content changes then claim foul when Doc James reverts it. Just two examples already in evidence in this Arbcomm case:

  • Doc James contributed to Atorvastatin regularly for 9 years only to have the pricing info deleted with the editor commenting "deleted drug "cost" fromm the Lead as per RfC"[261]. That was the editors only contribution to the article and now a claim that Doc James didn't leave an adequate edit summary in reverting that edit.
  • Doc James contributed and edited Down Syndrome for a decade only to have an editor drop in and add an alternative name in the lead which he edited to the infobox[262]. A battle resulted about where this content should go (and is now cited as evidence about his incivility) without mentioning that the instigating editor appears to have no other interest in content creation on this page[263] except to see this single edit in the first sentence. I would urge Arbcomm to read the Talk page of this; Doc James started the discussion, started the RfC, and offers some very compelling arguments for his position. With that, the consensus is split and the added text is still in the first sentence. Regarding the "...we have a history of being the two most prolific medical editors on English Wikipedia" comment cited above (a) that is factually correct and (b) it was not braggadocious but in response to an editors dismissive response to Ozzie agreeing with Doc James.

Walls of text and changing questions in RfCs[edit]

A significant issue with building consensus is the use of walls of text and editors rapidly changing scope and context of (originally) pointed RfC’s...

  • As entered in evidence above, and in answer to the question "Should the lead of ethoxuximide summarize the section on cost as "As of 2008 it was generally affordable in many areas of the world." by Doc James on Apr 5 (a modification from a previous sentence on March 31), I offered an answer[264] that is quoted as arbcomm evidence as "Ian Furst may not of realized he was answering the wrong question". When the flow of the talk page is reviewed[265] it can be seen my answer was in response to the RfC question. The critique (I believe) is aimed at the difference between the NOPRICE argument I discussed vs LEAD and WEIGHT. Left out, is that Sandy had originally opposed (the RfC in general) and the original sentence based on NOPRICE[266] then Sandy and Colin had left 2400+ word ‘updates’ under the RfC in which Sandy states, “...but don't mind if we mention relatively low cost in the body,”[267] and the conversation shifted to LEAD and WEIGHT without changing her opposed stance in the RfC above. Now, the insinuation is I’m a puppet for James after a thoughtful response to an RfC on a 13 word sentence.
  • This RfC[268][269] on lead structure resulted in no consensus in large part because every piece of opinion (from me at least) was met with walls of text. At one point, we had a chart of 7 aspects of the lead with 4 positions. Unless you were willing to argue 28 points, consensus was impossible without dedicating full-time to the RfC, in an effort to follow the arguments. I felt that I spent a ton of time on that one RfC and still added only 6% to the text. SG, on the other hand, monopolized 50%. Another example of walls of text from Colin and SG are here [270] where multiple editors appear frustrated by their conduct, “I've had enough of this garbage. I am now taking this page off of my watchlist. Do not ping me or ask me to come back. --Tryptofish (talk) 00:03, 26 April 2018 (UTC)” or here [271], an RfC I purposely avoided knowing it would be an issue, and where 60% of the text is from WAID, SG or Colin.
  • This RfC[272] which asked for acceptable wording suggestions resulted in a 1,900 word (initial) response from Colin without offering a suggestion on wording then subsequent walls of text each time James posted.

Other efforts to block content creation[edit]

Accepting that there is not consensus to add or removing certain drug prices, I believe that the walls of text we've seen in the discussions about MEDMOS, LEAD and Talk pages are designed to discourage and exhaust the editors who are attempting to add the content. This is based on my previous experience with Colin during his mission to stop VideoWiki[273]. To repeat, myself, James and Pratik came together for a 6 month push to make the platform Wikipedia compliant and engaging. At each stage of development and in almost any forum we needed to post, Colin would participate with 1,000+ word comments, links to his essay on his opposition to video, dismissive remarks about the project, hyper-critical remarks about the quality, and belittle stated reasons for the project. Examples can be found in the discussions about a namespace for scripts, templates for offline discussion, even congratulations on a Slate article and minor edits of related files on Commons. Constant critiques like, "...boring Siri slide show...", "...better of watching a video created by an Indian government agency...", "...glorified PowerPoint slideshows with tedious robot narration...", "...half-baked "solution" to a problem Wikipedia does not have...", etc... by the same person in multiple forums of Wikipedia is both exhausting and a little frightening. It certainly made me second guess posting in many discussions and it absolutely took much of the enjoyment out of volunteering for the project.

Summary[edit]

I hope this helps explain why myself, Doc James, and many others choose to engage with quicker edits, revisions, talk, and RfCs where a decision is needed. Normal discourse, in certain circumstances, is nearly impossible when Talk page discussions are met with walls of text, whataboutism, and constant modifications to the target issue. This should be enjoyable for all, and I applaud the deep engagement of all involved to the Wiki movement, however the vilification of James is misplaced imo and the tactics used to dominate discussions is pushing editors to the sidelines. Ian Furst (talk) 12:41, 21 April 2020 (UTC)[reply]

Evidence presented by Evolution and Evolvability[edit]

Conduct[edit]

I've found conversation on WT:MED getting heated way more frequently than other wikiprojects I've been involved in. This sometimes gets in the way of productive discussions, even when I think participants fundamentally agree. Writing FAs / improving lead readability / forming outside partnerships / video content / translation / offline content are presented as incompatible or competing in a way that sets up unconstructive friction and that I don't think is necessary (example discussion).

Since there are also a number of specific content questions being simultaneously brought up, I'm not sure getting into the details of content questions is really the point, but I'll briefly respond to a couple of comments above.

Pricing[edit]

To the extent that this is also about content, I've already commented in the earlier RfC that I think that including pricing in medical articles (drugs and others) is notable in most cases. I really don't think inclusion of medical drug prices is advertising or promotion (often the opposite).

Video content[edit]

The collaboration with Osmosis was a good idea, since video content is an under-utilised potential for a non-paper encyclopedia (and something I've found readers often bring up). However, the main problem was lack of editability such that a video with a single error had to be excised in its entirety and in the end all were removed (I imagine a bit disappointing for he contributors). Granular and collaborative video editing via videowiki was a reasonable response to this. I've not seen it unfairly pushed on anyone who doesn't want to contribute.

Encouraging academics to contribute to Wikipedia[edit]

Again, I think there are false dichotomies drawn between internal FA processes versus external quality assurance and academic outreach activities (Cochrane collab, journal publishing etc). Articles involved in these partnerships are not protected at a greater rate than others (as far as I can detect), and all participating partners are explicit that any content in Wikipedia is a) decided by the Wikipedia community and b) is expected to continually evolve.

Template[edit]

Since Template:Academic_peer_reviewed was also brought up here, I just want to add a couple of notes about it.

  1. It's not a WPMEDF template, it's used for a range of articles (category), and indeed the dengue article is the only one of its kind for which that template is omitted.
  2. The peer review performed by Open Medicine was not internal.

T.Shafee(Evo&Evo)talk 06:54, 24 April 2020 (UTC)[reply]

Evidence presented by WhatamIdoing[edit]

I've been trying to figure out what the locus of this case is, and I don't think I've entirely figured it out. However, I think this might be useful for people to know:

No simple "sides"[edit]

It would be a mistake to classify most WikiProject Medicine editors as being wholly pro-prices or anti-prices. Most editors do not hold extreme views in either direction and support the inclusion of some price information without supporting the inclusion of some other price information.

As an example, since I removed database-sourced drug pricing from one article after the massive RFC on MSH's IMPPG database concluded that database-sourced drug pricing violates NOR, it might seem convenient for someone to paint me as being on the "anti-price side", but it's not true. I removed this price because my understanding of the RFC outcome is that this is not acceptable. Similarly, people might think it convenient to present Tryptofish as being on the "pro-price side", but I have long supported including more price content than Tryptofish (contrast, e.g., our views in the 2016 RFC). We should be suspicious of oversimplifications and us-versus-them sentiment.

NB that in this I apparently differ from User:RexxS, who seems to indicate that the first sentence of the first bullet point is a sort of topic sentence, and that everything else in that bullet is about what's acceptable in an article's lead but not the body. I believe that the second sentence is the key outcome for the RFC: "While basic calculations are not considered original research, the pricing statements in the examples require interpretation of primary sources that may not be straightforward." NOR bans the use of primary sources except when the interpretation is "straightforward". Content that violates NOR will still violate NOR even if it's cut out of the lead and pasted into the body.

Two stories about errors in articles[edit]

While writing the RFC question, there were several frustrating moments. One is easily illustrated by this timeline:

I don't know how to explain this in a way that lets everyone come out smelling like roses. Either:

  • There really were incorrect numbers in some articles, in which case IMO it is fair and factual for the RFC's question to say so, – or –
  • There weren't any incorrect numbers, so there was no need for the correction that Doc James made in the middle of his complaints about the RFC's question saying that some content was incorrect.

Perhaps S Marshall is correct, and we have some editors who are stretched so thin that they can't remember what they're doing for even 24 hours in a row?

Post-RFC, the part that was most discouraging to me personally was that one of the disputes was over whether the list price from a single supplier to accredited healthcare facilities in a single African country should be described as "the wholesale cost in the developing world", or if it would have to be described as something like "In 2014, according to the International Medical Products Price Guide, one organization offered this drug for sale to accredited healthcare agencies in the Democratic Republic of the Congo at a price of about $0.20 per 250 mg pill." Everyone agreed that it is wrong to describe the Democratic Republic of the Congo as "the developing world" (or as "LMICs", which is an abbreviation for the same concept). Everyone agreed that one organization's list price is not "the" wholesale cost. This particular example was discussed extensively before and during the RFC. There was not a single editor in any discussion who thought this was a correct statement, because it's an obviously stupid error. Note particularly that in the RFC on 3 February 2020, Doc James agreed (again) that the original statement should be "adjusted" to stop misrepresenting the Dem Rep Congo as being the same as the entire developing world. So it's settled, right?

A couple of days after the RFC closed, Colin removed this incorrect and unanimously rejected statement from that article.[274] Doc James put the same, un-adjusted, still-incorrect statement back in the article a couple of hours later.[275] We had to have yet another discussion about whether the Democratic Republic of Congo is "the developing world" on the talk page of the article before Doc James agreed to correct the error. Why did it take so much effort to make such a small change?

We still haven't achieved agreement on whether that price is WP:DUE (should any Wikipedia article actually report a single year's list price from any single supplier to accredited healthcare facilities in any single mid-sized developing country?) or on whether the RFC closing statement, when it said that using this complicated primary-source database was "not straightforward" (the word choice is straight out of WP:PRIMARY, on what Thou Must Not Do), means that using this source at all violates WP:NOR, but my point is that just getting "the wholesale cost in the developing world" turned into "The wholesale cost from an NGO in the Democratic Republic of Congo" took way too much effort from way too many editors ("NGO" is real-world WP:TLA for non-governmental organization). That error shouldn't have been put in the article in the first place, and once it was there, it should have been fixed the instant it was reported, not months later and after multiple (and multiply forgotten? I don't think they were insincere) agreements to that it was wrong.

There are still more than 500 articles to go. I don't want to have this kind of discussion 500 more times. I want to be able to fix these errors and remove inappropriate uses of this source without having to say, over and over, "By the way, you treated the 'buyer' and 'supplier' prices as being directly comparable again, even though page 18 of the PDF you're citing tells you to definitely not do that" at each of a couple hundred articles, and without worrying about the already lengthy list of edit wars and reversions in User:Colin/PriceEdits#Conflict getting any longer. I do not have any confidence that I can remove WP:DUE and WP:NOR violations from these articles without Doc James reverting the bad content back in.

History of the 2020 RFC on drug prices[edit]

To expand upon Barkeep49's #Timeline of MOS Dispute, I add:

  • The 2010 advice in MEDMOS said "Do not include dose, titration or pricing information except when they are extensively discussed by secondary sources, or necessary..." [e.g., when understanding the next bit of the article requires knowing some of these numbers]. It was never a blanket ban. Note also that it expects secondary sources (e.g., one that analyzes changes in prices over time, or between countries, or contrasts the cost of one treatment with another), while NOTPRICES asks for an independent source (e.g., a newspaper article) plus a "justified reason" (undefined).
  • 2016: The 2016 RFC happened because Doc James was systematically adding price content to drug articles, and some editors objected. It concluded that "Except in the cases where the sources note the significance of the pricing (which did have consensus), there is no consensus to add the pricing to the articles".
    • I think most editors interpreted this statement as meaning that there should generally not be pricing content in most articles (unless the stated exception applied); however, after the RFC concluded, Doc James continued adding more price content in the following months, mostly using a source that does not note the significance of any price (examples: [276][277][278][279][280]; notice that the last diff contains a factual error that's still in the article, but I don't imagine removing that erroneous sentence – which is what AFAICT was the conclusion from both the 2016 RFC and the 2020 RFC – would do anything except provoke an edit war).
  • September 2019, Doc James cited the 2016 RFC – the one that concluded 'no consensus', not 'add prices whenever you can find a source' – as his reason for adding a line in WP:MEDMOS that supported inclusion of price content.
  • December 2019: ANI decided that the most salient problem was content and demanded an RFC on how to handle drug prices. Several editors spent the next six weeks talking about what the RFC should say. We considered multiple formats (e.g., a question with pro/con statements, a vote vs a discussion, etc.) and multiple questions (e.g., everything at once, a small question about content in the lead that isn't in the body, a proposal for what MEDMOS should say, etc.). The question we settled on was about whether the current price-related content that Doc James wrote using MSH's IMPPG database as the (sole) source (i.e., not including articles such as Insulin, which contain price content from other sources) complied with Wikipedia's guidelines and content policies.
    • I drafted the January RFC, but I can't claim any credit for the original idea of focusing on this source. I thought it was a good idea, because I thought that the narrower scope would let us build consensus and identify some best practices on a smaller, more objective question before trying to tackle more general, subjective points.
    • My own plan was to use the comments from this narrower question to develop a second RFC, at a later date, on what advice MEDMOS should provide. I still think this is needed, but so long as people can't agree whether "There is no consensus on whether drug prices should be included in articles at all" means "the WP:ONUS is on you to prove consensus to add anything about prices to any article" or "nothing's prohibited, so we can add as much as we want, and others have to prove that there's a solid consensus for removing it", then I don't think we're ready to proceed to general advice yet.
    • In December, ANI thought that clarity on the content questions was the key point, and I still agree with them. Looking at the behavioral issues, it appears that we might need the kind of clarity that leaves no room for judgment, like "every article about drugs must include some content from this database" or "the use of this database is banned in all articles", but I do think that clarity on the content issues, written in a way that is impervious even to a determined advocate, would solve the immediate problems.

Ignoring content problems is long-term problem[edit]

Important context: There were (and still are) some factual errors in our articles. Consider the corrections of this arithmetic error and this claim misrepresenting a single supplier's list price for a single country as "the" cost in the entire developing world in Ethosuximide, or this discussion about whether the source said 12¢ vs 15¢.

We hope and normally expect that editors will correct all objective factual errors that are reported. In this case, however, there were instead complaints from a few editors about the way the errors were reported. Getting editors to pay attention to widespread or persistent errors often requires a significant effort, and when you make that effort and finally succeed in getting people's attention, then, sometimes, some editors ignore the substantive part of your complaint and jump on you for being too noisy about it.

It reminds me a bit of the progression towards the end of https://everydayfeminism.com/2015/12/tone-policing-and-privilege/ First you're told that you're too noisy and that it's not civil to let people know that you're upset about a serious problem, so you try again, and again, but ultimately even your mildest, most robot-like, unemotional comment about the problem is still being rejected as being "uncivil", until you give up, and the factual errors persist in the articles. Obviously, it is easier for people to complain that they don't like the way an editor made them feel than to learn enough about this complicated database to be able to check and correct claims 500+ articles, but that doesn't mean that the real problem is the editors who are sounding the alarm. The real problem is that we had – and we still have! – factual errors in many articles.

Not only do we not solve the problems, we then blame editors for being frustrated by our inaction. We're all supposedly against factual errors, but we eventually dragged Colin off to ANI to complain about "incivility" without addressing ourselves to the reported factual errors. The RFC only happened because a couple of highly experienced editors at ANI realized that the alleged incivility would evaporate the moment the errors were removed. This is not just the parties. This is not just WPMED. This is community-wide. We're supposedly all against copyvios, too, and the backlog at Wikipedia:Contributor copyright investigations goes back to 2011. Community-wide, we don't put our money where our mouths are, and we punish people who refuse to be quiet about the problems that we don't want to solve.

I don't know how to solve this, but I do think that how we handle this is a long-term problem. The correct response to "Help, help, disaster!" isn't for someone to drag you to ANI or to tell you that you're over-reacting. One functional response would be for us to deal with problems before editors decide that the only way to get a response from us is to start screaming, but we can't really mandate that people WP:VOLUNTEER to pay attention and do the hard work. That was true years ago, when support from Gordonofcartoon was the only reason I didn't quit Wikipedia in the face of a very determined self-promoter, whose problems were ignored by the community until we ended up begging for help at ArbCom 11 years ago,[281] and it's still true now. We need to come up with a system that gets content problems get solved when they're first reported.

Affiliations[edit]

Several editors have commented on affiliations, so in addition to saying that Doc James is a corporate officer for m:WPMEDF, he is also on the m:Wikimedia Foundation Board of Trustees, and that I am a part-time contractor for the Wikimedia Foundation. None of this has anything to do with any of that, of course.

About the result of the 2020 RFC on drug prices[edit]

Wikipedia:Manual of Style/Medicine-related articles/RFC on pharmaceutical drug prices concluded that citing MSH's IMPPG database to support a claim about how a drug's price violates WP:NOR.

Evidence presented by User:Some1[edit]

Behavioral issues by Doc James, QuackGuru, Ozzie10aaaa, and Bluerasberry extend beyond medicine-related articles[edit]

I see that Hipal/Ronz has added information regarding the iPhone 11 article to their evidence section. I want to expand on this a bit more since I participated in the RfC and saw several other problems that others have mentioned in their evidence that also pertain to this non-medicine-related RfC.

iPhone 11 timeline:

  • 16:47, 27 September 2019 Hipal/ Ronz removes the Price table on the iPhone 11 article citing "per NOPRICES, POV"
  • 16:28, 30 September 2019 Doc James shows up three days later and undoes Hipal’s edit, stating that this has "been in the article a long time” (Note: This was Doc James' first ever edit on this article)
  • 17:51, 30 September 2019 Hipal undoes Doc James' edit a little more than an hour later “per NOT, POV - see user talk page”
  • 18:00, 30 September 2019 QuackGuru shows up 9 minutes later, reverts Hipal, and re-adds the table with an edit summary of "Please start a RfC and consider pinging me when it is started. The prices improve this article per Larry Sanger's WP:IAR." (Note: this was QuackGuru's first edit ever on this article)
  • 18:11, 30 September 2019 Discussion begins on talk page with QuackGuru supporting the prices
  • 18:22, 30 September 2019 11 minutes later, Doc James joins in and also supports per WP:PRICES (So far, there's only Doc James and QuackGuru supporting the price table, and Hipal and Yamla opposing the price table; RfC hasn't begun yet)
  • 16:05, 9 November 2019 Ghostofakina removes the price table stating it is unnecessary
  • 17:33, 9 November 2019 QuackGuru reverts and re-adds the table back with the edit summary: useful content per WP:MEDPRICE
  • 20:06, 9 November 2019‎ Ghostofakina reverts QuackGuru, stating Useful though it may be, this violates WP:NOPRICE. There is no price section in iPhone 11 Pro, XS, XR or X, and information on pricing is already found in the iPhone article.
  • 20:27, 9 November 2019‎ QuackGuru reverts Ghostofakina again, with the edit summary: helpful content on pricing (start a RfC if you disagree)
  • 00:47, 10 November 2019 RfC was officially started by Taewangkorea (uninvolved editor). Link to the full RfC: Talk:IPhone_11/Archive_1#RfC_about_including_pricing_information_in_article (To avoid any confusion, my username was previously Someone963852 before my username change)
  • 14:18, 10 November 2019 13 hours later, Ozzie10aaaa joins in and votes the same way as Doc James [283][284]
  • 15:53, 13 November 2019 Bluerasberry shows up and supports "per WP:PRICES, which is an essay to which [he] contributed."
  • 13:10, 23 November 2019 Bluerasberry makes a comment. Currently, there's 4 supports (Doc James, Quack Guru, Ozzie10aaaa, and BlueRasberry) and 7 opposes.
  • 14:12, 23 November 2019 An hour after Bluerasberry's comment, QuackGuru creates a new topic titled "List of mobile phone prices" on the WikiProject Medicine talk page
  • 21:51, 24 November 2019 WhatamIdoing responds "It's true that WP:Other stuff exists... However, the price of mobile phones is not relevant to this particular group of editors."
  • 00:30, 26 November 2019 QuackGuru adds pricing information to the article
  • 00:34, 26 November 2019 Seraphimblade reverts a few minutes later stating that “WP:NOPRICE is policy.”
  • 00:50, 26 November 2019 QuackGuru then goes to the talk page and asks for an explanation "10 sources"
  • 01:07, 26 November 2019 17 minutes later, Seraphimblade gives a detailed explanation for the revert:

    I can read the content the sources supported, and I can read the policy. WP:NOPRICE is clear: Unless the price is significant, we omit it. If it's significant, there will be a lot more to say about it than just "The price is $X.XX". It's not enough for sources to just mention the price, they would also need to go into detail as to why that's significant or important. Otherwise, it's just a factoid, and general practice is to omit it. I did read the sources you cited above, and they just mention the price, and in a couple cases say it's similar to its predecessors. They don't say much else about it, or that it's anything of note.

  • QuackGuru doesn't respond on the iPhone 11 talk page, but instead goes to the Wikipedia talk page (Talk:Wikipedia) to get another explanation for the revert. Seems like the edits got hidden or deleted but I believe the below are the timestamps:
    01:36, 26 November 2019 diff hist +364‎ Talk:Wikipedia ‎
    12:14, 26 November 2019 diff hist +318‎ Talk:Wikipedia ‎
    21:02, 26 November 2019 diff hist +356‎ Talk:Wikipedia ‎
  • 20:31, 25 December 2019 Almost two months later, the RfC was concluded with 4 supports and 10 opposes and the consensus being against including the chart of prices on the iPhone 11 article.

PRICES/NOPRICES is not the only problem[edit]

As seen from the evidence and diffs above, problems that I'd noticed:

  • All of the Support votes in the RfC came from Med project editors who are also trying to push drug prices: Doc James, QuackGuru, Ozzie10aaaa, and Bluerasberry
  • Doc James and QuackGuru's first ever edit on the iPhone 11 article were to add prices with no additional justification as to why it'll improve the article
  • QuackGuru reverts any removal of the price table and demands others start RfCs if they disagree [285][286], despite the WP:ONUS being on them for inclusion
  • Doc James, an admin, ignoring Wikipedia policy (WP:NOPRICES/Wikipedia:What Wikipedia is not An article should not include product pricing or availability information unless there is an independent source and a justified reason for the mention.) and instead cite WP:PRICES, an essay, as a reason for their vote without providing any strong or additional justification [287] in order to push prices to the article
  • Ozzie10aaaa joins in quickly after the RfC has started and votes the same way as Doc James [288][289] Similar to Doc James, Ozzie10aaaa has no further justification of how WP:Prices would improve the article, just "Per Wikipedia:Prices"
  • Bluerasberry supports the inclusion of the table mainly because of "WP:PRICES, which is an essay to which [he] contributed" [290] with his examples of "drug prices" seeming a lot like WP:Advocacy instead of improving the article itself
  • QuackGuru adding a single "iPhone 11 retails for $699." line to the iPhone article [291], making the article read like it is a sales catalogue
  • QuackGuru posting about mobile phone prices to the WikiProject Medicine page which another editor said was irrelevant to the project; complaining on the Talk:Wikipedia page even though they got an explanation for the revert already in the discussion they started on the article talk page
  • An RfC was started by an uninvolved editor and lasted almost two months because this small group of editors wanted to push prices into the article per their "essay", demanded RfC's to be started if editors disagreed, and refused to WP:LISTEN. Besides the 4 total support votes all coming from Doc James, QuackGuru, Ozzie10aaaa, and Bluerasberry, the rest of the editors who participated in the RfC all opposed the inclusion of prices (10 opposes).

This was my one-off experience seeing this POV price pushing and related behavioral problems in action just by participating in the RfC. Hopefully these problems won't continue spreading to any more non-medicine-related articles.

Doc James and Blueraspberry's advocacy on Wikipedia[edit]

From Wikipedia:Advocacy:

Advocacy is the use of Wikipedia to promote personal beliefs or agendas at the expense of Wikipedia's goals and core content policies, including verifiability and neutral point of view. Despite the popularity of Wikipedia, it is not a soapbox to use for editors' activism... advertising... or other forms of advocacy. Wikipedia is first and foremost an encyclopedia which aims to create a breadth of high-quality, neutral, verifiable articles and to become a serious, respected reference work. Some editors come to Wikipedia with the goal of raising the visibility or credibility of a specific topic, term or viewpoint leading to disproportionate coverage, false balance and reference spamming. When advocates of specific views prioritize their agendas over the project's goals or factions with different agendas, battling to install their favored content, edit-warring and other disruptions ensue. Wikipedia operates through collaboration between editors to achieve the encyclopedia's goals.

  • Doc James: [292] "We know that the pharmaceutical industry really really wants to suppress the cost of medications" "Wikipedia is not censored."
  • Blueraspberry: [293][294] "For drugs knowing whether a dose is $1 versus $10 versus $100 versus $1000 is essential... prices are messy to report globally but somehow Wikipedia articles need to communicate when a product exists to benefit and be accessible for the poverty, lower, middle, or upper economic class of consumers... do not care about exact prices, but prices are one way to distinguish products for the lower class versus the upper class." "wish that Wikipedia could communicate which products are for everyone and which ones are luxury products."

Others above have provided extensive evidence of Doc James and Blueraspberry's advocacy and related behavioral issues with specific examples in their sections, especially regarding Doc James inserting prices into hundreds of articles without any concern for WP:DUE, WP:NOPRICES, WP:V, WP:OR, WP:NPOV, ignoring consensus, and edit warring and starting RfC's to get them in because of WP:IDHT issues. (At the time I'm writing this (April 26), there are currently two RfC's open under the Wikipedia:Requests_for_comment/All "Math, science and technology" section: Talk:Ethosuximide and Talk:Simvastatin, both started on March 30, 2020 by Doc James, 3 hours apart and both about costs and prices.)

Doc James reverts and re-adds video before discussion on the 2019–20 coronavirus pandemic‎‎ article[edit]

I don't think there is any consensus to incorporate the video into the lede of the article at all, nevertheless it was added by Doc James twice, which is not covered by WP:BRD any more.

We are an encyclopedia, not a video site. Foremostly, our medium is text enriched with static illustrations. While an occasional animation is okay (as is, IMHO, a link to a quality video in the External Links section), many people consider "moving" contents a distraction and annoyance. If a video would be actually needed to convey the message, it means that we failed in our core discipline to explain the topic in prose.

In the case of videos, users not having suitable plugins installed and scripting enabled may f.e. just see a large empty box instead of a video. This looks very odd, in particular in the lede of a high-profile article such as this one. It completely ruins the page layout and makes people stop reading the article beyond the lede. I would appreciate for the video to be removed again. (A link to it under EL would be fine with me.)

But ultimately the editor's thoughts and opinions on the video didn't matter, because the "consensus" was 3 to 1 with Doc James (creator of the video), Ozzie10aaaa ("video is very good...IMO"), and Ian Furst ("Disclosure that I was part of the development of the Videowiki platform."; first ever comment on the article's talk page and contributor to the video) supporting the video.

Evidence presented by Tryptofish[edit]

I began editing Wikipedia in 2008. Early in my editing time, I worked on schizophrenia and some related pages, but I switched fairly soon to focusing most of my science-related editing on basic neuroscience, pharmacology, and physiology, rather than on medical content. In the spring of 2018, however, I came to observe a significant instance of the conflicts in the case area: about Doc James' addition of medical videos to multiple pages. The history of the conflict goes back quite a few years before that, but this is a time period of which I can speak from personal observation.

March–April 2018[edit]

March 26: Colin opens discussions in which he expresses concern about the videos, at WT:MED: [295], and at Jimmy Wales' talk page: [296]. I did not participate in either of those discussions, but most of the named parties in the case feature prominently there.

March 28: I saw an RfC announcement of an RfC that Doc James had initiated in response to those discussions, and I decided to participate in it. I made several contributions: [297], [298], [299], [300], [301]. Please note that I was largely disagreeing with Doc James, and expressing opinions that were usually similar to those of Colin and SandyGeorgia.

The Discussion section of the RfC begins with an interchange between Doc James and Colin: [302], [303], [304]. Please note the contrast in tone: Doc James is polite and encouraging of other opinions, whereas Colin is mocking and sarcastic. Looking back at the discussions starting on March 26, above, there is a similar pattern.

Seeing that exchange, I said this: [305]. As best as I can tell from memory and from the editor interaction tool, that diff is the first time that Colin and I had directly crossed paths.

March 29: An ANI complaint begins, generating heated argument but no action: [306]. I say this: [307].

March 30: Doc James recognizes and accepts that community consensus was against him, and promptly fixes all of the edits that he had made: [308]. This is also noted later in the RfC closing statement: [309]. Thus, in this particular instance (and I do not mean to extrapolate to any other events in the history of the overall dispute), Doc James sought community input via an RfC when he recognized that there was a problem, readily accepted that consensus was against him, and made an effort to enact the consensus himself.

Roughly at the same time, there was also heated and lengthy discussion at Doc James' talk page: [310]. I joined that discussion fairly late into it, on April 2.

April 2: I make some comments on Doc James's talk, trying to be helpful: [311], [312], [313], [314], [315], [316], [317], [318], [319], [320].

March 30: Now, going back a few days, I have a brief and not-particularly important discussion with WhatamIdoing: [321], [322]. No big deal, but I mention it only because it led to another discussion, between SandyGeorgia and me at my talk page: [323], [324]. Please note several points. It's a very friendly talk, and Sandy explicitly notes that she regarded me as neutral in the ongoing dispute. When I reply, please note in context what I said about not wanting to say anything bad about Doc James et al. – I'm saying that "I do not consider myself to be on either 'side'".

Following from that, Colin cites that comment of mine at Doc James' talk page as if I were taking sides with Doc James, and, surprisingly, says that I "sound exactly like an apologist for sexual abuse in the workplace": [325], [326]. WhatamIdoing astutely and correctly notes in her evidence section that editors may tend to regard me as pro-prices, even though I have repeatedly said the opposite. That's been a problem throughout this overall dispute: editors are regarded as being on "sides" even if they are not.

Anyway, I decided, based on my discussion with Sandy at my talk page, that I would like to work with her on some content work, improving the page on Dementia with Lewy bodies. Please go to here: [327], on Archive 2 of the talk page, and read down to the bottom of the archive page, then continue with Archive 3, going as far as here: [328]. Don't worry about the content details, but instead, focus on the vibe between Sandy and me. You will see that, over a lot of editing, it was consistently friendly, collaborative, and productive.

The situation changes on April 18, here: [329]. Sandy and another editor (not a party here) disagree about "should" language, as in people with this disease should take such-and-such medication, in the context of WP:NOTHOWTO. I largely agreed with the other editor. As the discussion goes along, Casliber makes this edit: [330], and says this on the talk page: [331]. There's some further discussion, and a growing sense that the sentence needs to be changed further. So I make this edit: [332], and say this on the talk page: [333]. In hindsight, my talk page comment comes across as smug, and I am sincerely sorry about that. But, taken in the context of Casliber's comment, and of all the editing I had been doing there up to that point, it's hardly a major disruption. And when Sandy further improves on my edit, I readily agree that her version was better than mine: [334]. It went similarly with other similar changes: [335], [336]. Some differences of opinion, but it all gets worked out.

But Colin then entered the discussion, saying this: [337]. Please look at that closely. He isn't really trying to help me understand earlier discussions of which I might not be aware, nor looking for ways to get to consensus. He is tut-tutting me, and schooling me, in a condescending way that makes it sound like I should defer to those who are wiser than I am. I respond: [338]. Colin then replies in a more helpful way: [339], and I try to work with him: [340]. But Colin doubles down: [341]. There is a direct line connecting those comments to me with the comments on this evidence page about "factoid" editing: [342]. I hope that ArbCom does not regard editors who make multiple small edits as inferior, because the community sure doesn't. And it strikes me as ironic that, whereas Colin cares so much about WP:NOTPRICES in the recent dispute about drug prices, he was so dismissive of WP:NOTHOWTO back then. In any case, I decided that I should just walk away at that point: [343], and I never edited that page again.

Much later, in the December 2019 ANI dispute, Colin repeatedly misrepresented what I had previously said (explanation at [344]), and ended by telling me to "go watch something nice on telly": [345]. It's understandable that editors can sometimes get angry, but I believe that what we have here is a pattern over many years, and it has given rise to many of the problems that are to be addressed by this case.

I have not looked in detail into how Colin interacts with other editors, but I'm aware of this edit summary from a link provided in the most recent ANI case: [346]. There's certainly things to be said about Jytdog, but a lack of reading comprehension is not one of them. Also, Literaturegeek posted some evidence here and then changed their mind: [347], [348]. In my opinion, it was within the case scope, and seems to document a lot of incivility directed at Doc James.

For whatever it may be worth, I'll link to this: [349], to demonstrate via just one example that I'm quite capable of working with the review standards at FAC. I'm not talking in this evidence about high standards, or about who is right or wrong about writing style. I'm talking about conduct.

Recent RfC on drug pricing[edit]

In the last days of drafting the RfC, Barkeep49 urged editors doing the drafting to be attentive to the need for the RfC to be neutrally worded: [350], [351]. Rosguill served as am uninvolved administrator to evaluate the draft for neutrality, and identified some potential problems: [352]. Ronz/Hipal made some helpful edits to try to address those concerns: [353]. The overall discussion is at Wikipedia talk:Manual of Style/Medicine-related articles/Archive 12#Polishing the draft, and is rather sprawling, but I get the impression that, outside of Ronz/Hipal's editing, there was a lot of resistance to going along with Rosguill's recommendations.

About the RfC itself, the closing statement is here: [354]. In evaluating the various evidence in this case, it is worth noting that editors would typically look at that closing statement to find the results of the RfC. If an editor is suspected of ignoring the consensus, it is important to evaluate whether that editor was aware, at the time, of any modifications of the close that were posted elsewhere. Subsequently, Colin requested further clarification of the closing statement at WT:MED: [355], and got this reply: [356]. This was later copied to the RfC talk page, but editors would have to look there to find it. I think the two closers did an admirable job with a difficult task, and am not finding fault with them, but these significant revisions leave me with some discomfort. I could imagine posing the question as something like "Editors disagree about the meaning of the part that says "no consensus" (diff, diff). Could you please clarify that, with particular attention to presenting prices in the lead, the roles of WP:OR, WP:V, and WP:WEIGHT, the role of WP:NOTPRICES, the presentation of prices in infoboxes, and the roles of secondary sources versus primary databases. Thanks." Instead, the question was non-neutral, and pretty nearly dictated Colin's preferred close while asking the closers to simply say OK to it. I'm not saying any of that was a violation of policy, but it just doesn't sit right with me.

Although they are opinions, rather than evidence as such, I will close with these two sets of comments, from during the drafting of the RfC: [357], [358], and after the close of the RfC: [359], [360]. --Tryptofish (talk) 23:51, 27 April 2020 (UTC)[reply]

I'm disappointed to see that Sandy has posted "evidence" that is, in effect, retaliation for my posting of my evidence here. It's wildly inaccurate, and I will demonstrate that on the Workshop page below. After all, I'm not a party, and this kind of thing has a chilling effect on editors who will want to provide evidence in future cases (probably a good reason to return to limits on word count and diff number in the future). I guess that's an illustration of how WP:BATTLEGROUNDy this whole thing has become. --Tryptofish (talk) 22:26, 28 April 2020 (UTC)[reply]

Response to what Sandy Georgia posted about me ([361])[edit]

Some broad points:

Instead of explaining why the evidence I presented was mistaken, she unfortunately takes the approach of claiming that I did a bunch of bad things, as if two wrongs make a right.

And about the things she links to me saying, let's compare and contrast:

I've reported here about being compared to a sex offender and being told to go watch something nice on TV.
Sandy complains of me that I asserted that editors were not listening to me and were making discussion difficult.

Some specifics:

"Old baggage": In my evidence, I've been careful to present the chronology accurately, but Sandy presents events out of chronological order, by years, in order to make it look like I brought a prior grudge to the DLB page. But my evidence shows that it didn't actually happen that way. And I provided a diff (repeated here: [362]), that explains what happened at Commons.
"Caused consternation": That makes it sound like I was conspiring with Barkeep49 to keep something secret. Actually, Barkeep had earlier said this to me on my talk page: [363], and I was simply following up with him. Editors working on the RfC draft had agreed to take time off over the holidays and resume active work on January 2: [364], and it was January 2 when I reported it to everyone else, the same day as the other draft: [365]. Note that Sandy also says that the draft "was already well developed and we were under some time pressure". That's what I was referring to when I later used the term "running out the clock": editors were only discussing the other version, and using the time pressure to keep saying that they would only have time to work on that one and not really look at anything else.
But since Sandy linked to this: [366], let me point out something about that. I later put at WT:MED a neutral notice about the discussion, and disclosed it at the RfC drafting page: [367]. Sandy, however, assumed bad faith about my notice and directed some accusatory comments at me until I set her straight: [368].
"Stirred the pot": Those three diffs are an unrelated one from 2018, plus two where I was merely discussing things with Barkeep. And the comment to Doc James was simply giving him some advice and trying to get him to become more active in the planning of the RfC. And I made a judgement that things were just getting too adversarial in those discussions, and just decided that I should leave entirely. Note: [369], where I clearly stated self-awareness of the fact that I didn't like the way I had started to feel and act.
What Colin posted on Barkeep's talk page: He actually misquotes some of what I said, and it's a real stretch to call any of that "personal attacks" (cf the sex offender and watch the telly stuff). Most of the comments I made were in user talk, which is where Barkeep said editors should raise concerns about conduct and procedures.
About making me a party: I think it's pretty clear where Sandy was going, based on exactly the accusations she makes about me here. All of this is really disappointing, because I tried very hard to not present Sandy negatively in my evidence here, but I guess my evidence touched a nerve with those editors who identify as adversaries of Doc James. --Tryptofish (talk) 23:49, 28 April 2020 (UTC)[reply]

Evidence presented by Literaturegeek[edit]

The core of the problem is that both Colin and Doc James care deeply about the content our readers are getting but they are coming at it from different angles and great conflict in the past has arisen.

Tryptofish has linked to my deleted version of my evidence, so I will repost it but with errors corrected and some improvements as well as expansion. Before posting this final version of my evidence, I have read through everyone’s evidence and I have removed some evidence already mentioned by others.--Literaturegeek | T@1k? 19:35, 28 April 2020 (UTC)[reply]

Doc James background[edit]

I don’t really care much about the drug pricing dispute before this ArbCom and having familiarised myself with it now I still don’t care much about it. So I never involved myself in it. I can see arguments both for and against including pricing information. In any event this dispute has attracted much (largely avoidable) drama.

Doc James has been a productive wikipedian for many years. He is very skilled at reading and interpreting the medical literature and summarising said sources. Many articles have been greatly improved by Doc James’s medical additions. He is doing very valuable work along with others, that no doubt is improving and saving lives, with regards to him translating LEADs of medical articles into multiple different languages. Much of the problems began when he seemed to veer away from his skill set and began doing extensive copy editing and trying to make technical words less technical (despite Doc James admitting on his profile that he has difficulties in this area such as spelling, choice of words etc), often he made an improvement but heated disputes arose with Colin and others who felt that he sometimes made the wording worse. In any event, spelling and word choice errors can be fixed by copy editing without all of the drama. Also, some in the community disagreed strongly with Doc James adding video content to medical articles, but their reaction was way over the top in terms of aggression. Disputes therefore arose regarding Doc James adding videos to articles and his grammar, Colin in my mind stood out as one of the most problematic editors, at this point in time (2 years ago) but he seems to have improved as I have not seen serious civility issues in more recent times, (although I have not followed the other disputes to be sure), but tensions still run high.

One thing that jumped out at me: When Ozzie comments on articles usually in agreement with Doc James’ it is as a consequence of Doc James posting on WP MED project page asking for second opinions wrt a dispute. Doc James is not specifically recruiting/canvassing Ozzie as an individual.

I do not have any evidence against Doc James to add to what has already been posted (and I do not know enough to refute or agree with what has been posted). I never gathered such evidence against Doc James during the one dispute that I did follow, namely the video dispute over two years ago, as I did not see Doc James as being a problem as he was calmly following dispute resolution processes e.g., an RfC (I have not followed any of the other disputes mentioned here). I do worry that the evidence against Doc James could act as mud that will colour the water and distract from the case that he is overwhelmingly a net positive high quality wikipedian. Clearly the evidence shows him to be a very productive editor but there is also evidence that suggests areas of concern i.e., it seems hard to dispute that he reverted too many times on occasion. For what it is worth I think Doc James should focus more on his strengths of summarising the medical literature and less so on areas that cause arguments, i.e., avoid drug prices. When he was doing this (focusing heavily on summarising sources) in his first years as a Wikipedian he had very few, if any, problems with his fellow senior editors; that is not to say Doc James is the problem here but it is to say that it seems like a dispute that is just not worth the effort. Perhaps pharma drug prices should be left to politicians and courts to resolve fair prices.

I notice that adding citations to the lead has come up. I have for many years supported adding references to the lead but for different reasons than for translation. I wrote the following during a talk page discussion about this: I have long come to the conclusion that the leads should be cited because a significantly large number of editors see non-cited text in the lead and simply remove it, or if you are lucky add citation need tag to text they dispute or query, assuming it is not cited. It also makes non-cited text more tempting for some editors to edit and change without referring to any reference because it is not immediately clear what reference refers to the lead text. The readers cannot quickly locate references to know how recent the sources are for the text in the lead. So yeah, I definitely favour citing the lead for verification purposes. It also makes it look professional and verified to our readers which we want as many people only read the leads and don’t trust Wikipedia text that is not cited. So the translation argument, that I only just learnt about during this ArbCom, only strengthens my preexisting POV that LEADS need to be cited. I do not think ArbCom should interfere with efforts to add citations to the lead.--Literaturegeek | T@1k? 19:35, 28 April 2020 (UTC)[reply]

Colin[edit]

Colin is a good editor, he is intelligent and for many years he edited the project peacefully and productively. I do not think that he should be site banned or blocked but rather some measure should be in place that compels him back to his productive behaviour, like a 12 month interaction ban to allow a cooling off of heads? Believe it or not I actually like Colin as an editor, and am grateful for his contributions, but I do not like the problematic behaviour from Colin, particularly that which occurred between 2 and 3 years ago. I can understand though how editing disputes can escalate and how stress levels can increase as I have myself have lost my cool during editing disputes. Indeed, due to the positive contributions of Colin, his net positive, I opposed, on ANI, a topic ban on Colin and instead supported a drug pricing RfC instead which I felt would be more positive; I also felt a follow up RfC to that RfC, by way of clarifying certain issues of dispute, would have been better than an ArbCom in the middle of a pandemic, but anyway.

Colin’s Battleground behaviour highlighted below was over the top and was never justified.

Colin has engaged in BATTLEGROUND behaviour. The evidence below of Colin not being civil to Doc James is more than two years old and I originally, as tryptofish noted, deleted it because ArbCom tends, usually, not to take action on evidence older than 18 months or so. So I previously deleted it after posting it but Tryptofish relinked to it suggesting it is still relevant, perhaps from a historical perspective or an interaction ban? The below evidence was all to do with the video dispute, which a community RfC resolved in favour of Colin’s position. I originally collected the below evidence over two years ago when insults were escalating dramatically, but at the time I felt uncomfortable posting it against a productive editor who has contributed much, as has Doc James, and then things calmed down and so I forgot about the file until I saw this ArbCom. So here are the diffs:

Colin insults Doc James as a deity in reference to people defending or agreeing with Doc James: perhaps Jytdog if you could stop worshiping the WP:MED deity for a moment

More WP:BATTLE attacks on Doc James: The WP:MED deity-bully is a problem for others to recognise and solve.

Colin appears to have OWNERSHIP issues due to a mistaken belief that because he largely wrote the first version of MEDMOS many years ago that his original intent trumps later viewpoints. This motivates him to say this about Doc James not following Colin’s original intention. “Doc James”, “modifying articles”, “destroying”, “vandalism“. However, to be fair, Sandy is correct to say that MEDMOS is a guideline (there should be on occasion some flexibility) and MEDMOS should not be treated as a policy.

Some more WP:BATTLE angry words from Colin: Secondly, if you make another comment like "How many instances of "patient" have you converted to "person" over the last two years?" I will take you to ANI to get you blocked.

Colin is not WP:CIVIL to his colleague: unlike Doc James, I shall use an edit summary when doing so

Colin engages in WP:HARASS with a Topic ban proposal for Doc James by Colin Colin seemed to be harassing Doc James with insulting hostile comments and trying to get him topic banned, but Colin, at that time, could not see his behaviour is actually a lot worse than Doc James’. In fact, Colin’s negative behaviour made me side with James on the video issue when I was sitting on the fence about the issue and not much motivated to get involved, partly because I respect both Colin and Doc James as Wikipedians in their work. In any event the topic ban was overwhelmingly rejected by the community.

More BATTLE conduct: Are Doc James and CFCF going to edit war on those too? If not, why not?

James, would you please, please, take this Citizendium nonsense to another project. More of Colin assuming bad faith, not civil, confrontational, etc.

More personalising disputes: Who's the bully asserting his authority with no consensus? James. Doc James’s interaction style is one of being calm so for Colin to behave so aggressively while calling Doc James a bully seemed hypocritical. It was also sad to see because I think Colin and Doc James were once on friendly terms many years ago.

James must show the material meets WP:V prior to reinsertion. He does not do that. He's a bully. I'm not asking you to give Ballena dictatorial control, and I don't think they are the sort of person to behave that way, unlike James.

better communication with the wider community is definitely one of the lessons you need to learn, and admit you need to learn. More belittling Doc James in front of his editing peers.

Colin insults an entire wiki med project

But there are real problems with his behaviour on his project, and frankly those problems are not helped by editors like you worshipping him........ James is so arrogant....... these videos are just a symptom of a deep illness affecting WP:MED, and James is at the core of it.......... This "making Wikipedia more shit" has been going on for years. James has good intentions for doing it.....

This then becomes a deliberate lie: you are now knowingly telling untruths to further your case. We've seen this about the lies that the videos were summaries of......... just about sums up the dreadful way that James edits Wikipedia and appears to encourage others to do likewise. Colin again personalising of disputes.

Wrt James "keeping his cool", well he has his worshippers who speak on his behalf, just as James speaks on behalf of Osmosis. Jtdog, CFCF...... guys like Tryptofish spend their time devoted to defending James Attacks Doc James and anyone who agrees with him, escalates disputes needlessly.

Personal attacks from Colin: Colin insults another medical editor

More personal attacking: Colin is hostile towards other medical editors if he perceives they made a mistake Perhaps this was due to the stressed state Colin was in due to the video dispute at the time.

It is very unfortunate to see so many senior WP MED editors being hostile to one another and I am reluctant to be joining the negativity and posting this evidence but I think it may well be for the good of the WP MED project for an interaction ban to be put in place, so, especially as tryptofish relinked to it, I am reposting it. Clearly this evidence is too old and stale to justify blocks or bans as such measures are for prevention not punishment, etc. However, it is clear the falling out between Doc James and Colin is a very long-term one, and I fear a permanent falling out and negative emotional energy is still being exchanged between the two. To bring about calm to this area an interaction ban might be beneficial. Maybe before ArbCom makes a decision a voluntary 12 month interaction ban could be enacted between them for both their sakes and to avoid the possibility of an official ArbCom ban. In the very long-term I would hope hostilities can fade and friendships can once again grow.--Literaturegeek | T@1k? 19:35, 28 April 2020 (UTC)[reply]

Evidence presented by CFCF[edit]

Summary and reflection[edit]

I deeply regret any incivility or rudeness on my part. With limited time to compile this testimony, I do not aim to be comprehensive. I have found this ArbCom filing very difficult as I have made considerable efforts to avoid engaging in the issue, yet have been unsuccessful. This is in part because of how widespread it has become, and in part my own failing to focus on what matters.

In direct response to disputes in early 2018 I took a longer break from Wikipedia, having been accused of conflict of interest for my engagement with Wikimedia Medicine, which has only ever been for the purpose of improving Wikipedia. These accusations were very distressing to me, and I reacted emotionally in a way I do not find befitting and am ashamed of. I felt overwhelmed by the size of the dispute and the amount of time some editors spent on it. I chose to recuse myself back then [370], striking my responses in the RfC.

Since then, I have experienced a tendency of discussions opened in the same very intense manner, with attempts by SandyGeorgia and Colin to restore policy changes since 2013. As I began editing in earnest in 2013 — it has been difficult to see dismissal of the considerable progress I have seen and felt I contributed to, such as in SandyGeorgia's WPMED History, where she presents a timeline and expresses WPMED is no longer focused on quality content.

I have found it difficult to work collaboratively with the aforementioned editors, repeatedly finding myself provoked for fear of losing decent content that, while not perfect, can be improved.
Regarding, for instance the loss of external collaborators, I summarized it in 2018 [371]:

  • No entity is likely to wade through a dispute like this without at least considering whether it's worth the effort. If all the videos they've spent years on, collaboratively drawing up together with very active editors on Wikipedia, and slowly rolling out into articles — can be deleted on a "whim", or the mere accusation of ulterior motives — I don't find it surprising they would want to cancel the project

I chose to avoid the latest RfC and have for at least 6 months attempted to avoid all interaction with SandyGeorgia and Colin outside the talk-page of WikiProject Medicine, where I found it necessary to present a counter-narrative to some of their most controversial views. I was very relieved that a December 7 decision at WP:ANI#Colin found that "The question of drug pricing is remitted to a single venue: Wikipedia talk:Manual of Style/Medicine-related articles § Product pricing". This community decision was violated on March 28. [372] This violation immediately precedes ArbCom filing.

A multidimensional philosophical dispute[edit]

To RexxS’s characterization of an experimentalist—conventionalist divide, I add the dimension of a generalist—specialist divide. One group of editors represents prolific WP:FA-editors, with an intense focus on improving one or a few articles at a time, the other group tends to edit many articles, improving little by little. My personal understanding is that both editing styles are acceptable.

I would also lift the comments by Evolution and Evolvability, that disputes may become heated, more-so than in other fields. My interpretation here is that this is due to the deeply personal nature of many medical topics, which have impacts on our lives and the lives of our loved ones. One below dispute in particular may have kindled animosity towards editors at WP:MED.

Endorsing other evidence[edit]

I endorse evidence presented by RexxS, Ian Furst, FeydHuxtable, Evolution and Evolvability, and Literaturegeek’s deleted evidence[373] (which if not restored, I hereby formally request be added to my evidence).

WP:NOTVOTE is misquoted[edit]

This is just one of many examples, but one that is especially illuminating of use of WP:NOTVOTE as a strategy.

On December 25th, SandyGeorgia complains that editors are not engaging RfC drafting, to which she responds to Tryptofish saying he will "sit back and see what others can do":

Who are "others" that we are waiting for to see what they can do? All of the "Me, too, per editor-so-and-so" !voters, who don't engage to develop consensus? Are you expecting someone new to show up here? It looks to me like we're looking at us, and if *we* don't come up with something, we end up at Arbcom. It should be well evidenced by now that I suck at formulating RFCs, so what are we thinking is going to happen next here? SandyGeorgia (Talk) 23:25, 25 December 2019 (UTC)

To me this represents a view that is fundamentally opposed to WP:RFC and WP:Consensus, and sheds lights on the tens or even hundreds of times in which WP:NOTVOTE is quoted by SandyGeorgia and Colin in order to reject endorsing votes. The problem with this view is that the consensus policy reads:

  • [It] is "not the vote" that matters, but the reasoning behind the !vote that is important.

I interpret this to mean that one can certainly endorse a reasoned opinion, as long as a rationale is presented. Asking editors to always present new or additional arguments discourages engagement through RfC, and leaves open as a strategy to use as many words as possible, i.e. WP:BLUDGEON. Else it allows the closing admin or editor to entirely reject the number of editors in favor of one view, essentially making the closing editor's view a WP:SUPERVOTE.

Timeline of conduct issues[edit]

There are issues besides these, however they are covered better by others.

2018[edit]

Prostate cancer

SandyGeorgia returns from a 4 year near-total hiatus in February 2018.[374].

  • Feb 15 2018 [375](Prostate-specific antigen), [376](Prostate cancer)
    Note edit summary: Wikipedia at its finest, add some balance, and remind that a family history of breast or ovarian cancer also should tip off your stupid doc to pay attention to screening
  • Feb 27: Issue raised at WT:MED [377]
    Note edit summary: Ashamed to be a Wikipedia medical editor
Pings 8 editors (WP:CANVAS), including Colin (uninvolved) to what is a content dispute over screening

Osmosis collaboration and VideoWiki

Colin returns in full from his own 4–5 year hiatus in March 2018.[379]

SG jumps into this issue with Colin and together devote a large amount of time, with discussion focusing on:

1) That the collaboration included donations from a for-profit entity, 2) A general opposition towards narrated video per Colin’s essay WP:NOTYOUTUBE, 3) Difficulty of editing videos, 4) A “hijacking” attempt from WP:MED with local “subverted consensus”, and issues first now being brought to the light of the broader community.

Doc James (DJ) responds regarding point 4 that the issue had been brought up 9 times between 2013–2017.(section 38.6)

During this dispute SandyGeorgia made repeated accusations of COI, adding tags to RfC responses by me and other members of WPMED.

(Total Osmosis-related discussions in 2018 WT:MED (288kb), User talk:Jimbo Wales (105,3kb), RfC iniatited by DJ (246kb), Topic Ban proposal for DJ (26kb) ,ANI#Colin(40kb)) Discussion ends with a termination of the collaboration on March 30 2018 and RfC judged moot on May 18 2018 Following this, DJ and Jytdog attempt to restart a Video Wiki project with a focus of allaying issues presented by SandyGeorgia and Colin, seeking consensus to introduce video in a way that is accepted by the community. (VideoWiki discussions: WT:MED, May 11 2019, 17 WT:MED, January 7 2019, WT:MED, February 27 2019, WT:MED, August 30 2019) Colin interprets his opposition to be fully endorsed in all aspects, dismissing video per WP:NOTYOUTUBE, calling the RfC an "oppose-fest".[389] (Multiple editors point of that the none of the discussions or closes fully endorse Colin’s concerns.)

The last of these discussions, where DJ posts enthusiastically that the Video effort is seeing media attention in Slate — Colin is quick to reply, and of a total of 19 posts by 8 editors in this discussion, Colin stands for 8. Of 28,6kb, Colin stands for 19,0kb ~2/3.

2020[edit]

Drug RfC
  • On December 7 in an AN/I-filing: #User:Colin, the community’s proposed and agreed upon action was that discussion be "remitted to a single venue”, with an RfC to take place there — explicitly to avoid bludgeoning and forumshopping. No mention of expiration of this ban after the RfC had taken place was made, or has to my knowledge been requested.
  • Colin opened discussion on March 28 at WT:MED.([390])

In this discussion Colin and SandyGeorgia bring forth that effort should be made to solve the issues. I profess that the current timing is poor due to the pandemic, and that the RfC was closed on multiple accounts as no consensus, which would require additional interpretation and work.

  • Responses:
SandyGeorgia:
Perhaps you will consider re-reading the RFC after a few days; let's not re-litigate it post-closing. The time to enter an opinion was during the RFC, not after. SandyGeorgia (Talk) 15:08, 29 March 2020 (UTC) [391]
Me:
[…]The RfC is extremely lengthy, and if one is expected to read the entire thing to interpret the closing and to implement it, it will not be done quickly.[…][392]
SandyGeorgia
It was the job of the admins to read the "extremely lengthy" RFC and their summary and conclusions are not long at all; it is quite consise, and not hard to understand. […] Thanks, SandyGeorgia (Talk) 17:01, 29 March 2020 (UTC) [393]

Other conduct issues[edit]

Incivility

Colin addresses the following remarks to me, where he makes fun of my age, alleges I do not understand English, and states that I am only acting as a part of DJ's fanclub:

  • Carl, I don't know if this phrase translates to Swedish. I was "editing medical articles" while you were still wearing short trousers. I created and helped write the book on editing medical articles. Every single time you have ever written "per MEDRS", you've been quoting me. I made that an official guideline, with help from the very people you've been attacking. That was a hard battle, and you have no idea how much abuse and conflict was endured to achieve it. Without me and them, that would still be merely an essay, or tagged as a failed proposal. The reason I gave up editing medical articles is entirely down to Doc James and attacks from his worshipers. And I'm far, far from alone in this. You might want to think about that, and think about what Wikipedia is. Please just read the first two paragraphs from Wikipedia:About and think about what it says. Have a great Easter. -- Colin°Talk 23:02, 30 March 2018 (UTC) [394]
  • CFCF hope you don't mind me not rebutting the many mistakes in your comment. Life is too short, and I'd rather discuss mistakes in all our drugs articles, and an egregious breach of WP:NOT by one editor with a fanbase. -- Colin°Talk 13:38, 4 December 2019 (UTC) [395]
Dismissing concerns and alternative views

SandyGeorgia is consistently dismissive of my contribution and the general contribution of WP:MED. (Small set of examples)

In Wikipedia_talk:WikiProject_Medicine/Archive_134#WPMED_History by SandyGeorgia
  • I express "a need to strongly distance myself from [the history … and that the] end-goal of WP:MED is certainly not the production of Featured Articles, but the production of an entire corpus of articles which are "decent"."
  • SandyGeorgia responds:
    I appreciate your confirmation that you and a small handful validate the history as I present it: WPMED is no longer focused on quality content. I would be so pleased if our GAs were not as full of holes as our neglected FAs are. SandyGeorgia (Talk) 15:57, 20 March 2020 (UTC)
Earlier in the same discussion
  • I point out that the lack of medical FAs is likely due to faults not only within WP:MED, and that the FAC-process is ill-suited for medical articles. [396]20:49, 7 March 2020 (UTC)
    SandyGeorgia:
    I am unware of any "lack of understanding of concessions" that need to be made for medical articles, and I suspect if something like that existed, I'd know about it. [397][…]I'm not aware of you ever having worked on articles at the FA level,[1] so it would be helpful if you refrain from discouraging others who might be willing. SandyGeorgia (Talk) 22:57, 7 March 2020 (UTC)[398]

After disengaging from one discussion for a few weeks, SandyGeorgia pings me, reflecting that I should be more civil.[399] She later apologizes,[400] to which accept and apologize for any potential rudeness on my part.[401] I do not engage in the issue more.

Response to other evidence[edit]

SandyGeorgia presents evidence against me.

2018
  • I admit I was overly defensive of the Osmosis project in 2018. I regret using poor wording, and was overly emotional in defending what I perceived as hundreds or thousands of hours of editor time at stake. (See section(s) above)
  • Regarding formal edits: moving the discussion was necessary as it was over 200kb and was lagging the rest of page; though I admit I did it improperly in the heat of the moment. SandyGeorgia similarly separated and split discussions here, and I have since split and archived parts of discussions without complaint (even ones where I have been involved).
2019
  • I should certainly not have called Colin "clueless" in December 2019. After the AN/I report in early December, where I voted — I regretted having engaged, and actively chose not to engage in the RfC, avoiding the issue until it was again brought to WTMED, from where it had been barred.
  • I find it telling of the nature of the dispute that my message at WP:ANI is presented as evidence here. #User:Colon/WPMED_Break_1
    I then, as now, remarked upon the insistence of diffs as an nonviable option for of representing issues of editing style, with no proper tool to track WP:BLUDGEONING. I believe the messages I wrote at ANI were certainly not appreciated, but they were also not necessarily WP:UNCIVIL. I was clear that they represented my view, and as may be evident in this filing, there is considerable evidence of Colin doing the things I then asserted he had done.[402]
2020
  • As for recent evidence, I believe it is not conclusive. SandyGeorgia accuses me of changing others' indentation, yet it is she who initially moves my post to a separate subheader. ([403] Edit summary: back on topic, [404] Edit summary: separate issue, subsequently editing it out of context.)
    I also made attempts to rectify the "non-neutral" header, as per her request.[405]

Evidence presented by Cas Liber[edit]

Subtler than many disputes[edit]

What strikes me about this is that most parties actually get on with each other for significant segments of time, and what needs to be looked at is subtler ways of influencing the consensus process such as filibustering, wikilawyering etc. This should take place in the workshop. Sorry - time is limited and I only realise I am obliquely/distantly involved in this.

Accessibilty vs accuracy[edit]

Doc James has an admirable view of getting the information out to as many people as possible worldwide in a format they can understand. However, we have differences at times in that I feel that accuracy is sacrificed - I saw this with the videos and at times with wording in some medical articles. I will try to add some before evidence phase closes (placeholder)

Evidence presented by {your user name}[edit]

{Write your assertion here}[edit]

Place argument and diffs which support the first assertion; for example, your first assertion might be "So-and-so makes personal attacks", which should be the title of this section. Here you would show specific edits where So-and-so made personal attacks.

{Write your assertion here}[edit]

Place argument and diffs which support the second assertion; for example, your second assertion might be "So-and-so makes personal attacks", which should be the title of this section. Here you would show specific edits where So-and-so made personal attacks.